Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3030366	p-kysc	mg/l (mg/l)	8601	42452	0.04%
3030366	s-kysc	mg/l (mg/l)	2122	4769	0.00%
3030366	p-kysc	— (—)	1244	2087	100.00%	Distribution not available
3030366	s-kysc	— (—)	475	850	100.00%	Distribution not available
3030366	kystatiinic(p-kysc)	mg/l (mg/l)	16	17	0.00%
3030366	kystatiinic(4507p-kysc)	mg/l (mg/l)	6	6	0.00%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Gout

960

2257

4.11

321.37

4.7

2.6

2.23

1.61

mg/l

54.25

883

2029

Genitourinary diseases

1842

3212

2.96

318.28

7.6

4.1

1.58

1.10

mg/l

97.30

1737

2989

Gout, FINNGEN

960

2546

4.00

317.29

4.7

2.5

2.23

1.64

mg/l

51.70

883

2286

Implicit viral Sepsis

723

1581

4.91

309.44

7.5

3.8

2.01

1.41

mg/l

37.87

683

1427

Chronic periapical parodontitis

776

1800

4.60

308.08

5.5

2.5

1.79

1.49

mg/l

12.64

743

1635

Viral Sepsis

723

1588

4.88

307.75

7.5

3.8

2.01

1.41

mg/l

38.10

683

1434

Implicit bacterial Sepsis

1233

3054

3.89

307.65

5.3

3.0

2.16

1.50

mg/l

76.22

1147

2726

L04AD Calcineurin inhibitors

1705

1061

26.14

307.65

12.5

5.0

1.90

1.27

mg/l

87.08

1680

996

IgA nephropathy (IgA glomerulonephritis)

326

213

23.99

307.65

6.1

2.8

1.88

1.52

mg/l

4.97

320

198

Other and unspecified anaemias

1283

3596

3.62

307.65

5.0

3.6

1.99

1.58

mg/l

36.08

1179

3245

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

889

1913

4.99

307.65

9.4

8.9

1.61

1.30

mg/l

18.56

866

1809

Bacterial infection, other or unspecified

1602

4394

3.44

307.65

6.1

3.2

1.96

1.46

mg/l

61.17

1492

3978

Other bacterial diseases

2866

7211

2.84

307.65

6.6

3.5

1.87

1.36

mg/l

118.76

2663

6635

Preparatory care for dialysis

681

345

35.51

307.65

6.6

3.8

2.35

1.53

mg/l

36.15

662

313

Anaemias

1100

974

8.05

307.65

7.7

3.4

1.74

1.05

mg/l

89.89

1042

929

Hypertensive diseases

2473

4174

3.48

307.65

6.4

3.1

1.70

1.17

mg/l

142.53

2340

3886

Glomerular diseases

1875

1606

15.10

307.65

7.9

4.2

2.06

1.41

mg/l

93.99

1794

1475

Fever of other and unknown origin

1797

5027

3.45

307.65

7.2

3.2

1.72

1.43

mg/l

26.64

1698

4595

Unspecified kidney failure

596

522

13.30

307.65

6.3

2.3

2.31

1.28

mg/l

79.49

556

461

GASTRO-related operations

2299

3717

3.19

307.65

6.6

2.5

1.45

1.27

mg/l

18.73

2192

3386

Hypertensive diseases (excluding secondary)

1937

2692

4.38

307.65

7.1

3.2

1.67

1.07

mg/l

143.71

1847

2536

Diabetic nephropathy

971

1531

7.33

307.65

5.5

2.8

2.34

1.66

mg/l

59.98

920

1367

Disorders resulting from impaired renal tubular function

488

332

23.53

307.65

10.8

5.1

2.30

1.53

mg/l

26.36

470

309

Extracorporeal dialysis

894

550

26.76

307.65

9.6

4.8

2.50

1.44

mg/l

83.10

866

506

Acute tubulo-interstitial nephritis

1563

4116

3.48

307.65

6.7

3.3

1.89

1.19

mg/l

136.25

1461

3753

Explicit Sepsis

1468

3806

3.90

307.65

8.8

3.7

2.01

1.42

mg/l

71.72

1384

3457

Glomerular disorders in diseases classified elsewhere

1333

927

19.79

307.65

6.3

3.1

2.15

1.48

mg/l

61.45

1270

842

Cardiovascular diseases

1817

3327

3.06

307.65

8.0

4.6

1.44

1.06

mg/l

73.16

1739

3153

Renal failure

3673

2770

14.54

307.65

6.5

3.0

2.18

1.27

mg/l

307.65

3426

2481

Persons encountering health services for specific procedures and health care

3412

7291

3.00

307.65

6.1

3.7

1.76

1.31

mg/l

122.62

3217

6703

Secondary hypertension

1039

519

27.72

307.65

8.8

4.3

2.05

1.11

mg/l

123.79

990

489

ILD medications: immunosuppressive drugs

2711

5815

4.76

307.65

9.4

2.8

1.73

1.34

mg/l

85.59

2601

5339

Cardiovascular diseases (excluding rheumatic etc)

2027

3620

3.34

307.65

7.7

4.4

1.51

1.06

mg/l

102.40

1936

3433

Other anaemias

1292

3634

3.60

307.65

5.0

3.6

1.99

1.58

mg/l

36.34

1188

3278

Metabolic disorders

2664

6520

2.61

307.65

4.7

3.8

1.73

1.40

mg/l

54.16

2465

6025

Heart failure, not strict

2860

4670

4.47

307.65

5.5

3.2

2.06

1.28

mg/l

268.09

2674

4260

Nephropathy related operations

1805

1124

24.99

307.65

10.2

4.5

2.26

1.33

mg/l

163.46

1758

1040

Acute renal failure

1102

1287

9.67

307.65

5.5

2.5

2.31

1.26

mg/l

162.55

1032

1159

Heart failure and antihypertensive medication

836

1052

5.54

307.65

5.1

2.7

2.20

1.14

mg/l

121.38

781

967

Nephrotic syndrome

384

339

16.45

307.65

15.1

9.7

1.95

1.23

mg/l

25.19

374

318

Bacterial Sepsis

1394

3563

3.65

307.65

5.5

3.2

2.12

1.47

mg/l

84.23

1295

3211

Other disorders of kidney and ureter

737

1118

7.55

307.65

9.0

3.7

2.13

1.55

mg/l

34.62

703

1018

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

3311

7320

3.38

307.65

5.7

3.8

1.76

1.38

mg/l

79.75

3079

6739

Condition for Implicit Sepsis (Organ dysfunction codes)

2373

6430

2.77

307.65

5.0

3.3

1.90

1.35

mg/l

120.87

2213

5882

Dialysis

728

330

42.34

307.65

13.1

8.2

2.15

1.10

mg/l

114.05

719

314

Kidney transplant status

1246

535

63.95

307.65

12.1

6.9

2.02

1.23

mg/l

84.50

1228

500

Malignant neoplasm of head and neck, excluding all cancers (controls excluding all cancers)

511

745

7.70

307.65

3.1

2.7

1.19

1.69

mg/l

31.52

499

666

ILD medications: prednisolone, methylprednisolone, prednisone

3398

6655

2.98

307.65

7.1

2.6

1.69

1.37

mg/l

67.21

3178

6095

Azathioprine

742

1452

5.60

307.65

12.0

4.5

1.68

1.35

mg/l

17.63

707

1356

Other disorders involving the immune mechanism, not elsewhere classified

387

330

17.26

307.65

10.6

7.1

1.81

1.44

mg/l

7.07

376

311

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

3269

6689

3.46

307.65

7.8

3.0

1.74

1.34

mg/l

99.73

3076

6158

Other dialysis

538

321

33.16

307.65

12.4

7.0

2.22

1.43

mg/l

33.36

530

301

Any gastric operation

2299

3717

3.19

307.65

6.6

2.5

1.45

1.27

mg/l

18.73

2192

3386

Glomerulonephritis

912

957

12.00

307.65

9.8

5.3

1.89

1.45

mg/l

24.94

878

881

Chronic kidney disease

3236

1894

22.20

307.65

6.9

3.4

2.22

1.28

mg/l

307.65

3028

1694

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

375

311

18.16

307.65

10.9

7.3

1.81

1.44

mg/l

6.94

365

294

Aplastic and other anaemias

1486

3899

3.81

307.65

5.5

3.6

2.02

1.57

mg/l

46.54

1367

3521

L04AA Selective immunosuppressants

1719

1959

10.47

307.65

10.3

3.5

1.89

1.35

mg/l

84.19

1673

1818

Care involving dialysis

1331

646

35.64

307.65

9.8

5.1

2.41

1.32

mg/l

143.63

1298

597

Chronic nephritic syndrome

460

308

21.14

307.65

7.0

3.0

1.98

1.50

mg/l

11.56

443

281

ILD medications

3565

6828

2.96

307.65

7.4

2.8

1.64

1.36

mg/l

58.28

3346

6262

Antihypertensive medication - note that there are other indications

1787

3016

3.34

307.65

8.3

4.0

1.45

1.05

mg/l

81.71

1716

2839

ILD medications: azathioprine

742

1282

6.36

307.65

12.0

3.3

1.68

1.26

mg/l

27.17

707

1190

Hypertension, essential

2142

3871

3.26

307.65

4.0

2.2

1.72

1.19

mg/l

122.90

1993

3593

Congenital malformations of the urinary system

575

656

11.39

307.65

10.0

10.3

1.85

1.30

mg/l

28.19

563

620

Septicaemia

1435

3679

3.96

307.65

9.0

3.9

2.02

1.46

mg/l

64.27

1352

3342

Cystic kidney disease

439

304

22.33

307.65

9.1

6.2

1.94

1.39

mg/l

16.93

430

286

Deposits [accretions] on teeth

666

782

10.36

307.65

20.9

4.6

1.52

1.26

mg/l

8.78

655

737

Dental caries

1495

2509

6.55

307.65

11.2

3.0

1.70

1.39

mg/l

25.23

1466

2312

Heart failure,strict

1400

3046

3.45

307.65

4.3

2.7

2.24

1.34

mg/l

152.37

1269

2751

Chronic periodontitis

753

1204

6.96

307.65

5.2

2.4

1.88

1.55

mg/l

12.99

735

1084

Transplanted organ and tissue status

1752

894

35.04

307.65

12.3

4.7

1.92

1.25

mg/l

98.10

1726

839

Hypertension

2473

4164

3.48

307.65

6.4

3.0

1.70

1.17

mg/l

142.10

2339

3877

Dialysis, with operation codes

1828

926

30.15

307.65

9.7

4.5

2.27

1.15

mg/l

261.09

1781

863

Implicit Sepsis

2146

5708

3.03

307.65

5.2

3.3

1.96

1.39

mg/l

110.30

2000

5194

First line medication for Crohn's disease

3390

6654

2.86

307.65

7.3

2.9

1.60

1.37

mg/l

39.42

3179

6119

Renal tubulo-interstitial diseases

4255

5465

6.44

307.65

5.9

3.3

2.01

1.17

mg/l

307.65

3951

5009

Diabetic nephropathy, excluding more controls

964

1049

9.03

307.65

5.5

2.7

2.35

1.52

mg/l

80.50

913

955

Dentinal caries

1246

2200

6.22

307.65

8.9

3.0

1.75

1.40

mg/l

26.78

1221

2026

Other septicaemia

1326

3277

4.21

307.65

9.0

3.8

2.04

1.47

mg/l

60.86

1255

2967

Insulin medication

1758

5706

2.73

304.35

4.6

4.2

2.03

1.41

mg/l

111.20

1597

5288

Direct fill therapy

694

1508

5.10

302.48

11.7

6.5

1.70

1.34

mg/l

17.65

685

1423

Hypertensive Renal Disease

262

179

17.74

302.27

5.6

2.2

2.41

1.39

mg/l

27.54

245

157

Other disorders of fluid, electrolyte and acid-base balance

920

2356

3.96

299.52

5.5

3.3

1.94

1.54

mg/l

24.84

841

2120

Autoimmune diseases excluding thyroid diseases

2754

6868

2.28

295.59

4.4

1.64

1.40

mg/l

34.25

2574

6346

Type 2 diabetes, wide definition

2027

5272

2.58

295.31

3.9

2.7

1.92

1.44

mg/l

83.55

1843

4849

Autoimmune diseases excluding thyroid diseases, strict definition

2692

6702

2.29

293.06

4.4

1.64

1.40

mg/l

33.98

2517

6195

Insulin, combination of fast acting with intermediate-acting or long-acting

1759

6374

2.63

288.67

4.6

4.0

2.03

1.45

mg/l

98.88

1598

5871

Other heart diseases

1362

2947

3.15

285.86

5.8

4.4

1.67

1.06

mg/l

91.53

1277

2786

Insulin, intermediate and long-acting

1591

5927

2.73

284.03

4.3

4.0

2.03

1.45

mg/l

90.47

1442

5457

Insulin, fast-acting

1208

3986

3.18

282.21

5.0

4.8

2.05

1.39

mg/l

85.00

1099

3687

Any reimbursement code in KELA

1480

2453

3.09

276.83

6.5

2.3

1.43

1.07

mg/l

51.92

1406

2291

Insulin, fast-acting or short human

1214

4185

3.03

262.41

5.0

4.8

2.05

1.43

mg/l

77.09

1105

3868

Malignant neoplasm of head and neck

419

656

7.22

261.14

3.0

2.7

1.20

1.70

mg/l

27.25

408

588

2235

6159

2.33

260.74

5.0

3.3

1.75

1.41

mg/l

49.07

2071

5668

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

2235

6159

2.33

260.74

5.0

3.3

1.75

1.41

mg/l

49.07

2071

5668

Diseases of pulp and periapical tissues

1051

3367

3.25

257.73

5.4

2.7

1.74

1.46

mg/l

16.49

997

3070

Inflammatory bowel disease treatment related agents

2872

7905

2.11

257.69

6.1

3.5

1.59

1.44

mg/l

15.17

2640

7326

Certain infectious and parasitic diseases

2447

5536

2.26

251.25

5.6

2.9

1.60

1.31

mg/l

42.27

2280

5098

Influenza and pneumonia

2633

8314

2.13

251.03

5.6

4.0

1.70

1.38

mg/l

55.02

2451

7706

Heart failure, strict

1467

3950

2.77

250.32

4.2

3.1

2.24

1.53

mg/l

106.13

1327

3570

Autoimmune diseases

2818

6926

2.12

249.72

4.3

4.4

1.59

1.39

mg/l

22.77

2624

6403

Gout, idiopatic and unspecified

794

2192

3.85

248.09

4.6

2.6

2.28

1.63

mg/l

49.97

738

1948

General symptoms and signs

2705

6435

2.15

246.61

4.8

3.1

1.56

1.39

mg/l

16.35

2534

5909

Anaemia in chronic diseases classified elsewhere

230

185

16.76

245.44

8.0

4.6

2.45

1.61

mg/l

15.38

206

169

Hypertensive heart and/or renal disease

698

1290

4.38

244.68

4.8

2.3

2.28

1.34

mg/l

76.13

628

1173

All-cause Heart Failure

1429

3876

2.75

241.03

4.2

3.1

2.24

1.53

mg/l

103.63

1294

3501

Endocrine, nutritional and metabolic diseases

2083

4557

2.37

240.33

5.5

4.5

1.53

1.21

mg/l

51.28

1956

4271

Gout, unspecified

679

1728

4.20

238.70

4.7

2.6

2.28

1.62

mg/l

43.93

634

1535

Chronic periodontitis, complicated

443

818

6.04

232.99

5.1

2.8

1.92

1.57

mg/l

8.17

433

756

Disorders of other endocrine glands

1269

4685

2.77

232.46

7.1

5.1

1.74

1.40

mg/l

24.24

1192

4334

Diseases of arteries, arterioles and capillaries (FINNGEN)

700

1184

4.31

232.04

4.7

2.2

2.02

1.13

mg/l

81.28

661

1104

Diseases of liver

1013

3393

3.12

230.79

4.8

3.2

1.69

1.54

mg/l

6.20

948

3091

Gout, strict definition

620

1519

4.38

229.94

4.7

2.6

2.36

1.65

mg/l

45.80

576

1344

Pneumonias (Asthma/COPD co-morbidities)

2463

8314

2.10

228.93

5.3

4.1

1.75

1.38

mg/l

63.40

2283

7702

Type 1 diabetes

895

2801

3.35

228.54

5.4

5.9

1.99

1.28

mg/l

74.08

840

2639

Infections, IBD-co-morbidities

578

895

4.95

227.82

7.2

3.7

1.96

1.23

mg/l

46.10

547

834

Used for control exclusion in common control thyroid runs

2629

6516

2.08

223.21

4.5

1.57

1.39

mg/l

19.58

2451

6036

Diarrhoea and gastroenteritis of presumed infectious origin

1818

7383

2.29

222.89

7.6

3.8

1.67

1.41

mg/l

25.47

1715

6832

All pneumoniae

2466

8422

2.06

219.71

5.3

4.2

1.75

1.39

mg/l

61.56

2287

7809

Acute peritonitis

346

536

7.35

218.37

9.5

3.9

2.18

1.57

mg/l

17.55

334

482

Pneumonia, organism unspecified

2226

7727

2.13

217.57

5.3

4.1

1.77

1.39

mg/l

59.02

2059

7148

Certain disorders involving the immune mechanism

690

1901

3.87

216.67

8.1

4.5

1.74

1.46

mg/l

10.76

655

1768

Presence of other functional implants

1288

3442

2.72

214.49

3.7

2.4

1.82

1.53

mg/l

22.06

1125

3087

Intestinal infectious diseases

2270

8725

2.07

208.66

6.7

3.6

1.68

1.43

mg/l

28.20

2126

8046

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

2133

5975

2.16

205.07

6.2

3.7

1.39

1.51

mg/l

8.11

2023

5484

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

2128

5973

2.15

203.51

6.2

3.7

1.39

1.51

mg/l

7.97

2019

5483

Malignant neoplasm, wide definition for exclusion

2128

5975

2.15

203.36

6.2

3.7

1.39

1.51

mg/l

7.96

2019

5485

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

2367

8389

2.02

200.95

5.4

4.2

1.76

1.39

mg/l

57.70

2190

7778

Diabetes mellitus

2396

7143

2.04

200.79

4.0

1.77

1.34

mg/l

84.83

2201

6634

Diabetes, varying definitions

2387

7132

2.04

199.59

4.0

3.9

1.77

1.34

mg/l

84.37

2196

6619

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

2260

6802

2.07

197.75

4.0

3.9

1.83

1.35

mg/l

96.03

2059

6309

Persons encountering health services in other circumstances, wide

2853

7824

1.92

196.50

5.1

3.9

1.64

1.42

mg/l

28.16

2652

7209

Fibrosis and cirrhosis of liver

349

608

6.43

195.48

5.4

3.4

1.79

1.57

mg/l

3.93

331

555

Other diseases of hard tissues of teeth

1590

5246

2.31

191.38

10.2

2.8

1.49

1.41

mg/l

2.99

1511

4806

Isolated proteinuria

226

253

11.10

191.00

5.6

3.8

1.77

1.50

mg/l

2.96

217

233

Failure and rejection of transplanted organs and tissues

162

113

21.51

189.75

13.1

6.3

2.32

1.33

mg/l

13.69

157

104

Type 2 diabetes

2171

6354

2.07

188.33

3.6

2.8

1.79

1.38

mg/l

68.54

1987

5866

Tramadol

1798

5359

2.20

186.30

3.8

2.7

1.72

1.46

mg/l

26.20

1652

4926

Diabetes, insulin treatment (Kela reimbursement)

2341

7307

2.00

186.26

4.0

3.9

1.84

1.38

mg/l

91.51

2130

6780

Malignant cancer of tonsil and base of tongue, excluding all cancers (controls excluding all cancers)

187

167

14.14

185.41

3.5

2.5

1.13

1.56

mg/l

7.48

187

148

Malignant neoplasm

2086

6053

2.09

184.97

6.2

3.7

1.40

1.53

mg/l

9.31

1966

5552

Disorders of parathyroid gland

597

1630

3.80

184.86

5.5

3.0

2.10

1.58

mg/l

22.27

567

1460

Type 1 diabetes, wide definition, subgroup 1

726

2283

3.34

184.30

5.2

6.0

2.02

1.25

mg/l

69.72

678

2158

Polyarthropathies

1752

5424

2.20

182.82

4.2

3.9

1.90

1.42

mg/l

67.57

1598

5021

Hyperkalaemia

252

334

8.45

182.40

5.4

3.1

2.31

1.64

mg/l

14.39

233

297

Primary_lymphoid and hematopoietic malignant neoplasms

668

2016

3.47

181.20

8.1

3.9

1.51

1.66

mg/l

4.00

624

1805

Disorders of lipoprotein metabolism and other lipidaemias

1807

5361

2.16

178.34

3.8

3.0

1.76

1.47

mg/l

31.03

1651

4913

Diabetic retinopathy, excluding more controls

782

1341

3.46

176.81

5.0

2.8

2.10

1.50

mg/l

42.44

717

1224

Other diseases of blood and blood-forming organs, wide

675

2100

3.38

174.97

6.4

4.2

1.50

1.52

mg/l

0.26

629

1934

Abnormal findings on examination of urine, without diagnosis

261

384

7.89

173.66

5.6

4.7

1.75

1.56

mg/l

2.08

247

353

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

994

2284

2.82

172.68

4.9

2.6

1.66

1.09

mg/l

64.53

933

2143

Type 1 diabetes, wide definition

743

2462

3.16

172.41

5.4

6.1

2.02

1.27

mg/l

67.37

694

2328

Oral corticosteroids

2360

7500

1.94

172.08

3.7

3.2

1.63

1.46

mg/l

14.30

2147

6931

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

508

1338

4.07

170.77

5.6

3.3

1.82

1.61

mg/l

5.25

481

1226

Hyperparathyroidism

527

1398

3.92

170.55

5.7

2.9

2.16

1.59

mg/l

22.16

501

1247

Malignant neoplasm of oral cavity, excluding all cancers (controls excluding all cancers)

235

318

8.43

167.72

2.6

2.5

1.18

1.59

mg/l

11.65

230

282

Diseases of peritoneum

390

853

4.94

167.68

8.6

3.7

2.10

1.55

mg/l

18.42

374

779

Sub-endpoint used in defining T1D endpoints

914

3375

2.77

167.61

5.3

5.4

2.01

1.40

mg/l

57.54

857

3134

Chronic tubulo-interstitial nephritis

189

194

10.97

167.26

5.9

2.2

2.10

1.19

mg/l

22.24

178

183

Congenital malformations, deformations and chromosomal abnormalities

1453

6432

2.22

166.05

6.7

4.2

1.57

1.38

mg/l

13.96

1385

5985

Insulin, fast-acting (human)

500

1329

3.97

164.93

5.5

3.5

2.00

1.30

mg/l

44.53

471

1240

Oesophageal varices

243

353

8.06

163.92

6.9

5.2

1.80

1.58

mg/l

2.74

233

319

Gingival hyperplasia

231

319

8.69

163.81

21.8

4.3

1.74

1.36

mg/l

5.86

223

295

Neoplasms

1903

5003

2.08

162.92

7.5

4.1

1.38

1.39

mg/l

0.06

1822

4622

Care involving use of rehabilitation procedures

1400

6095

2.23

162.52

5.6

3.8

1.61

1.34

mg/l

25.12

1302

5584

Other disorders of teeth and supporting structures

599

1810

3.46

162.17

4.6

2.5

1.73

1.50

mg/l

6.06

561

1636

Hyperlipidaemia, other/unspecified

907

3254

2.72

161.31

4.1

2.7

1.90

1.57

mg/l

19.02

822

2937

Hydronephrosis

332

652

5.40

161.01

5.5

3.1

1.90

1.21

mg/l

27.43

308

597

Diabetes medication

2288

7431

1.90

158.74

3.9

1.79

1.37

mg/l

79.59

2086

6910

Other heart diseases, wide

2125

6889

1.95

158.43

5.1

4.4

1.66

1.31

mg/l

52.51

1970

6442

Nausea and vomiting

773

2694

2.93

158.27

9.2

5.2

1.68

1.43

mg/l

9.89

721

2486

Other disorders of gingiva or/and edentulous alveolar ridge

267

442

6.84

157.96

19.7

3.9

1.68

1.37

mg/l

5.46

256

404

Glucagon-like peptide-1 (GLP-1) analogues

1242

4495

2.33

155.43

3.6

2.8

2.05

1.56

mg/l

50.63

1100

4097

Persons encountering health services for other counselling and medical advice, not elsewhere classified

2482

7788

1.85

154.70

5.8

3.9

1.65

1.42

mg/l

27.32

2324

7177

Second line medication for Crohn's disease

1356

6353

2.19

151.05

9.2

3.7

1.53

1.46

mg/l

2.78

1273

5869

Hernia of abdominal wall, postoperative

429

1086

4.11

150.59

6.4

2.3

1.84

1.40

mg/l

16.93

395

964

Any event in cancer register

2035

6311

1.95

149.87

5.7

3.6

1.41

1.51

mg/l

6.66

1918

5801

Cirrhosis of liver, NAS

246

396

7.06

149.79

5.6

3.5

1.84

1.63

mg/l

2.66

233

358

Statin medication

1577

4200

2.15

148.61

4.9

2.8

1.64

1.30

mg/l

41.45

1486

3898

Other medical care

878

3352

2.63

147.40

3.5

3.1

1.66

1.44

mg/l

9.16

821

3018

Diabetic retinopathy, strict definition

619

1766

3.29

146.11

5.3

3.2

2.15

1.72

mg/l

20.17

569

1611

Disorders of tooth development and eruption

307

604

5.56

145.42

30.6

4.8

1.26

1.14

mg/l

2.83

297

578

Persons with potential health hazards related to communicable diseases

1013

4246

2.44

144.69

8.4

5.5

1.45

1.32

mg/l

4.86

965

4017

L04AX Other immunosuppressants

1313

6182

2.18

144.45

9.3

3.7

1.54

1.46

mg/l

3.27

1231

5706

Ulcer of lower limb, not elsewhere classified

430

1133

4.03

144.02

4.8

2.7

2.37

1.62

mg/l

30.29

396

1018

Atrial fibrillation and flutter

709

1548

3.07

143.28

3.5

2.2

1.83

1.12

mg/l

64.53

659

1444

Hypothyroidism (congenital or acquired)

589

985

3.51

141.04

4.7

2.9

1.40

1.05

mg/l

21.22

547

935

Other retinal disorders

1370

5230

2.15

140.98

4.6

3.1

1.94

1.57

mg/l

33.12

1230

4763

Primary_lymphoid and hematopoietic malignant neoplasms

668

2344

2.98

140.37

8.1

4.0

1.51

1.61

mg/l

2.26

624

2112

Diseases of arteries, arterioles and capillaries

1432

5156

2.12

139.40

4.2

2.9

2.02

1.57

mg/l

46.54

1323

4657

Coagulation defects, purpura and other haemorrhagic conditions

566

1824

3.26

138.36

6.3

5.1

1.60

1.48

mg/l

2.11

536

1689

Opioids

2113

5969

1.89

138.27

3.5

2.9

1.57

1.42

mg/l

10.08

1962

5503

Other disorders of skin and subcutaneous tissue

1460

6618

2.06

138.23

4.9

3.4

1.88

1.51

mg/l

35.11

1346

6039

Disorders of lens

1477

4520

2.10

136.28

5.2

3.0

1.92

1.50

mg/l

42.70

1338

4166

Hypothyroidism and >3 levothyroxin purchases

574

977

3.46

134.28

4.5

2.8

1.39

1.05

mg/l

20.21

533

927

Hypothyroidism, levothyroxine purchases

574

977

3.46

134.28

4.5

2.8

1.39

1.05

mg/l

20.21

533

927

Heart failure and bmi 25plus

829

2193

2.69

133.61

3.7

2.7

2.32

1.57

mg/l

62.83

742

1970

Disorders of choroid and retina

1701

6455

1.96

132.78

4.3

3.1

1.88

1.54

mg/l

37.07

1531

5905

Symptoms and signs involving the urinary system

1665

6696

1.96

132.26

4.8

3.7

1.74

1.52

mg/l

16.17

1521

6136

COPD/asthma/ILD related infections

2223

6168

1.83

131.17

4.5

3.3

1.57

1.41

mg/l

14.72

2062

5676

COPD/asthma related infections

2223

6168

1.83

131.17

4.5

3.3

1.57

1.41

mg/l

14.72

2062

5676

Disorders of mineral metabolism

296

634

5.04

130.62

5.2

4.3

1.86

1.43

mg/l

9.18

274

584

Iron deficiency anaemia

935

3962

2.40

129.69

5.2

3.9

1.94

1.53

mg/l

25.85

857

3608

Isolated proteinuria with specified morphological lesion

116

18.25

128.52

5.6

2.1

1.92

1.47

mg/l

2.83

110

Malaise and fatigue

1038

3825

2.31

128.39

4.2

3.2

1.77

1.48

mg/l

16.99

937

3468

Malignant neoplasm of oropharynx, excluding all cancers (controls excluding all cancers)

143

147

11.90

128.34

3.6

2.4

1.11

1.61

mg/l

8.22

143

128

Nutritional anaemias

1050

4615

2.27

127.48

4.9

3.8

1.92

1.54

mg/l

25.96

964

4184

Oxycodone

792

3061

2.57

126.99

3.4

2.7

1.69

1.59

mg/l

2.00

730

2769

Complications of surgical and medical care, not elsewhere classified

2033

8154

1.82

126.64

4.9

3.3

1.77

1.47

mg/l

33.58

1884

7482

Erysipelas

1139

4854

2.19

125.53

3.9

2.7

2.05

1.46

mg/l

57.60

1029

4411

Cholangitis (primary sclerosing, PSC)

265

538

5.42

125.27

7.7

5.5

1.56

1.45

mg/l

1.20

257

497

Human immunodeficiency virus [HIV] disease

160

199

10.07

124.90

2.9

3.2

1.18

1.37

mg/l

2.79

152

188

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

207

337

6.93

124.49

6.3

2.8

2.01

1.27

mg/l

21.90

200

327

Autoimmune diseases related-to ILD

1814

8766

1.85

124.46

3.9

3.7

1.52

1.49

mg/l

0.77

1665

8093

Hepatic failure, not elsewhere classified

194

297

7.50

124.28

5.6

3.2

1.79

1.57

mg/l

2.24

185

272

Oedema, not elsewhere classified

697

2652

2.69

123.06

4.4

2.9

1.90

1.51

mg/l

19.09

641

2378

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

269

562

5.15

122.18

3.8

3.0

1.87

1.71

mg/l

1.65

244

492

Unspecified haematuria

963

3632

2.33

121.63

5.0

3.3

1.78

1.60

mg/l

5.97

885

3295

Bleeding

1771

7006

1.87

121.44

5.5

3.8

1.86

1.48

mg/l

44.21

1648

6401

Human immunodeficiency virus [HIV] disease resulting in other conditions

148

177

10.55

119.34

3.1

3.3

1.17

1.37

mg/l

2.89

141

167

Other and unspecified iron deficiency

746

3003

2.56

118.77

5.0

4.1

1.93

1.51

mg/l

23.04

681

2735

Persons encountering health services in other circumstances

893

3892

2.35

118.70

4.0

4.2

1.62

1.40

mg/l

10.46

822

3583

Covid-19 confirmed case

722

2872

2.60

118.24

6.7

3.9

1.81

1.48

mg/l

15.00

675

2634

Cerebrovascular diseases (FINNGEN)

645

1664

2.84

117.42

4.7

2.5

1.71

1.11

mg/l

45.58

600

1554

Gastrointestinal diseases

1354

3289

2.09

117.23

7.4

2.8

1.42

1.28

mg/l

6.77

1279

3048

Malignant neoplasm of tonsil, excluding all cancers (controls excluding all cancers)

125

122

12.76

116.65

3.6

2.5

1.12

1.59

mg/l

6.70

125

108

Purpura and other haemorrhagic conditions

418

1256

3.52

115.07

6.4

5.3

1.60

1.48

mg/l

1.67

395

1158

Unspecified nephritic syndrome

143

172

9.86

113.52

6.8

2.5

1.87

1.52

mg/l

2.79

136

156

Other viral diseases

801

3400

2.43

113.19

10.7

5.7

1.59

1.32

mg/l

13.94

767

3213

Non-ischemic cardiomyopathy

675

2134

2.68

112.92

4.6

3.2

2.10

1.49

mg/l

41.06

604

1921

Hypo-osmolality and hyponatraemia

415

1247

3.46

112.81

5.1

3.3

1.84

1.55

mg/l

7.52

377

1131

Vitreous haemorrhage

327

851

4.10

111.84

5.2

3.0

2.12

1.57

mg/l

15.26

307

772

Ascites

255

550

5.00

111.65

5.9

3.0

1.99

1.57

mg/l

8.80

244

498

Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

185

301

6.78

110.76

3.9

2.5

1.88

1.68

mg/l

1.63

170

261

Depression medications

614

1054

2.98

109.60

3.7

2.6

1.35

1.04

mg/l

16.59

583

999

Other disorders of urethra and urinary system

1374

5338

1.96

109.42

4.8

3.6

1.69

1.48

mg/l

12.69

1266

4875

Osteopathies and chondropathies

1167

5515

2.05

109.30

5.0

3.7

1.71

1.50

mg/l

11.08

1076

5054

Bronchitis

2183

8497

1.71

108.44

5.1

3.3

1.61

1.47

mg/l

9.03

2028

7818

Diabetic retinopathy

903

2516

2.36

106.89

4.8

3.3

2.10

1.77

mg/l

17.02

824

2285

Diseases of oral cavity, salivary glands and jaws

1941

5651

1.79

106.74

7.1

2.8

1.53

1.44

mg/l

3.96

1821

5159

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

820

3135

2.35

106.72

3.5

3.0

1.40

1.67

mg/l

17.20

774

2791

Hypertensive Heart Disease

448

1171

3.22

104.58

4.4

2.3

2.23

1.36

mg/l

42.09

393

1062

Volume depletion

279

679

4.35

104.24

6.0

5.0

2.07

1.52

mg/l

12.05

265

607

Other cataract

901

3156

2.26

104.23

5.8

2.9

1.90

1.54

mg/l

23.65

829

2883

Viral infections characterized by skin and mucous membrane lesions

992

4776

2.13

103.19

8.6

4.5

1.67

1.43

mg/l

13.07

937

4427

Atrial fibrillation and flutter with reimbursement

533

1176

2.98

102.23

3.1

2.2

1.83

1.14

mg/l

49.17

492

1092

Provisional assignment of new diseases of uncertain etiology

998

4845

2.11

101.46

6.5

4.0

1.67

1.44

mg/l

11.83

925

4468

Missing teeth due to accident, extraction or parodontitis

326

905

3.79

101.14

4.6

2.5

1.67

1.54

mg/l

1.33

313

816

Codes for special purposes

998

4851

2.10

101.13

6.5

4.0

1.67

1.44

mg/l

11.82

925

4473

Peripheral artery disease

902

3372

2.20

98.77

4.1

2.6

2.21

1.66

mg/l

42.88

825

2999

Acute upper respiratory infections of multiple and unspecified sites

1565

6576

1.81

97.62

6.2

3.5

1.54

1.45

mg/l

3.48

1470

6064

Diseases of the skin and subcutaneous tissue

2181

6573

1.68

97.41

4.6

3.8

1.57

1.41

mg/l

14.52

2020

6081

Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers)

371

1149

3.38

96.90

3.9

3.1

1.34

1.65

mg/l

11.41

356

1018

Infections of the skin and subcutaneous tissue

1295

6987

1.88

95.39

6.6

4.3

1.70

1.42

mg/l

19.91

1223

6485

Factors influencing health status and contact with health services

720

1459

2.52

94.62

4.3

2.1

1.55

1.31

mg/l

9.41

671

1345

Other diseases of liver

451

1587

2.96

94.39

4.4

3.3

1.72

1.49

mg/l

4.85

415

1457

Type 2 diabetes, definitions combined

1755

6047

1.75

94.37

3.2

2.7

1.72

1.39

mg/l

40.39

1593

5572

Disorders of gallbladder, biliary tract and pancreas

1932

7422

1.70

94.26

4.6

3.2

1.69

1.51

mg/l

14.70

1790

6794

Valvular heart disease excluding rheumatic fever

976

3458

2.11

93.59

4.9

4.4

1.86

1.40

mg/l

33.45

885

3175

Disorders of calcium metabolism

209

443

5.08

93.46

5.5

4.2

2.05

1.45

mg/l

11.35

191

409

Adjustment and management of implanted device

409

1371

3.09

93.11

3.5

3.2

1.99

1.53

mg/l

16.55

366

1213

Other special examinations and investigations of persons without complaint or reported diagnosis

1507

4177

1.85

92.81

5.1

2.8

1.51

1.46

mg/l

1.04

1387

3856

Other diseases of urinary system

2063

7022

1.67

92.44

4.6

4.0

1.65

1.47

mg/l

15.16

1895

6466

Type 2 diabetes, strict (exclude DM1)

1759

6111

1.74

92.05

3.2

2.7

1.72

1.40

mg/l

39.58

1596

5634

Pure hypercholesterolaemia

1351

4917

1.87

91.81

3.4

3.0

1.77

1.50

mg/l

20.57

1226

4486

Viral warts

321

945

3.60

91.45

11.8

5.2

1.81

1.38

mg/l

10.40

303

883

Codeine

1815

5839

1.73

91.15

3.0

2.8

1.58

1.43

mg/l

9.22

1657

5381

2262

7404

1.63

90.78

4.6

3.3

1.58

1.47

mg/l

6.19

2092

6792

Complications of procedures, not elsewhere classified

1555

7741

1.76

90.77

4.2

3.2

1.72

1.48

mg/l

18.72

1446

7092

Charcot foot

110

127

10.34

90.29

5.3

2.9

2.29

1.30

mg/l

13.97

102

118

Cardiac arrhythmias

1228

4289

1.92

90.09

3.9

4.3

1.60

1.23

mg/l

37.04

1133

4015

Hepatocellular carcinoma, excluding all cancers (controls excluding all cancers)

123

163

8.48

89.28

5.2

3.0

1.68

1.67

mg/l

0.05

114

142

341

1056

3.36

88.99

4.7

3.0

1.64

1.35

mg/l

6.43

327

970

Abnormalities of breathing

1872

6665

1.69

88.08

4.2

1.61

1.40

mg/l

17.61

1708

6198

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

818

1823

2.28

87.60

4.7

2.9

1.46

1.25

mg/l

10.08

770

1672

Senile cataract

1206

3962

1.92

86.81

4.2

2.7

1.93

1.54

mg/l

30.63

1088

3632

Amputation

281

786

3.77

86.31

4.7

2.6

2.44

1.71

mg/l

19.24

265

686

Osteoporosis

516

1929

2.63

86.25

4.8

3.2

1.71

1.63

mg/l

1.02

464

1728

Diseases of the digestive system

969

4925

2.01

86.21

5.6

4.3

1.83

1.54

mg/l

14.81

903

4493

Type 2 diabetes, definitions combined, including avohilmo

1742

6094

1.71

86.12

3.1

2.7

1.71

1.39

mg/l

37.92

1579

5626

Non-rheumatic valve diseases

939

3385

2.07

85.74

4.7

4.0

1.89

1.41

mg/l

34.06

849

3103

Other nutritional deficiencies

1270

6902

1.83

85.56

3.8

3.9

1.80

1.42

mg/l

34.22

1159

6424

Atherosclerosis, excluding cerebral and coronary sclerosis

818

3098

2.16

85.08

3.9

2.6

2.19

1.68

mg/l

35.46

745

2744

Other diseases of biliary tract

255

679

3.98

84.40

6.7

4.4

1.68

1.51

mg/l

2.17

243

614

Benign neoplasms

1564

5089

1.76

84.34

4.6

3.7

1.54

1.41

mg/l

6.48

1477

4688

Medical observation and evaluation for suspected diseases and conditions

1457

4176

1.81

84.10

4.9

2.8

1.49

1.46

mg/l

0.58

1336

3855

Viral hepatitis, IBD co-morbidity

178

361

5.21

83.38

3.9

2.4

1.41

1.15

mg/l

4.62

173

336

Other diseases of blood and blood-forming organs

226

560

4.33

82.97

3.2

1.36

1.59

mg/l

3.70

210

511

Malignant neoplasm of oropharynx

106

131

9.87

82.85

3.6

3.0

1.12

1.63

mg/l

7.94

106

119

Other (not insulin) diabetes medications

1769

6433

1.68

81.42

3.1

2.8

1.76

1.42

mg/l

41.69

1591

5941

Other necrotizing vasculopathies

224

560

4.28

81.18

6.0

3.3

1.70

1.62

mg/l

0.60

210

506

Gingivitis and periodontal diseases

1778

5498

1.69

81.12

4.9

2.6

1.58

1.45

mg/l

6.94

1657

5008

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)

187

406

4.91

81.09

6.2

2.8

1.60

1.70

mg/l

0.79

173

356

Arthropathies in other diseases classified elsewhere

152

278

6.02

80.85

4.8

2.9

2.17

1.48

mg/l

9.49

142

258

Symptoms and signs involving the digestive system and abdomen

2168

6842

1.61

80.69

5.6

3.9

1.52

1.44

mg/l

3.86

2010

6316

Diseases of the eye and adnexa

1800

5420

1.68

80.43

5.6

4.3

1.53

1.31

mg/l

19.89

1685

5105

Erosion of teeth

119

175

8.22

80.13

24.4

4.0

1.66

1.14

mg/l

6.29

119

169

Other pulmonary diagnosis

1632

4796

1.73

79.67

3.9

3.2

1.55

1.37

mg/l

12.36

1529

4427

Malignant neoplasm of urinary organs, excluding all cancers (controls excluding all cancers)

291

877

3.47

79.57

4.7

3.2

1.87

1.71

mg/l

1.93

267

772

Diseases of oesophagus, stomach and duodenum

2094

8069

1.59

78.97

3.8

3.9

1.64

1.46

mg/l

15.40

1924

7451

Dyspnoea

1697

7921

1.66

78.81

3.5

3.9

1.77

1.49

mg/l

27.85

1538

7302

Sleep disorders (combined)

1926

7891

1.62

78.45

3.1

3.7

1.63

1.48

mg/l

9.39

1757

7312

Fungal Sepsis

145

264

6.04

77.47

6.0

3.5

1.95

1.45

mg/l

6.49

139

237

All influenza

587

2575

2.34

77.47

7.6

4.6

1.73

1.43

mg/l

11.15

548

2373

Peripheral artery operations in Hilmo

310

987

3.27

77.27

4.7

2.5

2.36

1.69

mg/l

18.42

288

865

Tubulo-interstitial nephritis, not specified as acute or chronic

173

365

4.97

77.22

6.2

3.2

2.05

1.21

mg/l

17.57

164

333

Complications of medical and surgical care

1365

7588

1.73

76.49

4.9

3.2

1.81

1.51

mg/l

20.83

1263

6946

Hypokalaemia

274

815

3.51

76.39

6.1

3.6

1.71

1.48

mg/l

3.77

252

739

Exposure to unspecified factor

1919

9444

1.60

75.86

4.3

4.4

1.57

1.46

mg/l

5.86

1768

8747

Other necrotizing vasculopathies (FG)

181

405

4.76

75.66

5.9

3.1

1.67

1.49

mg/l

1.93

171

360

Other problems related to primary support group, including family circumstances

374

1308

2.92

75.59

27.8

6.6

1.20

1.19

mg/l

0.12

367

1253

Dentofacial anomalies [including malocclusion]

578

2514

2.33

75.41

16.6

3.0

1.29

1.31

mg/l

0.36

554

2335

Haemolytic anaemias

157

318

5.50

74.91

9.7

7.2

1.67

1.50

mg/l

1.46

152

292

Excluding asthma or asthma-COPD overlap

1608

4796

1.70

74.44

4.0

3.2

1.55

1.37

mg/l

12.32

1508

4427

Parodontitis or operation codes

1702

7749

1.64

74.27

4.0

2.9

1.70

1.52

mg/l

13.95

1587

7088

Hypoplasia of dental enamel , including avohilmo

217

575

4.42

74.11

35.0

13.7

1.32

1.02

mg/l

11.49

211

565

Obesity due to excess calories

920

4862

1.93

73.49

3.6

3.9

1.90

1.41

mg/l

35.56

831

4520

Parodontitis

1695

7749

1.63

73.00

4.0

2.9

1.70

1.52

mg/l

13.82

1580

7088

Molar incisor enamel hypoplasia

230

635

4.18

72.99

35.3

13.0

1.30

1.01

mg/l

11.80

224

624

Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)

259

768

3.53

72.76

4.9

3.2

1.85

1.71

mg/l

1.42

237

680

Drug-induced cataract

124

209

6.80

72.54

14.4

3.9

1.99

1.42

mg/l

5.57

119

191

ILD differential diagnosis

1598

4792

1.69

72.51

4.0

3.2

1.55

1.38

mg/l

11.69

1498

4423

COPD differential diagnosis

1598

4793

1.69

72.47

4.0

3.2

1.55

1.38

mg/l

11.62

1498

4424

Thrombocytopenia, unspecified

227

622

3.90

72.42

7.3

4.9

1.65

1.55

mg/l

0.81

211

569

Implicit fungal Sepsis

134

243

6.07

71.97

5.7

3.4

1.98

1.47

mg/l

6.04

128

218

Chronic periodontitis, including avohilmo

1685

7759

1.63

71.62

4.0

2.9

1.71

1.51

mg/l

14.36

1571

7096

Noninfective enteritis and colitis

1002

5481

1.86

71.58

4.8

5.0

1.49

1.44

mg/l

1.17

927

5080

Malignant neoplasm of tonsil

117

9.62

71.58

3.5

2.8

1.12

1.59

mg/l

6.57

107

Sleep apnoea

1744

7404

1.62

71.26

3.0

3.3

1.66

1.50

mg/l

9.91

1586

6846

Explicit bacterial Sepsis

262

793

3.45

71.15

6.5

4.1

2.02

1.38

mg/l

15.33

241

711

Parasetamol

1656

5150

1.66

70.68

4.0

3.5

1.56

1.37

mg/l

13.91

1539

4812

Polyneuropathies and other disorders of the peripheral nervous system

488

2061

2.45

70.56

6.7

3.5

1.89

1.61

mg/l

7.35

454

1860

Systemic connective tissue disorders

678

3276

2.12

70.06

4.2

3.3

1.64

1.55

mg/l

1.87

621

2976

Other obstructive and reflux uropathy

133

244

5.80

69.90

4.6

4.4

2.02

1.17

mg/l

12.01

127

226

In situ neoplasms

586

2553

2.23

69.16

4.1

2.6

1.79

1.64

mg/l

3.03

536

2266

Other diseases of pleura

874

4086

1.93

68.84

4.3

3.5

1.91

1.64

mg/l

11.62

803

3678

Chronic hepatitis, not elsewhere classified

138

269

5.64

68.53

4.8

3.3

1.58

1.44

mg/l

1.05

129

248

Alcoholic liver disease

274

875

3.29

68.51

4.9

2.8

1.91

1.60

mg/l

5.72

256

799

Other and unspecified polyneuropathies, also in other diseases

429

1737

2.56

68.10

4.9

2.9

1.98

1.64

mg/l

8.87

398

1570

Amputation of toe

205

547

3.98

67.84

4.9

2.8

2.37

1.70

mg/l

12.86

192

486

Idiopathic gout

239

708

3.56

67.50

4.1

2.7

2.35

1.64

mg/l

15.54

223

633

Other acute lower respiratory infections

1105

6049

1.77

66.96

6.3

4.7

1.65

1.47

mg/l

8.82

1028

5577

Venous thromboembolism

977

5258

1.83

66.62

3.8

2.8

1.85

1.61

mg/l

10.18

895

4757

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1117

6424

1.76

66.52

4.9

3.2

1.82

1.53

mg/l

16.34

1037

5871

Other reaction to severe stress, and adjustment disorders

748

3815

2.00

66.44

6.7

3.7

1.55

1.35

mg/l

7.52

705

3576

Benign neoplasm of colon, rectum, anus and anal canal

919

3510

1.90

66.43

3.5

2.8

1.80

1.61

mg/l

7.29

854

3136

Invasive ventilation

237

708

3.57

66.40

8.0

6.1

1.81

1.49

mg/l

4.23

220

657

Codeine or tramadol medication

2138

7821

1.53

66.15

3.0

1.60

1.50

mg/l

5.64

1943

7231

Heart failure and coronary heart disease

644

2280

2.16

65.92

3.7

2.7

2.38

1.73

mg/l

43.53

585

2019

Myeloproliferative diseases

226

656

3.63

65.87

3.5

2.9

1.36

1.64

mg/l

6.46

218

589

Other diseases of the digestive system

651

3174

2.10

65.78

5.9

3.8

1.92

1.60

mg/l

11.00

608

2850

Acute upper respiratory infections

1963

8032

1.55

65.59

5.2

3.4

1.51

1.50

mg/l

0.31

1833

7370

Hypothyroidism, strict autoimmune

1266

4926

1.72

65.55

3.7

3.3

1.58

1.45

mg/l

5.50

1156

4527

Colitis, primary sclerosing, strict definition

10.64

65.31

5.4

4.6

1.48

1.26

mg/l

1.48

Viral and other specified intestinal infections

519

2269

2.29

65.03

12.3

5.8

1.48

1.24

mg/l

10.53

495

2138

Neurological diseases, wide definition

712

1703

2.13

64.87

7.5

5.1

1.38

1.14

mg/l

12.70

676

1610

Melanocytic naevi

540

2464

2.24

64.67

6.4

3.3

1.62

1.49

mg/l

2.94

514

2245

Osteomyelitis

207

577

3.83

64.47

5.3

4.9

2.22

1.54

mg/l

14.31

194

530

Obesity and other hyperalimentation

1150

6681

1.73

64.44

3.5

3.8

1.85

1.42

mg/l

36.66

1046

6209

Other bacterial intestinal infections

391

1556

2.59

64.23

5.5

3.5

2.02

1.51

mg/l

14.81

361

1407

Obesity

1144

6651

1.73

64.11

3.5

3.8

1.85

1.42

mg/l

36.85

1040

6181

GI-bleeding

649

3201

2.07

63.54

5.8

3.8

1.93

1.61

mg/l

11.41

605

2871

Symptoms and signs involving the circulatory and respiratory systems

2040

6716

1.54

63.42

4.8

4.2

1.49

1.40

mg/l

4.65

1889

6248

Streptococcal septicaemia

221

649

3.57

63.17

6.9

4.5

2.03

1.45

mg/l

10.39

201

588

Artificial opening status

169

416

4.35

62.73

7.0

4.8

1.66

1.35

mg/l

3.60

159

376

Abdominal and pelvic pain

2058

6826

1.53

62.71

5.2

3.9

1.51

1.44

mg/l

3.01

1894

6300

Paroxysmal tachycardia

409

1395

2.53

62.58

4.3

4.1

1.63

1.10

mg/l

24.70

373

1309

Other diseases of intestines

2105

8173

1.51

62.49

4.5

1.57

1.42

mg/l

11.42

1954

7585

Reimbursement for rheumatic diseases

1084

6317

1.74

61.99

5.0

3.8

1.51

1.50

mg/l

0.07

1004

5792

Other CVD (FINNGEN)

216

475

3.69

61.71

3.9

2.0

1.90

1.19

mg/l

23.79

192

438

Enlarged lymph nodes

350

1357

2.66

60.67

4.6

3.4

1.38

1.41

mg/l

0.31

333

1241

Pacemaker

609

2898

2.09

60.57

3.7

3.3

2.03

1.72

mg/l

10.69

540

2572

Dermatitis

1133

6748

1.70

60.30

5.1

3.8

1.63

1.51

mg/l

4.69

1049

6193

Carcinoma in situ of skin of other and unspecified parts of face

175

453

4.05

60.19

5.1

2.2

2.02

1.83

mg/l

1.45

160

383

Sleep apnoea, including avohilmo

1789

7589

1.55

60.12

3.0

3.3

1.65

1.50

mg/l

9.56

1622

7026

Bacterial intestinal infections, IBD co-morbidities

395

1630

2.50

60.10

5.4

3.9

2.01

1.55

mg/l

12.71

366

1478

Myeloproliferative diseases (CML excluded)

206

599

3.63

59.96

3.4

2.8

1.36

1.64

mg/l

6.18

199

538

Cardiomyopathy

375

1512

2.55

59.94

5.7

3.9

1.87

1.42

mg/l

17.65

348

1378

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

235

518

3.44

59.40

3.6

2.8

1.79

1.34

mg/l

10.54

219

473

Ischaemic heart disease, wide definition

1401

5422

1.64

59.39

3.8

2.8

1.87

1.51

mg/l

33.64

1280

4946

Continuous positive airway pressure

444

1653

2.38

59.23

6.9

5.5

1.74

1.27

mg/l

19.46

409

1540

Coronary atherosclerosis

1236

4785

1.69

59.20

3.9

2.8

1.94

1.53

mg/l

37.59

1128

4345

Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)

284

1003

2.93

59.16

5.1

3.1

1.54

1.69

mg/l

2.04

263

885

Ischemic heart diseases

1421

5540

1.63

58.64

3.9

2.9

1.86

1.50

mg/l

34.69

1300

5057

Viral pneumonia

306

1132

2.80

58.49

5.6

5.1

1.93

1.42

mg/l

13.61

287

1043

Other viral diseases, not elsewhere classified

474

2145

2.27

58.07

13.4

6.9

1.47

1.32

mg/l

3.68

447

2032

Parodontitis and operation codes

1548

7749

1.57

57.55

3.9

2.9

1.69

1.52

mg/l

10.36

1438

7095

Pain in throat and chest

1598

6270

1.57

57.49

4.0

3.7

1.53

1.42

mg/l

5.09

1461

5816

Cellulitis

486

2235

2.24

57.49

6.6

4.4

1.79

1.45

mg/l

10.82

460

2065

Benign neoplasms

1944

7247

1.51

57.37

4.4

3.8

1.58

1.44

mg/l

9.68

1815

6698

Inflammatory bowel disease

670

3474

1.97

56.97

4.0

4.1

1.43

1.44

mg/l

0.18

622

3228

Finngen Rheumatological endpoints

1860

7042

1.52

56.58

3.8

3.7

1.62

1.40

mg/l

22.63

1725

6531

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

1747

7502

1.53

56.40

4.2

3.1

1.70

1.51

mg/l

13.48

1609

6888

Enterocolitis due to Clostridium difficile

247

833

3.08

56.03

5.2

3.5

2.22

1.60

mg/l

12.52

225

739

Lymphoid leukaemia

171

461

3.96

55.95

16.7

6.5

1.24

1.50

mg/l

4.70

158

412

Essential (haemorrhagic) thrombocythaemia

118

239

5.32

55.86

3.4

2.6

1.28

1.61

mg/l

4.40

113

208

Acute bronchitis

810

4411

1.83

55.09

5.4

4.8

1.72

1.50

mg/l

8.72

748

4050

Headache

1107

5569

1.68

54.87

5.8

3.1

1.41

1.38

mg/l

0.72

1027

5114

Rare circulating lymphoid malignancy, excluding all cancers (controls excluding all cancers)

130

292

4.91

54.85

21.0

8.7

1.12

1.39

mg/l

4.78

121

265

Benign neoplasm: Colon

777

3231

1.87

54.54

3.6

2.7

1.85

1.64

mg/l

7.38

719

2883

General examination and investigation of persons without complaint and reported diagnosis

1276

4168

1.65

53.73

6.4

2.8

1.54

1.46

mg/l

2.18

1213

3850

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

1120

6338

1.66

53.58

3.6

3.5

1.68

1.59

mg/l

2.64

1047

5751

Other renal tubulo-interstitial diseases

135

6.92

53.29

6.1

3.1

1.88

1.15

mg/l

8.04

128

Cystitis

1467

5749

1.58

53.14

4.4

3.9

1.60

1.47

mg/l

7.06

1357

5270

Syncope and collapse

758

3679

1.85

53.00

3.9

2.9

1.70

1.50

mg/l

7.17

693

3327

Other inflammatory liver diseases

189

564

3.54

52.94

5.1

3.6

1.55

1.50

mg/l

0.33

179

524

Constipation

1606

7585

1.53

52.90

4.0

4.6

1.61

1.51

mg/l

4.07

1443

7013

IBD patients in KELA-register

508

2454

2.12

52.86

3.8

4.2

1.39

1.41

mg/l

0.31

472

2296

Asthma, unspecified (mode), excluding more controls

866

3855

1.79

52.79

3.9

3.2

1.61

1.33

mg/l

15.82

799

3552

Examination and observation for other reasons

1127

4136

1.68

52.16

4.9

2.8

1.53

1.46

mg/l

1.86

1057

3820

Hypothyroidism, drug reimbursement

238

553

3.13

52.11

4.3

2.7

1.62

1.07

mg/l

15.82

222

521

STROKE

979

3987

1.73

51.71

4.0

2.9

1.74

1.36

mg/l

27.92

899

3665

Congenital malformations of gallbladder, bile ducts and liver

146

7.64

51.52

17.7

13.3

1.51

1.20

mg/l

2.50

140

Budesonide

286

1092

2.70

51.26

3.5

3.1

1.43

1.41

mg/l

0.15

262

1010

Melanocytic naevi of trunk

247

877

2.91

51.01

7.2

3.2

1.70

1.47

mg/l

3.62

233

802

Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)

230

787

3.02

50.69

4.3

2.3

1.97

1.85

mg/l

0.96

208

678

5-aminosalicylic acid

442

2057

2.20

50.62

4.0

3.4

1.36

1.38

mg/l

0.29

404

1905

Contact with and exposure to communicable diseases

651

3462

1.91

50.62

7.2

5.8

1.32

1.29

mg/l

0.58

611

3296

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1003

6066

1.68

50.37

4.6

3.1

1.84

1.54

mg/l

15.05

931

5527

Acute pancreatitis

406

1834

2.27

50.22

5.1

3.1

1.80

1.56

mg/l

5.08

366

1660

Agranulocytosis

261

965

2.81

50.12

8.8

4.3

1.48

1.49

mg/l

0.07

244

890

Inflammatory bowel disease, strict (require KELA)

508

2508

2.07

49.88

3.8

4.2

1.39

1.42

mg/l

0.47

472

2343

Other specified disorders of kidney and ureter

115

252

4.94

49.75

9.0

4.0

1.94

1.59

mg/l

2.57

108

230

Presence of cardiac and vascular implants and grafts

716

2957

1.86

49.34

3.3

2.3

2.06

1.56

mg/l

30.42

641

2655

Exclusions for E4_PCOS_BROAD

424

1966

2.22

49.34

8.4

7.7

1.49

1.34

mg/l

2.71

396

1862

Malignant neoplasm of urinary organs

234

824

2.96

49.32

4.6

3.3

1.87

1.66

mg/l

2.82

213

740

Other and unspecified dermatitis

919

5471

1.70

49.19

5.3

3.9

1.65

1.49

mg/l

6.03

852

5023

Acute sinusitis

943

5261

1.69

48.85

4.8

3.2

1.50

1.42

mg/l

1.83

878

4872

Pain in limb

1480

7066

1.53

48.64

5.1

4.2

1.67

1.46

mg/l

14.50

1362

6545

Carcinoma in situ of skin of other and unspecified parts of face

175

524

3.50

48.62

5.1

2.5

2.02

1.81

mg/l

1.89

160

453

Cutaneous abscess, furuncle and carbuncle

523

2643

2.02

48.09

5.5

3.8

1.79

1.42

mg/l

14.13

496

2455

Crohn disease

310

1272

2.52

48.01

4.2

4.7

1.43

1.41

mg/l

0.19

295

1194

DVT of lower extremities and pulmonary embolism

722

4036

1.81

47.84

3.7

2.7

1.83

1.64

mg/l

5.47

665

3628

Pulmonary heart disease, diseases of pulmonary circulation

568

2965

1.95

47.36

3.5

3.0

1.86

1.64

mg/l

5.47

526

2667

Iron deficiency anaemia secondary to blood loss (chronic)

316

1315

2.47

47.31

5.3

3.5

1.98

1.58

mg/l

8.01

291

1187

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

569

2941

1.95

47.23

19.7

4.7

1.27

1.29

mg/l

0.26

553

2778

Other diseases of lip and oral mucosa

312

1294

2.48

47.02

5.0

2.6

1.46

1.50

mg/l

0.43

298

1173

Rare circulating lymphoid malignancy

130

331

4.32

46.70

21.0

9.2

1.12

1.45

mg/l

6.35

121

304

Congenital malformations of the circulatory system

397

1778

2.24

46.57

9.8

10.2

1.25

1.32

mg/l

1.14

386

1695

Congenital malformations of heart and great arteries

376

1651

2.29

46.35

9.3

10.8

1.25

1.30

mg/l

0.76

366

1573

Abnormal findings on examination of blood, without diagnosis

880

4915

1.70

46.34

5.0

3.7

1.66

1.61

mg/l

0.86

813

4485

Acute pancreatitis (for exclusion)

406

1898

2.19

46.16

5.1

3.1

1.80

1.57

mg/l

4.73

366

1725

Ulcerative colitis

511

2604

2.01

45.90

4.1

4.0

1.45

mg/l

0.04

472

2418

Cardiomyopathies, Primary/intrinsic

266

1037

2.65

45.85

5.9

3.9

1.93

1.41

mg/l

16.01

249

944

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

186

601

3.23

45.63

3.2

2.9

1.83

1.65

mg/l

1.63

167

536

Persons encountering health services for examination and investigation

1301

4177

1.58

45.45

4.4

2.8

1.49

1.46

mg/l

0.42

1203

3856

Other viral hepatitis

183

593

3.24

44.87

4.4

3.5

1.40

1.35

mg/l

0.35

178

558

Lymphoid leukaemia

171

534

3.40

44.81

16.7

6.8

1.24

1.54

mg/l

5.86

158

485

Cardiomyopathy (excluding other)

268

1064

2.60

44.49

5.8

3.9

1.93

1.41

mg/l

16.31

251

966

Multiple myeloma, excluding all cancers (controls excluding all cancers)

121

300

4.27

44.44

3.8

3.3

1.80

1.62

mg/l

1.22

110

263

Asthma, excluding more controls

1276

4374

1.57

44.35

3.7

3.2

1.51

1.32

mg/l

12.58

1182

4048

AV-block

310

1184

2.43

44.32

4.0

3.7

1.95

1.51

mg/l

11.30

276

1057

Other symptoms and signs involving the urinary system

234

874

2.78

44.08

5.1

4.1

1.75

1.55

mg/l

2.49

221

802

Haemorrhage from respiratory passages

620

3149

1.86

44.05

5.1

3.6

1.81

1.56

mg/l

8.16

578

2869

645

3367

1.83

43.94

4.2

2.6

1.84

1.74

mg/l

1.85

586

2996

Pneumonia due to other infectious organisms, not elsewhere classified

103

229

4.83

43.71

6.2

3.4

1.80

1.52

mg/l

2.15

208

Pleural effusion

299

1259

2.44

43.69

3.7

2.9

2.10

1.69

mg/l

8.28

276

1121

Asthma, unspecified (mode)

879

4189

1.68

43.57

3.9

3.1

1.61

1.39

mg/l

10.33

811

3846

Melanocytic naevi

540

2855

1.93

43.44

6.4

3.5

1.62

1.45

mg/l

4.49

514

2639

Multiple myeloma and malignant plasma cell neoplasms

120

301

4.22

43.40

3.9

3.3

1.80

1.62

mg/l

1.22

109

264

Skin changes due to chronic exposure to nonionizing radiation

606

3135

1.86

43.37

4.2

2.6

1.86

1.76

mg/l

1.60

548

2777

In situ neoplasms

586

3182

1.87

43.27

4.1

2.6

1.79

1.61

mg/l

4.29

536

2861

Malignant neoplasm of kidney, except renal pelvis

213

766

2.90

43.27

4.9

3.3

1.85

1.65

mg/l

2.34

194

689

Malignant neoplasm of liver and intrahepatic bile ducts

106

245

4.66

42.92

9.1

3.8

1.80

mg/l

0.00

216

Actinic keratosis

590

3050

1.87

42.85

4.2

2.6

1.86

1.77

mg/l

1.61

533

2698

Seborrhoeic keratosis

396

1889

2.15

42.71

5.5

2.6

1.77

1.60

mg/l

3.37

367

1705

L01XX Other antineoplastic agents

145

420

3.65

42.65

3.6

2.9

1.40

1.71

mg/l

4.60

137

377

Non-follicular lymphoma, hilmo, excluding all cancers

196

678

3.00

42.64

6.2

3.2

1.52

1.66

mg/l

1.34

181

605

Other soft tissue disorders, not elsewhere classified

1728

7424

1.45

42.59

4.9

4.3

1.61

1.44

mg/l

10.78

1592

6891

Viral hepatitis

197

689

2.99

42.20

4.3

3.6

1.40

1.39

mg/l

0.06

191

647

Other noninfective gastroenteritis and colitis

503

2623

1.96

42.19

5.8

6.3

1.57

1.42

mg/l

3.68

471

2442

Convulsions, not elsewhere classified

463

2319

2.01

41.99

7.7

3.8

1.52

1.37

mg/l

2.76

431

2128

Peripheral arterial reconstruction

317

1395

2.33

41.85

3.8

2.6

2.29

1.76

mg/l

14.11

288

1225

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

462

2351

2.01

41.75

2.8

2.9

1.84

1.45

mg/l

14.33

416

2197

Conduction disorders

501

2153

1.97

41.66

3.7

4.1

1.90

1.42

mg/l

20.90

453

1963

Carcinoma in situ of skin of upper limb, including shoulder

123

6.39

41.18

4.7

2.4

2.07

1.74

mg/l

1.84

106

Acute suppurative otitis media

554

2798

1.88

41.08

10.5

5.5

1.36

1.26

mg/l

2.40

529

2658

Zoster [herpes zoster]

330

1491

2.27

40.90

5.9

3.2

1.82

1.59

mg/l

4.54

305

1338

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

828

3386

1.69

40.68

3.7

2.7

1.78

1.67

mg/l

2.60

752

3022

Use of hypnotics and sedatives

1917

7907

1.41

40.56

3.5

3.6

1.59

1.50

mg/l

4.61

1767

7300

Other functional intestinal disorders

812

4685

1.67

40.45

5.2

5.4

1.59

1.47

mg/l

3.18

735

4313

Pre-eclampsia

336

1536

2.23

40.30

3.8

2.8

1.48

1.33

mg/l

3.42

319

1439

Chronic pancreatitis

270

1129

2.47

40.27

4.7

3.0

1.79

1.55

mg/l

3.87

245

1033

Hard cardiovascular diseases

1348

5810

1.50

40.13

4.0

3.1

1.85

1.51

mg/l

30.09

1240

5315

Other metabolic disorders

240

950

2.59

40.04

5.9

4.1

1.45

1.36

mg/l

1.03

226

880

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

739

2957

1.74

39.96

3.6

2.7

1.81

1.70

mg/l

2.10

666

2627

Other diseases of arteries and capillaries

195

699

2.89

39.76

5.0

3.2

2.03

1.53

mg/l

7.49

179

622

Dermatitis and eczema

1965

9306

1.40

39.52

4.6

4.1

1.55

1.47

mg/l

3.85

1821

8603

Other gastritis (incl. Duodenitis)

425

2147

2.02

39.22

3.9

3.0

1.88

1.59

mg/l

7.47

388

1948

Sphingolipidosis, other/unspecified

41.12

39.08

4.9

3.1

1.27

1.02

mg/l

—

Diabetic neuropathy

301

1336

2.34

39.01

4.8

3.3

2.10

1.82

mg/l

4.80

273

1200

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

654

3290

1.76

38.91

3.5

2.9

1.49

1.37

mg/l

3.26

615

3060

Diseases of the respiratory system

1192

3888

1.55

38.85

4.2

3.4

1.53

1.40

mg/l

5.70

1109

3595

Mycoses

484

2564

1.93

38.82

5.5

3.6

1.70

1.51

mg/l

4.00

450

2350

Pre-eclampsia or eclampsia

352

1666

2.15

38.67

3.8

2.8

1.51

1.35

mg/l

3.54

334

1556

Other Crohn's disease

180

629

2.98

38.62

3.6

4.0

1.47

1.39

mg/l

0.70

173

590

Chronic viral hepatitis

155

499

3.27

38.53

4.0

3.1

1.40

1.34

mg/l

0.46

150

469

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

383

1878

2.09

38.52

3.9

4.0

1.37

1.43

mg/l

0.91

353

1756

Abnormal results of function studies

206

775

2.76

38.42

4.1

5.2

1.62

1.47

mg/l

1.60

190

718

All influenza (not pneumonia)

328

1518

2.22

38.38

8.1

4.9

1.67

1.37

mg/l

6.30

311

1417

Mucosal proctocolitis

282

1227

2.37

38.37

3.5

3.8

1.44

1.42

mg/l

0.10

263

1152

Symptoms and signs involving the skin and subcutaneous tissue

1169

7775

1.51

38.22

4.8

3.8

1.50

1.51

mg/l

0.06

1090

7137

Pulmonary embolism

497

2669

1.90

38.12

3.4

2.7

1.83

1.63

mg/l

4.12

460

2396

SLE (Finngen)

226

4.50

37.79

4.5

4.9

1.67

1.38

mg/l

2.24

212

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

659

2974

1.75

37.69

4.2

2.8

1.68

1.70

mg/l

0.22

611

2646

Hepatocellular carcinoma

153

5.54

37.61

6.4

2.8

1.83

1.91

mg/l

0.24

137

Late syphilis

111

6.65

37.59

5.0

3.1

2.08

1.50

mg/l

4.02

102

Other disorders of bladder

244

1005

2.50

37.59

3.2

2.9

1.69

1.61

mg/l

0.56

200

908

Pulmonary heart disease

497

2683

1.89

37.51

3.4

2.7

1.83

1.64

mg/l

3.86

460

2409

Episodal and paroxysmal disorders

2094

7843

1.38

37.43

4.0

4.7

1.49

1.44

mg/l

1.59

1920

7296

Other disorders of glucose regulation and pancreatic internal secretion

213

826

2.68

37.42

6.8

6.4

1.87

1.44

mg/l

8.11

195

765

Ulcerative colitis, NAS

304

1380

2.26

37.39

4.4

4.8

1.45

1.42

mg/l

0.30

284

1294

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

120

335

3.78

37.36

8.4

3.6

1.75

1.78

mg/l

0.09

108

295

Squamous cell neoplasms and carcinomas of the skin

230

927

2.56

37.07

4.3

2.5

1.97

1.82

mg/l

1.47

208

803

Symptoms and signs concerning food and fluid intake

220

870

2.61

36.86

12.1

4.4

1.45

1.41

mg/l

0.30

206

794

Syphilis

241

4.42

36.83

3.9

2.9

1.95

1.49

mg/l

2.78

224

Fall on same level

2141

8821

1.37

36.83

4.3

4.4

1.58

1.44

mg/l

9.67

1972

8204

Melanocytic naevi of trunk

247

1036

2.46

36.59

7.2

3.4

1.70

1.47

mg/l

3.53

233

959

Erosion of teeth, including avohilmo

359

1688

2.10

36.48

10.3

2.8

1.55

1.36

mg/l

3.87

338

1582

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

345

1666

2.12

36.22

4.0

4.1

1.35

1.42

mg/l

1.27

317

1558

Ulcerative colitis (strict definition, require KELA)

353

1719

2.10

36.22

4.0

4.1

1.35

1.42

mg/l

1.28

325

1606

Parodontitis or/and operation codes

1160

4590

1.52

35.70

4.2

3.2

1.64

1.48

mg/l

7.34

1081

4252

Vocal cord dysfunction

237

909

2.47

35.53

3.5

4.1

1.44

1.19

mg/l

4.66

224

861

Biguanides

1563

6802

1.43

35.51

2.7

3.0

1.72

1.47

mg/l

21.94

1399

6282

Lung transplant status

8.24

35.50

10.5

8.9

1.95

1.41

mg/l

4.21

Lung transplantation

8.24

35.49

10.5

8.9

1.95

1.41

mg/l

4.21

Asthma

1306

4756

1.48

35.48

3.7

3.2

1.51

1.37

mg/l

6.98

1210

4390

Other respiratory diseases principally affecting the interstitium

320

1514

2.16

35.42

3.7

2.9

1.88

1.69

mg/l

2.92

294

1350

Pregnancy hypertension

588

3050

1.76

35.14

3.6

2.9

1.48

1.36

mg/l

3.48

553

2842

Excessive attrition of teeth

683

2168

1.73

34.98

8.0

2.9

1.46

1.38

mg/l

1.76

637

2002

Attention to artificial openings

249

4.15

34.88

9.3

5.8

1.54

1.42

mg/l

0.69

222

Retention of urine

561

2694

1.79

34.86

3.4

3.0

1.98

1.66

mg/l

11.39

496

2433

Abnormalities of heart beat

584

3353

1.75

34.68

3.0

3.3

1.53

1.48

mg/l

0.74

522

3074

Persons encountering health services for specific procedures, not carried out

159

551

2.98

34.54

4.1

3.6

1.69

1.27

mg/l

5.22

145

510

Mood disorders, excluding more controls

1659

7250

1.40

34.18

3.6

3.1

1.51

1.48

mg/l

0.52

1535

6705

Multiple myeloma and malignant plasma cell neoplasms

120

357

3.55

33.98

3.9

3.5

1.80

1.76

mg/l

0.21

109

318

Dental pulpitis 2

1297

4540

1.48

33.82

5.4

3.6

1.58

1.47

mg/l

4.16

1203

4144

Cardiomyopathy, other and unspecified

169

613

2.85

33.79

5.1

3.6

1.86

1.40

mg/l

8.41

155

568

Other diseases of the respiratory system

368

1866

2.01

33.72

5.3

4.0

1.91

1.65

mg/l

4.97

330

1677

Other respiratory disorders and diseases

368

1866

2.01

33.72

5.3

4.0

1.91

1.65

mg/l

4.97

330

1677

Acquired absence of organs, not elsewhere classified

6.85

33.59

4.6

3.7

1.88

1.45

mg/l

2.15

Pre-eclampsia or poor fetal growth

436

2333

1.89

33.50

3.7

2.9

1.48

1.32

mg/l

4.45

413

2180

Hypothyroidism, other/unspecified

1491

6984

1.42

33.43

3.6

1.56

1.51

mg/l

1.40

1360

6445

Other disorders of white blood cells

144

484

3.12

33.31

5.8

4.1

1.61

1.54

mg/l

0.40

135

444

Sulfonylureas

575

2654

1.75

33.23

3.1

2.7

2.27

1.67

mg/l

30.82

502

2389

Suppurative and unspecified otitis media

678

3658

1.67

32.98

8.9

4.8

1.40

1.32

mg/l

1.85

640

3445

Benign neoplasm of mouth and pharynx

201

806

2.56

32.81

3.4

2.9

1.34

1.58

mg/l

4.61

189

723

Hypothyreosis and Thyroxine purchase for inclusion criteria

1519

7161

1.41

32.80

3.6

1.56

1.51

mg/l

1.41

1383

6600

Neurological diseases

1709

6218

1.39

32.73

5.3

4.7

1.45

1.39

mg/l

1.82

1597

5815

1092

6639

1.49

32.73

4.0

3.2

1.66

1.52

mg/l

6.26

1005

6134

Nonsuppurative otitis media

466

2213

1.85

32.57

9.6

6.0

1.35

1.28

mg/l

1.17

448

2083

Alcohol use disorder, Swedish definition

997

6182

1.51

32.56

3.9

3.1

1.68

1.53

mg/l

6.12

919

5703

Disorders of sclera, cornea, iris and ciliary body

928

6121

1.53

32.53

4.1

3.6

1.63

1.49

mg/l

5.50

870

5633

Other antidepressants

1855

7104

1.37

32.52

3.1

3.3

1.50

1.53

mg/l

0.94

1692

6559

Other disorders of skin and subcutaneous tissue, not elsewhere classified

263

1192

2.26

32.49

3.4

3.2

1.97

1.52

mg/l

9.27

242

1084

Dental operations

1167

4046

1.49

32.32

4.6

2.9

1.58

1.52

mg/l

1.37

1079

3682

Any mental disorder

2052

7659

1.35

32.32

4.8

3.8

1.53

1.48

mg/l

1.85

1895

7091

Other infectious diseases

173

651

2.75

32.29

4.8

4.0

2.09

1.59

mg/l

5.61

157

582

Anxiety disorders, excluding more controls

1443

6795

1.42

32.27

5.3

3.4

1.49

1.44

mg/l

1.37

1338

6298

Fentanyl

179

683

2.69

32.25

3.6

2.8

1.63

1.64

mg/l

0.05

165

608

Diseases of the musculoskeletal system and connective tissue

1143

3857

1.50

32.20

6.7

5.3

1.39

1.31

mg/l

3.04

1080

3622

Respiratory insufficiency

156

555

2.89

32.15

5.6

3.5

2.06

1.57

mg/l

5.97

139

495

Other embolism and thrombosis

245

1084

2.32

32.10

4.8

3.0

1.86

1.51

mg/l

4.48

226

981

1041

6460

1.50

32.03

4.0

3.3

1.66

1.53

mg/l

5.27

958

5966

Psychiatric diseases

2019

7529

1.35

32.02

4.8

3.8

1.53

1.47

mg/l

2.12

1870

6978

Benign neoplasm of colon, rectum, anus and anal canal

957

5735

1.52

32.00

3.4

2.8

1.82

1.63

mg/l

7.88

887

5165

Dental caries 1 and operation codes

1565

5744

1.41

31.93

5.2

3.5

1.58

1.48

mg/l

4.43

1455

5266

Dental caries 1

1416

5094

1.43

31.69

5.3

3.5

1.58

1.48

mg/l

3.85

1326

4648

Other arrhythmias

999

5108

1.51

31.61

3.1

3.4

1.61

1.37

mg/l

14.51

896

4726

Speech and linguistic disorders, excluding more controls

223

898

2.42

31.50

19.2

10.1

1.22

1.16

mg/l

0.89

213

859

Pain, not elsewhere classified

437

2395

1.85

31.48

5.0

3.1

1.54

1.40

mg/l

2.79

399

2185

Amputation of ankle bones

161

4.90

31.47

5.4

2.8

2.74

1.76

mg/l

7.54

145

Dental caries, including avohilmo

1412

5091

1.43

31.25

5.3

3.5

1.58

1.48

mg/l

3.95

1321

4646

Pain (limb, back, neck, head abdominally)

1459

5182

1.42

31.23

5.9

4.2

1.49

1.44

mg/l

1.62

1359

4795

ILD, hospital admission 2, with pulmonary infections

178

690

2.66

31.23

3.8

3.0

1.80

1.62

mg/l

2.03

165

622

Carcinoma in situ of skin of upper limb, including shoulder

160

4.89

30.82

4.7

2.7

2.07

1.81

mg/l

1.28

140

Otitis media, unspecified

278

1207

2.18

30.79

14.1

8.5

1.26

1.20

mg/l

0.80

266

1156

Asthma (only as main-diagnosis), excluding more controls

1085

4374

1.49

30.70

3.8

3.2

1.48

1.32

mg/l

8.87

1003

4048

COPD (mode)

486

2186

1.79

30.16

2.6

2.7

1.93

1.57

mg/l

10.79

422

1966

Systemic lupus erythematosus

267

3.79

30.14

4.5

4.1

1.67

1.47

mg/l

1.26

248

Cerebrovascular diseases

1186

5916

1.45

30.13

3.9

3.2

1.81

1.59

mg/l

11.57

1070

5379

Disorders of ocular muscles, binocular movement, accommodation and refraction

837

5455

1.54

29.88

7.8

5.1

1.42

1.39

mg/l

0.38

774

5089

Diseases of the ear and mastoid process

2111

8096

1.33

29.80

4.6

3.7

1.48

1.47

mg/l

0.29

1956

7512

Falls/tendency to fall

2065

7811

1.33

29.78

4.2

4.4

1.52

1.44

mg/l

4.01

1902

7269

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

670

2847

1.64

29.75

3.6

2.7

1.80

1.71

mg/l

1.49

601

2523

Diseases of middle ear and mastoid

1013

5643

1.48

29.72

6.8

4.1

1.42

1.40

mg/l

0.26

954

5259

Non-follicular lymphoma

196

816

2.48

29.70

6.2

3.5

1.52

1.65

mg/l

1.27

181

736

6-mercaptopurine

261

3.82

29.65

15.8

5.8

1.08

1.29

mg/l

2.67

244

Cardiodefibrillation

607

3709

1.66

29.59

3.2

2.9

1.90

1.69

mg/l

6.98

555

3334

Hernia of abdominal wall

772

4999

1.56

29.59

5.2

3.3

1.74

1.56

mg/l

6.94

711

4581

Candidiasis

246

1129

2.23

29.54

5.8

3.6

1.75

1.47

mg/l

4.03

230

1046

Viral pneumonia (unknown virus, not influenza)

159

601

2.75

29.53

6.2

4.9

1.86

1.45

mg/l

5.93

153

561

ILD, hospital admissions 3, with pneumonia sepsis

156

583

2.76

29.50

3.8

2.8

1.83

1.62

mg/l

2.26

144

514

Cholelithiasis, broad definition with cholecystitis

1338

6547

1.41

29.23

3.7

2.9

1.70

1.53

mg/l

8.53

1232

5955

Gastroduodenal ulcer

435

2431

1.81

29.23

4.2

2.8

1.98

1.67

mg/l

7.41

402

2190

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

676

2884

1.63

29.22

3.6

2.7

1.79

1.71

mg/l

1.43

606

2557

Other diseases of pancreas

159

604

2.73

29.21

3.7

3.3

1.80

1.55

mg/l

2.44

141

548

Alport

29.00

29.20

9.0

12.9

1.89

1.26

mg/l

0.99

Other benign neoplasms of skin

523

3026

1.72

29.15

4.3

3.0

1.67

1.61

mg/l

0.90

484

2699

Hypothyroidism, strict autoimmune, 3 medication purchases required

1338

6521

1.41

29.07

3.5

3.3

1.57

1.51

mg/l

1.48

1217

5997

Ulcerative ileocolitis

113

358

3.32

28.97

4.1

2.9

1.41

1.47

mg/l

0.34

105

332

Diverticular disease of intestine

1132

5218

1.45

28.86

3.3

2.9

1.77

1.56

mg/l

10.90

1032

4755

Paralytic ileus and intestinal obstruction

423

2361

1.82

28.77

4.2

3.4

1.75

1.60

mg/l

2.48

394

2125

Intestinal stricture

505

2971

1.73

28.63

4.6

3.5

1.75

1.61

mg/l

2.66

471

2675

Phlebitis and thrombophlebitis (not including DVT)

373

2009

1.89

28.57

4.5

2.8

1.87

1.52

mg/l

6.92

343

1835

Other arthritis (FG)

518

3075

1.71

28.37

4.2

3.8

1.75

1.42

mg/l

11.30

481

2830

Disorders of psychological development

315

1490

2.02

28.30

16.4

10.3

1.18

1.17

mg/l

0.08

302

1424

Other coagulation defects

153

580

2.73

28.20

5.0

4.5

1.58

1.49

mg/l

0.54

145

542

Cholelithiasis

1280

6414

1.41

27.98

3.6

2.8

1.70

1.53

mg/l

8.27

1178

5832

Dental pulpitis 2, only avohilmo

1300

4719

1.42

27.97

5.3

3.6

1.57

1.48

mg/l

3.20

1208

4307

Disorders of the thyroid gland

1568

7558

1.37

27.94

3.6

1.57

1.52

mg/l

1.47

1432

6969

Pericarditis

238

3.83

27.94

8.5

3.9

1.85

1.44

mg/l

3.07

220

Osteonecrosis

129

450

2.99

27.93

5.8

2.8

1.70

1.54

mg/l

1.10

121

410

Postprocedural endocrine and metabolic disorders, not elsewhere classified

194

827

2.40

27.70

4.0

3.3

1.43

1.37

mg/l

0.49

182

764

Melanocytic naevi, other sites/unspecified

148

557

2.74

27.62

6.8

3.3

1.69

1.44

mg/l

2.67

140

511

Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)

343

1821

1.92

27.49

3.3

2.9

1.41

1.72

mg/l

12.32

321

1625

Dipeptidyl peptidase 4 (DPP-4) inhibitors

212

945

2.30

27.42

3.0

2.8

2.10

1.59

mg/l

8.92

186

870

Benign neoplasm of other and ill-defined parts of digestive system

261

1262

2.11

27.34

4.0

2.7

1.83

1.65

mg/l

1.94

243

1127

Mood disorders

1753

8666

1.34

27.34

3.6

3.5

1.49

1.48

mg/l

0.13

1620

8012

Disorders of vitreous body

737

4703

1.55

27.31

3.9

2.9

1.81

1.62

mg/l

6.56

674

4259

Noninfectious colitis NAS

263

1279

2.11

27.26

4.8

5.5

1.61

1.45

mg/l

2.44

246

1187

Infections with a predominantly sexual mode of transmission

495

2932

1.71

27.24

3.7

3.1

1.51

1.36

mg/l

3.17

458

2762

Mood [affective] disorders

1749

8662

1.34

27.21

3.6

3.5

1.49

1.48

mg/l

0.09

1616

8009

Benzodiazepine use

1655

8814

1.35

27.17

3.1

3.4

1.57

1.51

mg/l

1.71

1493

8144

Elevated blood glucose level

181

758

2.47

27.14

7.7

5.2

1.72

1.49

mg/l

2.70

163

694

Carcinoma in situ of skin

133

480

2.86

26.91

4.7

2.4

2.04

1.77

mg/l

1.77

121

415

Myocardial infarction

816

3879

1.53

26.83

3.6

2.8

2.07

1.56

mg/l

35.42

744

3515

Crohn's disease of large intestine

133

483

2.87

26.78

4.1

4.5

1.52

1.38

mg/l

1.02

125

452

Disorders of vitreous body and globe

754

4845

1.54

26.61

3.9

2.9

1.81

1.62

mg/l

6.47

691

4387

Myocardial infarction, without ST-elevation

617

3581

1.61

26.56

3.4

2.7

2.17

1.70

mg/l

22.96

569

3186

Other or unspecified ileus, impaction or obstruction

309

1604

1.96

26.51

4.0

3.2

1.77

1.61

mg/l

2.11

283

1441

Left ventricular outflow tract obstruction (LVOTO), broad definition

247

1191

2.14

26.44

7.3

7.1

1.57

1.38

mg/l

2.33

231

1123

Open wound of lower leg

277

1392

2.04

26.25

4.8

4.5

1.86

1.47

mg/l

8.60

262

1281

SLE, ICD10

264

3.59

26.14

4.5

3.7

1.70

1.47

mg/l

1.52

245

SLE, strict definition

264

3.59

26.14

4.5

3.7

1.70

1.47

mg/l

1.52

245

Other specified/unspecified arthritis

455

2671

1.73

26.05

4.2

4.0

1.74

1.43

mg/l

9.11

424

2447

Asthma (mode)

1224

4792

1.41

25.96

3.6

3.2

1.49

1.38

mg/l

4.81

1141

4423

Procreative management

636

3417

1.59

25.72

7.2

6.1

1.26

1.33

mg/l

1.97

603

3238

Depression

1611

8340

1.34

25.54

3.7

3.6

1.49

1.47

mg/l

0.35

1488

7730

Benign neoplasm: Colon

786

5163

1.51

25.50

3.6

2.8

1.85

1.65

mg/l

7.63

727

4650

Intestinal malabsorption

112

382

3.07

25.34

7.2

4.1

1.72

1.45

mg/l

2.00

101

354

Other and unspecified disorders of white blood cells

101

325

3.26

25.29

6.4

4.3

1.53

1.58

mg/l

0.23

295

Presbycusis

212

971

2.22

25.23

3.4

2.4

1.88

1.86

mg/l

0.10

180

842

Other diseases of intestine

216

1004

2.20

25.21

5.6

3.4

1.75

1.58

mg/l

2.02

200

908

Bacterial pneumonia (organism specified)

729

4387

1.53

25.16

5.5

3.8

1.80

1.57

mg/l

8.22

668

3986

Injuries to the head

1886

9451

1.31

25.14

4.4

4.3

1.57

1.47

mg/l

5.14

1724

8761

Cyst of kidney

135

510

2.74

25.14

3.9

2.5

1.90

1.64

mg/l

2.38

127

455

Anxiety disorders

1524

8083

1.35

25.10

5.4

3.7

1.48

1.44

mg/l

1.28

1416

7514

Valvular operations

254

1259

2.06

24.99

5.2

5.1

1.83

1.42

mg/l

7.90

234

1150

Vasculitis limited to skin, not elsewhere classified

189

4.05

24.71

3.9

4.0

1.76

1.56

mg/l

0.68

171

Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

353

1627

1.85

24.64

3.4

2.8

1.40

1.78

mg/l

16.54

335

1428

Neurotic, stress-related and somatoform disorders

1505

8016

1.34

24.62

5.4

3.7

1.48

1.43

mg/l

1.14

1397

7455

Depression or dysthymia

1256

5089

1.39

24.51

3.6

3.4

1.51

mg/l

0.02

1149

4702

Other hearing loss

422

2425

1.73

24.47

4.0

3.0

1.79

1.70

mg/l

1.05

376

2185

Calcific aortic valvular stenosis

445

2585

1.71

24.42

3.3

3.1

2.12

1.76

mg/l

8.77

392

2282

Calcific aortic valvular stenosis, operated

445

2585

1.71

24.42

3.3

3.1

2.12

1.76

mg/l

8.77

392

2282

Retinal detachments and breaks

543

3393

1.62

24.41

3.9

2.8

1.84

1.61

mg/l

6.12

493

3073

Hypoglycaemia, other or unspecified

164

691

2.46

24.38

6.5

6.9

1.85

1.45

mg/l

5.33

150

642

Dental caries 3 and operation codes

1608

6200

1.34

24.31

4.5

4.1

1.59

1.47

mg/l

6.19

1492

5709

Cough

676

4258

1.54

24.26

6.9

4.9

1.47

1.43

mg/l

0.64

626

3930

Osteoporosis with pathological fracture (FG)

116

412

2.90

24.23

4.0

2.7

1.71

1.56

mg/l

1.21

109

365

Special screening examination for other diseases and disorders

163

684

2.44

24.21

5.6

3.0

1.69

1.49

mg/l

2.20

155

623

Disorders of refraction and accommodation

495

3021

1.66

24.18

9.9

6.4

1.40

1.33

mg/l

1.12

466

2852

Bacterial pneumoniae

643

3690

1.56

24.16

5.4

3.6

1.78

1.49

mg/l

10.59

586

3365

Gastro-oesophageal reflux disease

1084

6893

1.40

24.04

3.6

3.8

1.62

1.49

mg/l

4.21

997

6339

Acidosis

141

4.57

23.94

5.5

4.9

2.26

1.49

mg/l

7.17

129

Decubitus ulcer and pressure area

115

410

2.91

23.93

5.3

3.0

2.33

1.67

mg/l

5.75

104

361

Other and unspecified vasculitis limited to skin

176

4.12

23.83

4.0

1.80

1.59

mg/l

0.65

158

Hypoparathyroidism

266

3.44

23.71

4.0

4.5

1.75

1.50

mg/l

1.39

242

Other and unspecified local infections of skin and subcutaneous tissue

192

876

2.25

23.61

9.8

5.2

1.84

1.45

mg/l

4.64

181

811

Other external causes of accidental injury

1536

5764

1.34

23.59

4.2

4.5

1.52

1.44

mg/l

2.88

1423

5366

ILD, hospital admissions

248

1246

2.03

23.57

3.5

3.0

1.79

1.71

mg/l

0.74

229

1109

Dental caries 3

1470

5599

1.35

23.54

4.7

4.3

1.58

1.47

mg/l

4.92

1374

5138

Arthropathies

1675

6474

1.33

23.50

3.9

4.6

1.52

1.37

mg/l

8.99

1554

6032

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

404

2146

1.74

23.44

11.7

8.3

1.24

1.17

mg/l

1.24

394

2052

Benign neoplasm of mouth and pharynx

201

938

2.20

23.31

3.4

3.1

1.34

1.56

mg/l

4.12

189

856

Asthma (only as main-diagnosis)

1101

4756

1.41

23.26

3.8

3.2

1.49

1.37

mg/l

4.48

1019

4390

Disorders of skin appendages

783

5348

1.48

23.26

5.3

4.0

1.56

1.42

mg/l

4.52

741

4958

Secondary uncertain malignant neoplasm

222

1077

2.11

23.25

4.4

3.3

1.43

1.65

mg/l

3.65

210

971

Calcific aortic valvular stenosis, including rheumatic fever

439

2573

1.69

23.24

3.1

2.8

2.14

1.77

mg/l

9.38

387

2269

Other interstitial pulmonary diseases

249

1260

2.02

23.19

3.5

3.0

1.79

1.71

mg/l

0.70

230

1120

Dysphagia

383

2216

1.75

23.19

3.9

3.0

1.61

1.58

mg/l

0.19

352

2003

Chronic ulcer of skin, not elsewhere classified

130

503

2.67

23.08

3.9

2.6

2.21

1.58

mg/l

8.15

119

444

Operations 2 for CAVS

437

2566

1.69

23.06

3.1

2.8

2.14

1.77

mg/l

9.32

385

2263

Calcific aortic valvular stenosis, diagnosis (helper)

437

2566

1.69

23.06

3.1

2.8

2.14

1.77

mg/l

9.32

385

2263

Abnormal findings on diagnostic imaging of lung

717

4694

1.50

23.04

3.3

2.9

1.79

1.66

mg/l

2.93

668

4216

Cardiac arrest

107

316

2.99

22.95

5.1

2.9

2.05

1.18

mg/l

11.92

290

Interstitial lung disease endpoints

249

1267

2.01

22.84

3.5

3.0

1.79

1.71

mg/l

0.64

230

1125

Interstitial lung disease

249

1267

2.01

22.84

3.5

3.0

1.79

1.71

mg/l

0.64

230

1125

Certain conditions originating in the perinatal period

253

1145

2.02

22.76

15.9

11.7

1.19

1.10

mg/l

1.93

247

1107

Diagnoses used for exclusion with ILD

416

2479

1.70

22.63

3.8

3.0

1.74

1.60

mg/l

1.95

368

2248

Angina pectoris

912

4306

1.44

22.62

3.2

2.8

1.86

1.56

mg/l

16.36

819

3896

Other local infections of skin and subcutaneous tissue

198

932

2.18

22.52

9.6

5.0

1.82

1.45

mg/l

4.51

187

862

ILD, hospital admissions 1, main diag only

226

1118

2.07

22.48

3.6

3.0

1.79

1.69

mg/l

1.02

208

1003

Kidney diseases associated to Fabry's disease

53.16

22.38

4.9

2.9

1.27

1.02

mg/l

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

774

4170

1.48

22.37

3.4

2.7

1.83

1.71

mg/l

2.70

687

3729

Secondary and unspecified malignant neoplasm of lymph nodes

163

711

2.36

22.36

5.1

3.6

1.49

1.61

mg/l

0.92

154

645

Misadventures to patients during surgical and medical care

233

1168

2.04

22.29

4.4

3.1

1.87

1.52

mg/l

5.43

215

1067

Other systemic involvement of connective tissue (FG)

370

2130

1.75

22.21

3.2

3.0

1.64

1.46

mg/l

3.48

332

1931

Hyperaldosteronism

214

3.66

22.09

3.0

3.7

1.69

1.62

mg/l

0.18

196

Other skin changes

280

1500

1.90

22.03

5.0

3.8

1.80

1.60

mg/l

2.86

260

1359

Bacterial pneumonia, not elsewhere classified

599

3455

1.55

22.02

5.3

3.6

1.78

1.50

mg/l

9.73

546

3152

Asthma-related pneumonia

588

3829

1.55

22.00

5.3

4.9

1.73

1.54

mg/l

4.58

539

3496

Hypoplasia of dental enamel, prenatal

101

11.39

21.99

61.1

18.4

1.39

1.00

mg/l

4.24

101

Major coronary heart disease event excluding revascularizations

1015

5022

1.41

21.98

3.5

2.9

2.01

1.60

mg/l

30.66

915

4563

Behavioural syndromes associated with physiological disturbances and physical factors

534

3407

1.59

21.96

6.1

5.0

1.45

1.36

mg/l

1.36

495

3208

Other CVD

296

1614

1.87

21.96

4.1

3.1

1.89

1.71

mg/l

2.74

264

1433

Asthma-related pneumonia or sepsis

589

3839

1.55

21.95

5.3

4.9

1.73

1.54

mg/l

4.53

540

3505

Asthma, hospital admissions 3, pneumonia

589

3839

1.55

21.95

5.3

4.9

1.73

1.54

mg/l

4.53

540

3505

Stomatitis and related lesions

158

685

2.37

21.92

15.8

3.0

1.38

1.39

mg/l

0.06

149

636

Disorders of thyroid, IBD co-morbidities

257

955

1.98

21.91

3.0

1.58

1.21

mg/l

8.89

233

890

Sequelae of external causes of morbidity and mortality

396

2351

1.71

21.89

4.5

3.3

1.84

1.55

mg/l

6.33

366

2146

Sequelae with surgical and medical care as external cause

324

1819

1.81

21.88

4.7

3.2

1.89

1.58

mg/l

5.63

300

1657

Testicular dysfunction

102

360

2.99

21.88

2.9

3.0

1.44

1.41

mg/l

0.14

344

Disorders of magnesium metabolism

7.69

21.86

2.9

2.4

1.85

1.44

mg/l

1.20

Myocarditis

315

3.07

21.81

3.8

2.4

1.66

1.06

mg/l

7.86

289

Other and unspecified tonsillitis

603

3344

1.55

21.76

6.8

4.1

1.37

1.30

mg/l

1.47

590

3158

Malnutrition

223

3.65

21.71

14.6

14.1

1.39

1.36

mg/l

0.13

209

Nonalcoholic fatty liver disease

179

822

2.24

21.70

3.4

3.6

1.61

1.45

mg/l

1.44

162

771

Dental pulpitis 4

1892

7676

1.29

21.67

3.6

4.3

1.56

1.45

mg/l

6.77

1744

7097

Dental caries 2

1276

7493

1.35

21.66

7.7

3.7

1.39

1.42

mg/l

0.65

1206

6981

Collagenous colitis

167

746

2.30

21.65

4.7

4.4

1.56

1.53

mg/l

0.23

155

687

Malignant neoplasm of skin

882

4671

1.43

21.55

3.4

2.7

1.80

1.68

mg/l

3.06

789

4188

Diseases of pulp and periapical tissues, including avohilmo

1889

7670

1.29

21.52

3.6

4.2

1.57

1.45

mg/l

7.15

1740

7094

Endocrine disorders, other/unspecified

153

4.18

21.49

5.1

3.2

1.78

1.46

mg/l

1.47

140

Unknown and unspecified causes of morbidity

136

558

2.50

21.32

4.8

3.0

1.78

1.43

mg/l

3.68

128

506

Crohn's disease of small intestine

145

614

2.43

21.31

3.7

4.3

1.45

1.41

mg/l

0.23

138

578

Acute and subacute iridocyclitis

327

1856

1.79

21.29

3.9

3.5

1.66

1.49

mg/l

2.95

305

1713

Accidents

1515

5764

1.32

21.24

4.2

4.5

1.52

1.44

mg/l

2.87

1402

5366

Dental pulpitis 1

1888

7680

1.28

21.22

3.6

4.2

1.56

1.45

mg/l

6.82

1740

7101

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

125

494

2.59

21.19

3.8

2.9

1.47

1.23

mg/l

2.94

118

468

Iridocyclitis

378

2237

1.72

21.18

3.9

3.6

1.65

1.49

mg/l

3.15

354

2057

Asthma-related infections

971

6900

1.40

21.16

5.0

4.9

1.55

1.47

mg/l

2.06

905

6370

Asthma, hospital admission 2, infections

971

6900

1.40

21.16

5.0

4.9

1.55

1.47

mg/l

2.06

905

6370

Other symptoms and signs involving the digestive system and abdomen

265

1416

1.90

20.98

6.2

3.8

1.56

1.46

mg/l

1.33

245

1295

Melanocytic naevi, other sites/unspecified

148

637

2.39

20.94

6.8

3.9

1.69

1.47

mg/l

2.06

140

589

Haemorrhage, not elsewhere classified

251

3.32

20.89

5.5

3.3

2.29

1.58

mg/l

4.63

221

COPD-related respiratory insufficiency

198

959

2.11

20.88

3.3

2.7

2.21

1.74

mg/l

7.27

174

856

Other congenital malformations

216

1083

2.06

20.87

8.9

10.9

1.33

1.25

mg/l

0.60

206

1040

Drug-induced neutropenia

138

580

2.46

20.66

3.8

3.2

1.49

1.58

mg/l

0.61

129

535

Mixed hyperlipidaemia

300

3.09

20.60

3.4

2.6

1.98

1.55

mg/l

2.67

277

Ventral hernia

382

2285

1.70

20.57

4.8

3.0

1.82

1.59

mg/l

5.99

350

2081

Clear cell adenocarcinoma of kidney, excluding all cancers (controls excluding all cancers)

311

3.05

20.57

2.6

2.5

1.92

1.62

mg/l

2.35

276

Hernia

1551

8118

1.30

20.52

4.7

3.7

1.61

1.49

mg/l

5.94

1431

7481

Gastric ulcer

284

1566

1.84

20.36

4.0

2.8

1.94

1.68

mg/l

3.90

264

1407

Hypotension

248

1315

1.92

20.14

3.7

2.6

1.91

1.75

mg/l

2.06

218

1153

Type 1 diabetes, definitions combined

246

1301

1.93

20.14

5.8

9.6

1.68

1.13

mg/l

18.67

233

1253

External causes of morbidity and mortality

1230

4577

1.36

20.13

4.7

4.6

1.47

1.40

mg/l

2.17

1150

4264

Carcinoma in situ of skin

133

556

2.46

20.11

4.7

2.6

2.04

1.74

mg/l

2.15

121

489

Vitamin deficiency

104

387

2.79

20.07

6.2

4.0

1.57

1.51

mg/l

0.32

358

Vitamin deficiency, wide

104

387

2.79

20.07

6.2

4.0

1.57

1.51

mg/l

0.32

358

Stroke, excluding SAH

895

4755

1.41

19.96

3.8

3.1

1.87

1.64

mg/l

9.00

803

4307

Stroke, including SAH

949

5073

1.40

19.92

3.8

3.1

1.86

1.63

mg/l

9.94

854

4595

Other ulcerative colitis

127

523

2.51

19.92

5.1

3.9

1.45

1.44

mg/l

0.07

116

487

Dental caries 2 and operation codes

1235

7403

1.33

19.73

7.7

3.7

1.39

1.42

mg/l

0.51

1166

6896

Major coronary heart disease event

1088

5358

1.37

19.63

3.7

3.0

1.98

1.58

mg/l

31.41

984

4863

Soft tissue disorders

1863

7646

1.27

19.52

4.9

4.4

1.53

1.44

mg/l

4.13

1731

7100

Other endocrine disorders

190

902

2.13

19.45

18.6

14.4

1.38

1.15

mg/l

4.04

179

871

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

172

813

2.17

19.42

6.5

3.5

1.78

1.56

mg/l

2.35

158

739

Type 1 diabetes, strict (exclude DM2)

244

1304

1.91

19.37

5.8

9.8

1.68

1.13

mg/l

18.14

231

1256

Injuries to the knee and lower leg

1982

9067

1.26

19.19

3.8

4.1

1.55

1.48

mg/l

2.89

1838

8372

Herpesviral [herpes simplex] infections

199

998

2.04

19.12

6.2

3.9

1.66

1.44

mg/l

2.53

189

924

Benign neoplasm: Colon, unspecified

325

1891

1.73

19.03

3.6

2.7

1.97

1.72

mg/l

4.51

302

1670

Benign neoplasm: Skin of trunk

287

3.04

18.99

5.2

3.1

1.86

1.48

mg/l

2.00

263

DVT of lower extremities

291

1653

1.79

18.93

4.0

2.6

1.85

1.58

mg/l

4.27

267

1490

Anterior Iridocyclitis

337

1996

1.71

18.91

4.1

3.6

1.65

1.50

mg/l

2.55

315

1843

Obesity related asthma

528

3481

1.53

18.90

3.3

3.5

1.72

1.51

mg/l

5.13

481

3201

Other blood glucose lowering drugs, excl. Insulins

256

1402

1.86

18.83

2.9

2.8

2.06

1.59

mg/l

9.78

230

1280

Hypertrophic cardiomyopathy

362

2.80

18.75

4.9

4.4

1.72

1.65

mg/l

0.35

329

Arterial embolism and thrombosis

104

400

2.67

18.72

4.9

2.9

2.25

1.67

mg/l

4.72

344

Myocardial infarction, strict

724

3680

1.45

18.71

3.5

2.7

2.06

1.57

mg/l

29.96

656

3336

Diseases of salivary glands

281

1588

1.79

18.58

3.3

2.5

1.51

1.46

mg/l

0.54

266

1435

Secondary malignant neoplasm of respiratory and digestive organs, excluding all cancers (controls excluding all cancers)

243

1316

1.88

18.52

2.5

2.7

1.47

1.71

mg/l

3.92

224

1160

Malignant neoplasm of gum, excluding all cancers (controls excluding all cancers)

5.91

18.50

2.1

2.2

1.11

1.53

mg/l

4.25

Umbilical hernia

453

2905

1.58

18.45

5.5

3.4

1.68

1.52

mg/l

3.49

418

2685

Crohn's disease (strict) with PSC

19.36

18.31

5.8

10.9

1.64

1.76

mg/l

0.11

Other pulmonary heart/vessel disease

343

2.81

18.30

4.1

5.4

2.01

1.69

mg/l

2.04

308

Ulcerative colitis (strict definition, all Crohn cases excluded)

260

1446

1.83

18.25

3.9

4.2

1.34

1.41

mg/l

0.92

238

1352

Early onset COPD, excluding more controls

310

1811

1.73

18.21

2.9

2.8

1.81

1.49

mg/l

5.71

275

1649

malignant neoplasm of female genital organs, excluding all cancers (controls excluding all cancers)

220

1138

1.93

18.21

3.8

2.8

1.44

1.61

mg/l

2.69

206

1018

Personal history of other diseases and conditions

212

1102

1.96

18.16

10.3

5.9

1.31

1.11

mg/l

3.45

204

1051

Glaucoma

786

4936

1.41

17.98

3.3

2.9

1.73

1.67

mg/l

1.07

709

4445

Other complications of surgical and medical care, not elsewhere classified

166

798

2.13

17.94

4.7

3.7

1.57

1.42

mg/l

1.65

157

735

Fibrosis of liver

6.39

17.84

7.3

2.2

1.60

1.44

mg/l

0.51

Hepatomegaly and splenomegaly, not elsewhere classified

5.06

17.76

8.3

3.3

1.56

1.37

mg/l

0.72

Other leukaemias of specified cell type

11.99

17.69

12.5

5.3

1.85

1.37

mg/l

0.95

Hypopituitarism

176

873

2.08

17.68

10.1

9.3

1.33

1.28

mg/l

0.51

165

832

Speech and linguistic disorders

241

1275

1.87

17.54

19.0

11.3

1.20

1.16

mg/l

0.55

230

1226

Impotence

118

501

2.44

17.42

4.8

2.7

1.82

1.59

mg/l

1.56

110

459

Neuromuscular dysfunction of bladder

155

735

2.16

17.39

4.3

3.3

1.60

1.53

mg/l

0.44

139

665

Neovascular glaucoma

313

2.85

17.38

5.0

4.0

1.91

1.62

mg/l

2.17

284

Degeneration of macula and posterior pole

610

3453

1.47

17.38

3.3

2.8

1.88

1.70

mg/l

4.12

532

3097

Other specified congenital malformation syndromes affecting multiple systems

308

3.00

17.31

10.2

18.2

1.39

1.12

mg/l

1.44

302

KRA_PSY_EATING, excluding more controls

129

566

2.31

17.29

6.3

5.5

1.22

1.13

mg/l

0.66

115

540

Substance abuse, excluding more controls

906

5843

1.37

17.28

3.6

3.1

1.57

1.50

mg/l

1.51

828

5411

Non-Hodgkin lymphoma, all

292

2.92

17.28

2.2

3.0

1.58

1.81

mg/l

1.21

260

Extreme obesity with alveolar hypoventilation

315

2.84

17.21

2.7

2.9

2.14

1.52

mg/l

4.42

291

Intracranial trauma

955

5286

1.36

17.20

4.1

4.6

1.57

1.37

mg/l

9.48

875

4944

Visual disturbances and blindness

780

5637

1.40

17.16

4.9

4.2

1.57

1.51

mg/l

1.26

719

5174

Diseases of the myoneural junction and muscle

206

1087

1.94

17.15

3.8

4.5

1.91

1.54

mg/l

4.03

185

999

Prurigo nodularis

179

3.53

17.13

3.6

2.9

1.94

1.64

mg/l

1.19

163

738

5243

1.41

17.12

5.5

1.47

1.42

mg/l

0.90

694

4871

Rash and other nonspecific skin eruption

177

888

2.04

17.09

7.1

5.2

1.57

1.51

mg/l

0.34

164

814

Testicular hypofunction

323

2.83

17.08

3.0

2.9

1.44

1.42

mg/l

0.06

308

Disorders of eyelid, lacrimal system and orbit

1289

7838

1.30

16.95

4.1

3.7

1.55

1.53

mg/l

0.34

1179

7193

Problems related to lifestyle

175

877

2.03

16.89

3.1

3.0

1.54

1.34

mg/l

2.07

155

814

Other diseases of jaws

121

527

2.35

16.73

3.4

2.5

1.43

1.46

mg/l

0.16

116

486

Other pleural conditions

162

795

2.08

16.60

3.7

3.3

2.17

1.68

mg/l

6.30

149

698

Systemic lupus erythematosus, unspecified

234

3.13

16.57

4.1

3.8

1.61

1.47

mg/l

0.62

217

Urolithiasis

505

3395

1.50

16.55

4.1

3.1

1.65

1.64

mg/l

0.15

461

3084

Total colectomy operation

374

2.64

16.52

5.8

4.1

1.58

1.47

mg/l

0.63

349

Total colectomy

374

2.64

16.52

5.8

4.1

1.58

1.47

mg/l

0.63

349

Other diseases of stomach and duodenum

113

481

2.41

16.50

5.1

2.9

1.89

1.63

mg/l

1.96

101

436

Other disorders of lacrimal gland

481

3203

1.52

16.48

4.8

3.2

1.54

1.53

mg/l

0.06

438

2937

Other abnormal findings of blood chemistry

357

2.67

16.45

5.3

3.7

1.55

1.58

mg/l

0.12

330

Lichen simplex chronicus and prurigo

121

532

2.34

16.44

4.1

3.2

1.83

1.55

mg/l

2.16

113

486

Aortic aneurysm

342

2072

1.64

16.43

3.4

2.7

1.95

1.67

mg/l

5.74

316

1844

Acute laryngitis and tracheitis

236

1296

1.82

16.40

9.6

5.8

1.25

1.22

mg/l

0.29

228

1231

Other systemic involvement of connective tissue

385

2445

1.59

16.37

3.4

3.2

1.64

1.57

mg/l

0.83

347

2229

Disorders of lacrimal system

584

4046

1.46

16.35

4.7

3.4

1.53

1.54

mg/l

0.13

533

3702

Opening and dilatation of root channel of tooth

125

559

2.30

16.32

4.4

3.7

1.54

1.44

mg/l

0.58

119

522

Immunodeficiencies

114

492

2.40

16.28

10.4

7.1

1.59

1.40

mg/l

1.44

108

459

Glaucoma secondary to other eye disorders

326

2.73

16.11

5.0

4.0

1.91

1.66

mg/l

1.74

291

Basal cell carcinoma

753

4338

1.39

16.02

3.6

2.7

1.82

1.71

mg/l

2.45

676

3875

Secondary right heart disease

290

2.82

15.74

3.8

3.7

2.09

1.73

mg/l

2.30

261

Chronic gastritis

398

2574

1.56

15.65

2.9

2.8

1.71

1.64

mg/l

0.74

369

2317

Sarcoidosis

220

1221

1.83

15.64

3.3

3.1

1.71

1.50

mg/l

2.60

202

1130

Cholecystectomy

992

6653

1.33

15.63

3.4

2.9

1.67

1.56

mg/l

3.10

926

6042

Basal cell carcinoma, including avohilmo

769

4411

1.38

15.63

3.6

2.7

1.81

1.70

mg/l

2.48

690

3943

Calculus of kidney and ureter

470

3153

1.51

15.61

4.2

3.1

1.67

1.62

mg/l

0.61

429

2865

Keratitis

542

3740

1.46

15.57

4.3

3.5

1.66

1.48

mg/l

5.03

507

3448

Injury, poisoning and certain other consequences of external causes

997

3744

1.34

15.56

5.3

4.7

1.46

1.39

mg/l

1.65

927

3480

Injuries to the abdomen, lower back, lumbar spine and pelvis

591

4115

1.44

15.55

3.9

3.8

1.68

1.52

mg/l

3.54

546

3748

Localized swelling, mass and lump of skin and subcutaneous tissue

479

3230

1.50

15.50

5.3

4.1

1.39

1.51

mg/l

2.82

452

2955

Ischaemic Stroke, excluding all haemorrhages

806

4480

1.37

15.38

3.5

3.0

1.89

1.66

mg/l

8.62

721

4053

Duodenal ulcer

175

908

1.96

15.34

4.5

2.8

2.02

1.70

mg/l

3.72

159

817

Benign neoplasm of other and ill-defined parts of digestive system

261

1531

1.73

15.30

4.0

2.9

1.83

1.61

mg/l

2.72

243

1387

Other general symptoms and signs

105

444

2.41

15.23

9.0

6.6

1.35

1.28

mg/l

0.43

421

Anomalies of dental arch relationship, including avohilmo

346

1954

1.61

15.22

16.6

6.0

1.23

1.28

mg/l

0.68

321

1856

Acute pharyngitis

269

1582

1.71

15.21

10.1

5.0

1.28

1.27

mg/l

0.11

256

1492

Renal cell carcinoma of kidney, excluding all cancers (controls excluding all cancers)

204

3.14

15.03

2.8

2.5

1.86

1.73

mg/l

0.49

177

Benign neoplasm: Transverse colon

142

691

2.10

14.94

3.7

2.7

1.81

1.69

mg/l

0.82

130

612

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

508

3492

1.47

14.93

5.3

4.9

1.48

1.45

mg/l

0.43

466

3240

Later onset COPD, excluding more controls

271

1246

1.72

14.92

2.3

2.6

2.08

1.70

mg/l

6.51

230

1100

Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers

259

2.87

14.90

3.2

2.8

1.72

1.63

mg/l

0.31

227

Clear cell adenocarcinoma of kidney

370

2.55

14.84

2.6

2.9

1.92

1.67

mg/l

1.75

332

Visual impairment including blindness (binocular or monocular)

125

582

2.20

14.82

3.9

5.6

1.86

1.54

mg/l

3.03

118

528

Abnormal spermatozoa

202

1115

1.85

14.72

3.1

2.9

1.75

1.74

mg/l

0.05

179

1003

Pulmonary oedema

123

3.85

14.67

5.9

2.4

2.48

1.88

mg/l

2.92

109

Nonischemic cardiomyopathy

111

495

2.31

14.66

6.2

4.1

1.84

1.46

mg/l

4.29

103

457

All dysplastic lesions of the vulva

292

2.72

14.42

3.3

2.8

1.61

1.40

mg/l

1.32

272

Fracture of lumbar spine and pelvis

304

1882

1.63

14.40

3.6

3.1

1.83

1.65

mg/l

2.26

276

1686

Myelodysplastic syndrome, excluding all cancers (controls excluding all cancers)

158

3.41

14.39

3.6

3.5

1.50

1.67

mg/l

0.83

135

Exclusion endpoint for clefts

362

2.62

14.38

10.0

17.3

1.43

1.13

mg/l

1.69

353

Malignant neoplasm of nasal cavity and sinuses, excluding all cancers (controls excluding all cancers)

5.45

14.36

2.3

2.5

1.08

1.64

mg/l

4.97

Injuries to the ankle and foot

1110

7889

1.29

14.29

5.2

4.4

1.53

1.41

mg/l

4.14

1045

7353

Other arterial embolism and thrombosis

200

3.12

14.29

5.0

2.7

2.17

1.67

mg/l

2.32

174

Acute bronchiolitis

195

967

1.87

14.23

17.1

14.7

1.23

1.09

mg/l

2.25

189

937

Undetermined asthma, excluding more controls

175

935

1.90

14.00

5.4

3.3

1.45

1.33

mg/l

1.32

164

858

Open wound of ankle and foot

181

982

1.88

13.95

4.8

4.5

1.98

1.44

mg/l

7.97

173

914

Other joint disorders

1489

6370

1.25

13.82

3.4

4.2

1.43

1.38

mg/l

1.68

1380

5928

Abnormal findings on diagnostic imaging of other body structures

191

1058

1.84

13.73

3.5

3.4

1.58

1.52

mg/l

0.38

182

963

Crohn disease (strict definition, require KELA)

127

614

2.12

13.72

3.4

5.0

1.42

1.38

mg/l

0.25

121

578

Pruritus

168

895

1.91

13.67

6.0

4.0

1.83

1.47

mg/l

3.74

154

817

Chorioretinal inflammation

222

2.96

13.64

3.8

3.0

1.62

1.54

mg/l

0.29

207

Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)

163

859

1.92

13.57

2.6

2.7

1.88

1.86

mg/l

0.04

138

739

Exclusions for E4_PCOS_CONSORTIUM

1065

5181

1.30

13.55

5.3

4.8

1.44

1.38

mg/l

1.31

977

4837

Crohn disease (strict definition, require KELA, min 2 HDR)

125

604

2.12

13.53

3.4

5.0

1.43

1.37

mg/l

0.35

119

569

Nerve, nerve root and plexus disorders

1625

8326

1.23

13.48

3.3

3.1

1.67

1.51

mg/l

8.95

1486

7646

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

753

4576

1.35

13.41

3.6

2.9

1.51

1.47

mg/l

0.53

704

4208

Pain in joint

938

4756

1.31

13.33

3.4

3.6

1.52

1.44

mg/l

2.03

873

4397

Aortic valve malfunction, age under 60 years

185

1028

1.84

13.28

6.3

5.6

1.70

1.41

mg/l

3.30

170

965

Unspecified fall

771

5754

1.34

13.24

4.8

5.0

1.59

1.48

mg/l

2.58

700

5311

Concussion

793

5169

1.34

13.22

4.2

4.6

1.51

1.38

mg/l

4.64

726

4829

Malignant neoplasm of digestive organs

520

3616

1.43

13.19

4.5

2.8

1.71

1.72

mg/l

0.07

477

3235

Other benign neoplasms of skin

523

3702

1.43

13.16

4.3

3.1

1.67

1.58

mg/l

1.63

484

3341

Acute myeloid leukaemia and myelodysplastic syndromes, excluding all cancers (controls excluding all cancers)

232

2.85

13.11

4.5

4.2

1.44

1.62

mg/l

1.15

202

Secondary polycythaemia

179

3.16

13.06

1.8

3.1

1.45

1.56

mg/l

0.44

162

Other or ill-defined heart diseases

417

2.33

13.01

7.3

4.3

1.77

1.34

mg/l

3.19

393

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

131

654

2.05

12.99

3.5

4.8

1.43

1.38

mg/l

0.32

125

616

Benign neoplasm: Skin of trunk

351

2.47

12.95

5.2

3.4

1.86

1.55

mg/l

1.46

325

Diseases of male genital organs

1051

4127

1.30

12.93

4.4

4.9

1.58

1.47

mg/l

3.04

971

3866

Visual disturbances

697

5190

1.35

12.86

5.0

4.2

1.53

1.50

mg/l

0.42

642

4762

Mental and behavioural disorders due to psychoactive substance use

949

6951

1.30

12.86

3.6

3.3

1.57

1.51

mg/l

1.32

870

6436

Thyroiditis, ILD-related definition

174

957

1.85

12.82

3.4

4.4

1.47

1.40

mg/l

0.62

154

899

Discitis, unspecified

126

3.61

12.74

3.4

3.0

2.25

1.74

mg/l

1.96

114

Weight loss

167

911

1.87

12.72

6.7

6.3

1.51

1.50

mg/l

0.07

153

834

Special screening examination for infectious and parasitic diseases

366

1804

1.53

12.68

2.7

2.6

1.26

1.30

mg/l

0.43

345

1708

Obesity, other/unspecified

466

3255

1.44

12.64

3.1

3.3

1.75

1.40

mg/l

11.69

425

3029

Unspecified acute lower respiratory infection

249

1522

1.66

12.61

4.7

4.5

1.64

1.43

mg/l

2.91

235

1412

Injuries to the thorax

662

4912

1.36

12.50

3.5

3.2

1.76

1.56

mg/l

5.30

605

4492

Intestinal adhesions without obstruction

129

649

2.03

12.49

3.8

3.7

1.74

1.57

mg/l

1.15

122

583

Benign neoplasm of eye and adnexa

136

698

1.98

12.41

3.7

3.4

1.55

1.60

mg/l

0.25

122

624

Bipolar affective disorders

282

1783

1.60

12.39

2.7

3.1

1.41

1.36

mg/l

0.47

263

1675

Nonorganic sleeping disorders, excluding more controls

267

1667

1.62

12.37

3.9

4.1

1.48

1.37

mg/l

1.18

246

1556

Other diseases of anus and rectum

415

2847

1.47

12.34

4.1

3.5

1.67

1.56

mg/l

1.69

383

2584

Benign neoplasm of other and unspecified endocrine glands

171

948

1.83

12.30

3.1

1.56

mg/l

0.00

158

856

Other predominantly sexually transmitted diseases, not elsewhere classified

249

1534

1.64

12.19

3.6

3.2

1.45

1.33

mg/l

1.65

237

1453

Other and unspecified acquired haemolytic anaemias

4.39

12.17

6.8

4.0

2.15

1.56

mg/l

2.48

Use of pramipexole

301

1942

1.57

12.14

3.9

2.9

1.83

1.61

mg/l

3.32

277

1762

L01XE Protein kinase inhibitors

100

464

2.22

12.08

7.9

3.2

1.52

1.64

mg/l

0.90

419

Acne

184

1049

1.78

12.06

7.8

6.4

1.51

1.19

mg/l

5.02

178

993

Anxiety (asthma-related co-morbidities)

922

5654

1.29

12.04

4.8

3.9

1.39

1.37

mg/l

0.33

857

5296

Malignant neoplasm of gum

6.93

12.04

1.8

2.2

1.10

1.82

mg/l

3.33

Fitting and adjustment of other devices

404

2584

1.47

11.81

3.8

2.6

1.75

1.53

mg/l

5.20

344

2304

Covid-19 suspected case

314

2060

1.54

11.75

6.3

4.2

1.34

1.35

mg/l

0.09

283

1933

Disorder of lipoprotein metabolism, unspecified

181

1035

1.77

11.74

3.7

2.7

1.99

1.56

mg/l

6.91

165

932

Hydrocele

203

1200

1.72

11.73

4.9

4.4

1.86

1.61

mg/l

3.30

188

1099

Other interventions on the root canals of the tooth

159

3.17

11.70

7.3

4.9

1.88

1.37

mg/l

1.67

147

Spondylopathies

1237

6047

1.25

11.66

2.9

3.1

1.63

1.55

mg/l

2.49

1117

5561

ILD-related respiratory insufficiency

242

2.70

11.64

2.6

3.0

2.04

1.79

mg/l

1.23

217

Unspecified privation

172

973

1.80

11.63

4.5

4.0

1.73

1.48

mg/l

2.79

165

895

Astigmatism

139

740

1.93

11.52

14.1

10.6

1.32

1.28

mg/l

0.34

132

706

Other specific joint derangements/joint disorders

1134

6083

1.26

11.46

3.5

4.0

1.51

1.38

mg/l

5.42

1058

5664

Benign neoplasm: Ascending colon

161

897

1.82

11.43

4.0

2.6

1.87

1.69

mg/l

1.52

153

780

Malignant neoplasm of bone and articular cartilage of limbs, excluding all cancers (controls excluding all cancers)

4.34

11.38

20.3

7.5

1.25

1.51

mg/l

1.24

Seborrhoeic dermatitis

158

878

1.83

11.37

6.1

4.4

1.60

1.51

mg/l

0.60

146

802

Other anxiety disorders

661

4408

1.34

11.28

4.4

3.7

1.40

1.35

mg/l

0.89

609

4135

Heart failure and hypertrophic cardiomyopathy

142

3.27

11.23

4.2

2.9

2.07

1.60

mg/l

2.62

128

COPD

634

3908

1.35

11.20

2.6

3.0

1.94

1.68

mg/l

7.47

554

3524

Protein-energy malnutrition of moderate and mild degree

109

3.76

11.13

9.8

13.2

1.40

1.45

mg/l

0.13

Other disorders of ear

1421

7785

1.22

11.12

4.8

4.1

1.61

1.52

mg/l

3.40

1278

7201

Malignant neoplasm of endocrine gland, excluding all cancers (controls excluding all cancers)

119

607

2.00

11.12

7.1

4.1

1.49

1.48

mg/l

0.03

113

549

Crossbite

188

1026

1.75

11.11

21.9

12.6

1.15

1.14

mg/l

0.07

182

991

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

384

2653

1.46

11.10

3.0

3.2

1.45

1.36

mg/l

1.51

356

2488

Undetermined asthma

175

1007

1.76

11.08

5.4

3.3

1.45

1.41

mg/l

0.32

164

924

Colectomy operation

243

1528

1.61

11.03

4.1

3.0

1.78

1.62

mg/l

1.79

221

1378

Retinal vascular disorders

169

966

1.78

11.03

4.3

2.5

2.09

1.70

mg/l

4.71

153

854

All anxiety disorders

930

5901

1.28

11.00

4.8

3.7

1.39

1.37

mg/l

0.23

864

5525

Abnormal weight loss

147

810

1.85

10.92

4.1

6.1

1.52

1.51

mg/l

0.06

134

736

Use of antiglaucoma preparations and miotics

116

594

1.99

10.74

3.8

2.6

1.81

1.74

mg/l

0.34

106

521

Cerebral cysts

101

494

2.09

10.68

8.0

4.6

1.65

1.45

mg/l

1.26

456

Substance abuse

906

6850

1.27

10.67

3.6

3.3

1.57

1.51

mg/l

1.15

828

6342

Retinal detachment with retinal break

187

1111

1.71

10.65

3.4

2.7

1.85

1.61

mg/l

2.41

168

1010

Benign neoplasm: Caecum

130

694

1.90

10.63

2.9

2.7

1.92

1.71

mg/l

1.49

116

610

Retinal vascular occlusion

165

948

1.77

10.60

4.3

2.5

2.09

1.69

mg/l

4.75

150

839

Benign neoplasm: Tongue

179

2.89

10.57

3.1

1.33

1.58

mg/l

1.34

164

Open wound of head

822

6342

1.28

10.56

4.7

4.6

1.64

1.51

mg/l

3.86

752

5853

Fracture of foot, except ankle

366

2536

1.46

10.51

5.6

4.3

1.59

1.40

mg/l

3.55

342

2366

Symptoms and signs involving cognition, perception, emotional state and behaviour

1461

8502

1.21

10.45

3.4

3.7

1.60

1.51

mg/l

3.47

1338

7836

Symptoms and signs involving the nervous and musculoskeletal systems

845

6653

1.28

10.39

4.9

4.4

1.52

mg/l

0.08

779

6117

Myopia

201

1228

1.66

10.30

6.9

5.4

1.41

1.31

mg/l

0.78

189

1164

Combinations of oral blood glucose lowering drugs

388

2730

1.43

10.26

2.6

2.9

1.78

1.55

mg/l

4.89

340

2519

Other neurological diseases

1016

6563

1.25

10.25

4.1

3.4

1.68

1.58

mg/l

2.56

921

5986

Other and unspecified types of non-Hodgkin lymphoma, hilmo

313

2.37

10.23

3.2

3.1

1.72

1.73

mg/l

0.03

281

Dorsalgia

1609

7288

1.20

10.22

3.2

3.6

1.53

1.48

mg/l

1.41

1460

6750

Mixed specific developmental disorders

108

518

2.07

10.22

14.9

18.7

1.10

1.03

mg/l

0.99

108

511

Other chronic obstructive pulmonary disease

602

3767

1.34

10.21

2.6

3.0

1.95

1.68

mg/l

7.12

522

3391

Spondyloarthritis

254

1643

1.56

10.19

3.2

3.1

1.66

1.50

mg/l

2.06

230

1518

Polyarthrosis

248

1528

1.57

10.18

2.8

2.7

1.67

1.54

mg/l

1.38

218

1382

Abnormal blood-pressure reading, without diagnosis

359

2.26

10.10

6.9

5.5

1.22

1.39

mg/l

1.92

331

Urticaria and erythema

537

3996

1.35

10.09

6.9

5.1

1.44

1.40

mg/l

0.45

503

3727

Osteopathy in diseases classified elsewhere

4.75

10.06

9.6

3.6

1.52

1.57

mg/l

0.13

Glaucoma suspect

469

3423

1.38

10.00

3.4

2.9

1.67

1.64

mg/l

0.25

425

3084

Low back pain

1111

6956

1.24

9.99

3.2

3.4

1.57

1.49

mg/l

2.37

996

6433

Liver disorders in diseases classified elsewhere

9.15

9.96

6.4

2.7

1.93

1.32

mg/l

1.63

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

117

618

1.93

9.94

4.0

3.3

1.96

1.56

mg/l

3.17

109

566

Abnormalities of gait and mobility

185

1120

1.68

9.88

5.1

5.8

1.63

1.59

mg/l

0.31

171

1018

Oral leukoplakia and related diseases, including avohilmo

136

756

1.83

9.85

2.7

3.1

1.38

1.58

mg/l

2.11

126

698

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

105

540

2.03

9.84

9.8

15.1

1.36

1.14

mg/l

1.52

100

524

COPD related to multimorbidity

522

3259

1.36

9.83

2.6

2.9

2.04

1.72

mg/l

8.37

450

2926

Other congenital malformations of kidney

4.59

9.82

9.1

18.1

1.36

1.20

mg/l

0.48

Other and unspecified myopathies

130

714

1.85

9.79

3.8

3.7

2.10

1.59

mg/l

4.01

115

644

Chronic lower respiratory diseases

1982

9164

1.17

9.78

3.9

4.5

1.55

1.46

mg/l

4.71

1826

8500

Noninflammatory disorders of female genital tract

560

2084

1.36

9.77

5.5

3.7

1.35

1.39

mg/l

0.61

527

1928

Alcohol-induced chronic pancreatitis

118

631

1.91

9.72

4.0

2.9

1.82

1.55

mg/l

2.44

103

585

Alcohol-induced acute pancreatitis

334

2.29

9.70

3.4

3.0

1.91

1.53

mg/l

2.31

312

Malignant neoplasm of bone and articular cartilage

3.95

9.68

14.7

7.5

1.27

1.53

mg/l

0.92

Benign neoplasm: Sigmoid colon

214

1348

1.61

9.68

3.4

2.6

1.78

1.72

mg/l

0.40

201

1185

Renal cell carcinoma of kidney

259

2.47

9.66

2.8

2.9

1.86

1.80

mg/l

0.19

233

Dermatophytosis

193

1188

1.65

9.65

5.3

3.4

1.69

1.54

mg/l

1.45

180

1093

Delirium, not induced by alcohol and other psychoactive substances

153

884

1.75

9.64

3.2

2.6

1.98

1.73

mg/l

2.72

138

776

Other noninflammatory disorders of vulva and perineum

122

661

1.87

9.56

3.2

3.1

1.42

1.40

mg/l

0.09

115

613

Benign neoplasm: Rectum, anus and anal canal

235

1518

1.56

9.54

2.9

2.6

1.71

1.73

mg/l

0.11

219

1340

Benign neoplasm: Colon, unspecified

325

2250

1.46

9.44

3.6

2.7

1.97

1.66

mg/l

6.60

302

2017

Use of anticholinesterases

165

2198

0.60

9.43

2.0

2.5

1.66

1.87

mg/l

2.68

135

1910

N06DA Anticholinesterases

165

2198

0.60

9.43

2.0

2.5

1.66

1.87

mg/l

2.68

135

1910

Supplementary factors related to causes of morbidity and mortality classified elsewhere

454

3331

1.37

9.41

6.3

4.2

1.61

1.46

mg/l

2.44

406

3087

Oral leukoplakia and related diseases

450

2.07

9.40

2.8

3.2

1.50

1.64

mg/l

0.75

410

Non-invasive ventilation

271

1697

1.51

9.40

5.0

3.7

1.86

1.26

mg/l

16.93

249

1573

Other diseases of oesophagus

139

790

1.79

9.34

3.7

2.7

1.68

1.61

mg/l

0.45

129

717

Amenorrhoea

492

2.00

9.27

4.6

4.2

1.36

1.22

mg/l

1.07

464

Recurrent or chronic depression

607

3343

1.32

9.25

3.4

3.3

1.40

1.41

mg/l

0.08

552

3121

Vascular disorders of the intestines

459

2.04

9.23

4.3

2.8

2.18

1.72

mg/l

2.97

397

Sicca syndrome [Sjögren]

118

641

1.87

9.21

2.7

2.9

1.56

1.54

mg/l

0.12

109

591

Infective dermatitis

169

1018

1.68

9.21

3.8

3.3

1.59

1.52

mg/l

0.54

151

932

Amiodarone users

150

876

1.74

9.20

3.4

3.0

1.98

1.71

mg/l

3.22

143

792

Hyperfunction of pituitary gland

393

2.13

9.20

7.0

5.1

1.51

1.32

mg/l

1.04

368

Selective serotonin reuptake inhibitors

1636

7283

1.19

9.19

3.3

3.7

1.46

1.52

mg/l

1.77

1507

6736

Postmenopausal osteoporosis with pathological fracture

360

2.18

9.19

2.5

2.4

1.71

1.63

mg/l

0.35

317

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

490

2.02

9.19

13.9

11.3

1.33

1.12

mg/l

1.67

465

Sleep disorders

308

2123

1.47

9.17

3.8

4.3

1.50

1.41

mg/l

0.90

284

1983

Malignant neoplasm of nasal cavity and sinuses

4.55

9.16

2.7

2.5

1.08

1.66

mg/l

4.47

Specific development disorders of scholastic skills

117

633

1.88

9.06

19.5

12.4

1.19

1.08

mg/l

1.25

112

613

Other disorders of veins

489

3648

1.35

9.04

3.0

2.8

1.66

1.52

mg/l

2.96

458

3321

Crohn disease (strict definition, all UC cases excluded)

450

2.05

9.04

2.8

4.9

1.42

1.41

mg/l

0.04

421

Cerebral palsy and other paralytic syndromes

178

1093

1.65

9.02

7.3

5.4

1.49

1.43

mg/l

0.35

158

1011

Asthma (diagnoses ohter than nonallergic)

1308

9352

1.20

9.02

3.9

4.4

1.52

1.48

mg/l

0.95

1211

8632

Irregular menses

563

3472

1.32

8.91

4.5

3.3

1.44

1.35

mg/l

1.92

528

3234

Substance use, excluding alcohol

293

2013

1.47

8.90

3.2

1.49

1.41

mg/l

0.85

270

1882

Polyuria

294

2021

1.47

8.89

3.0

2.9

1.65

1.59

mg/l

0.56

260

1835

Other obstetric conditions, not elsewhere classified

350

1595

1.43

8.83

3.1

1.23

1.22

mg/l

0.11

326

1510

Digestive system disorders of fetus and newborn

7.18

8.80

13.3

25.6

1.14

1.08

mg/l

0.21

Benign neoplasm: Rectum

207

1325

1.58

8.80

2.9

2.7

1.64

1.72

mg/l

0.76

192

1167

Abrasion of teeth

339

1748

1.44

8.79

3.3

2.5

1.44

mg/l

0.02

317

1606

Unspecific neurodegenerative disorder

245

2516

0.67

8.77

2.2

2.5

1.72

1.86

mg/l

1.71

198

2207

Meniscus derangement

826

4510

1.26

8.75

2.7

2.8

1.56

1.47

mg/l

2.14

759

4152

Oesophagitis

456

2.02

8.72

4.5

3.5

1.78

1.59

mg/l

1.24

414

Spondylosis

759

5166

1.27

8.70

2.7

3.0

1.59

mg/l

0.07

672

4726

Lung diseases due to external agents

189

1188

1.61

8.70

4.5

3.0

1.76

1.69

mg/l

0.41

159

1069

Type of accident

416

3051

1.38

8.70

6.7

4.2

1.60

1.46

mg/l

2.21

373

2824

Acne vulgaris

141

823

1.74

8.69

6.2

6.1

1.45

1.18

mg/l

4.13

136

779

COPD, early/later onset

606

3950

1.30

8.65

2.6

3.0

1.95

1.69

mg/l

6.89

526

3564

Other and unspecified disorders of skin and subcutaneous tissue

499

1.96

8.62

2.6

3.4

1.84

1.53

mg/l

1.87

457

Other postsurgical states

521

1.94

8.58

12.9

5.3

1.26

1.30

mg/l

0.21

476

Degenerative macular diseases

159

962

1.68

8.55

3.4

2.5

1.98

1.69

mg/l

2.48

136

855

Inflammatory diseases of female pelvic organs

704

4172

1.28

8.54

3.3

3.2

1.43

1.42

mg/l

0.04

660

3836

Rosacea

154

926

1.69

8.49

5.4

3.3

1.56

1.49

mg/l

0.46

143

857

Rheumatoid arthritis

417

2785

1.37

8.49

2.9

2.7

1.68

1.49

mg/l

3.97

366

2528

Deep bite

229

1322

1.54

8.44

17.0

9.9

1.25

1.21

mg/l

0.52

217

1269

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

340

1554

1.43

8.44

3.1

1.24

1.22

mg/l

0.26

316

1473

Poisoning by drugs, medicaments and biological substances

346

2475

1.41

8.43

3.3

3.9

1.43

1.37

mg/l

0.64

320

2326

Other disorders of optic [2nd] nerve and visual pathways

108

589

1.87

8.42

6.9

6.6

1.56

1.45

mg/l

0.59

100

546

Toxic liver disease

145

2.90

8.42

7.8

3.3

1.63

1.49

mg/l

0.48

132

Insomnia

221

1451

1.54

8.41

3.4

3.9

1.54

1.42

mg/l

0.97

202

1354

Fracture of lower leg, including ankle

782

6242

1.25

8.40

4.5

3.7

1.62

1.50

mg/l

3.76

721

5732

COPD, hospital admissions

599

3926

1.30

8.38

2.6

3.0

1.95

1.69

mg/l

6.73

519

3543

Corneal ulcer

264

1800

1.48

8.38

4.4

3.7

1.73

1.45

mg/l

5.19

249

1668

Papulosquamous disorders

550

4226

1.31

8.37

3.4

1.57

1.52

mg/l

0.77

495

3878

Dental operations, only avohilmo

1139

4817

1.22

8.36

3.4

4.2

1.59

1.53

mg/l

1.14

1051

4419

Conjunctivitis (acute, non atopic)

433

3207

1.36

8.34

7.6

6.2

1.43

1.37

mg/l

0.80

416

3006

Folate deficiency anaemia

4.15

8.32

3.1

2.4

1.98

1.51

mg/l

1.67

Sensorineural hearing loss

1063

6137

1.22

8.29

4.3

3.5

1.69

1.59

mg/l

2.72

933

5621

Type 1 diabetes, strict definition, subgroup 1

165

1016

1.65

8.28

5.1

10.1

1.66

1.07

mg/l

16.83

155

987

Benign neoplasm: Descending colon

444

2.00

8.26

4.1

2.7

1.78

1.62

mg/l

0.94

393

Thoracic aortic aneurysm

192

1229

1.58

8.24

3.5

2.7

1.86

1.59

mg/l

3.32

182

1102

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

781

6142

1.25

8.23

3.3

3.7

1.43

1.53

mg/l

2.87

721

5686

Lung cancer and mesothelioma

231

1309

1.52

8.22

3.0

2.8

1.51

1.64

mg/l

1.68

216

1171

Ovarian cyst

442

1884

1.36

8.22

3.7

3.2

1.44

1.43

mg/l

0.04

408

1734

Gestational [pregnancy-induced] hypertension

277

1910

1.46

8.15

3.2

2.8

1.46

1.30

mg/l

2.88

259

1796

Superficial injury of lower leg

350

2524

1.40

8.15

4.1

4.4

1.65

1.42

mg/l

4.18

323

2337

Mental and behavioural disorders due to opioids

326

2.17

8.11

3.6

3.1

1.60

1.29

mg/l

1.81

306

Nonorganic sleeping disorders

267

1837

1.47

8.10

3.9

4.6

1.48

1.39

mg/l

0.86

246

1716

Excessive, frequent and irregular menstruation

485

2020

1.34

8.08

4.6

3.5

1.41

1.40

mg/l

0.01

457

1867

Other and unspecified glaucoma

490

1.93

8.04

3.2

3.0

1.84

1.73

mg/l

0.59

434

Type1 diabetes, definitions combined, early onset

168

1047

1.63

8.04

6.3

11.7

1.63

1.13

mg/l

14.88

158

1015

Malignant melanoma, excluding all cancers (controls excluding all cancers)

200

1298

1.56

8.04

3.7

2.7

1.72

mg/l

0.03

188

1143

Eating disorder

129

750

1.74

8.04

6.3

6.6

1.22

1.18

mg/l

0.21

115

712

Coxarthrosis [arthrosis of hip](FG)

706

4047

1.27

8.03

2.9

2.7

1.73

1.54

mg/l

7.19

636

3671

Functional dyspepsia

343

2471

1.40

8.03

3.2

3.1

1.57

1.51

mg/l

0.61

310

2264

328

2072

1.41

8.01

3.2

2.5

1.95

1.82

mg/l

1.52

283

1818

Benign neoplasm: Transverse colon

142

851

1.70

7.99

3.7

2.8

1.81

1.65

mg/l

1.21

130

764

Fracture of rib(s), sternum and thoracic spine

408

3027

1.36

7.97

3.2

3.0

1.83

1.60

mg/l

4.39

370

2739

Tooth eruption problems

238

1591

1.50

7.96

15.0

7.8

1.33

1.18

mg/l

2.74

231

1517

Multiple myeloma

172

2.64

7.96

2.7

2.8

1.94

1.84

mg/l

0.20

151

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

172

2.64

7.96

2.7

2.8

1.94

1.84

mg/l

0.20

151

Other chronic obstructive pulmonary disease, including avohilmo

715

4738

1.26

7.95

2.5

3.0

1.88

1.67

mg/l

6.40

626

4293

Dental caries 1, only avohilmo

1326

5708

1.19

7.92

3.6

4.7

1.56

1.51

mg/l

1.41

1234

5256

Polycystic ovarian syndrome, consortium definition

840

4089

1.24

7.91

3.9

3.2

1.51

1.40

mg/l

3.29

777

3775

237

1512

1.50

7.90

3.1

2.5

1.99

1.82

mg/l

1.50

202

1315

Endometriosis

415

1816

1.37

7.88

2.6

3.0

1.39

1.44

mg/l

0.74

383

1669

Other and unspecified rosacea

118

675

1.78

7.85

3.5

3.0

1.58

1.53

mg/l

0.23

110

624

Personality disorders, excluding more controls

343

2482

1.39

7.82

3.1

3.0

1.44

1.36

mg/l

1.05

315

2337

Mental and behavioural disorders due to alcohol

780

6139

1.24

7.77

3.6

3.3

1.59

1.53

mg/l

0.98

716

5677

Methotrexate

185

1190

1.57

7.75

2.6

3.1

1.54

1.45

mg/l

0.76

166

1096

Coxarthrosis

679

3648

1.27

7.71

2.9

2.7

1.73

1.53

mg/l

7.12

611

3319

Coronary revascularization (ANGIO or CABG)

629

3451

1.28

7.64

3.8

2.8

2.06

1.58

mg/l

26.41

571

3118

Abnormality of white blood cells, not elsewhere classified

3.89

7.63

7.2

3.7

1.73

1.35

mg/l

1.10

Pneumonitis due to solids and liquids

112

637

1.79

7.61

4.8

3.3

1.75

1.66

mg/l

0.39

565

Eating disorders

153

945

1.64

7.61

6.0

5.9

1.33

1.25

mg/l

0.58

139

895

Coronary artery bypass grafting

373

2083

1.37

7.56

3.3

2.6

2.19

1.66

mg/l

18.38

336

1857

Hypermetropia

140

850

1.68

7.56

16.4

10.1

1.49

1.29

mg/l

2.20

129

806

Benign neoplasm: Stomach

114

653

1.77

7.55

4.5

2.7

1.86

1.63

mg/l

1.83

106

579

Nail disorders

130

774

1.71

7.53

5.5

4.8

1.71

1.44

mg/l

2.36

119

723

Marasmic kwashiorkor

5.92

7.52

33.7

18.3

1.32

1.47

mg/l

0.36

Type 1 diabetes, strict definition

172

1098

1.59

7.47

5.7

10.4

1.65

1.08

mg/l

16.95

162

1065

Psoriasis

396

2956

1.35

7.46

3.5

3.3

1.57

1.51

mg/l

0.61

357

2722

Seropositive rheumatoid arthritis

304

2169

1.41

7.45

2.7

1.69

1.49

mg/l

3.16

273

1964

Conductive and sensorineural hearing loss

1125

6530

1.20

7.45

4.6

3.6

1.67

1.57

mg/l

2.94

992

5998

Specific development disorders of speech and language

143

844

1.67

7.44

18.3

12.9

1.20

1.17

mg/l

0.28

137

805

Dizziness and giddiness

1040

7044

1.20

7.39

3.3

3.4

1.61

1.55

mg/l

1.28

947

6449

COPD, hospital admission 2, with asthma infections

417

2671

1.34

7.39

2.6

3.0

2.05

1.72

mg/l

7.22

361

2396

Strabismus

409

3069

1.34

7.37

7.9

6.4

1.41

1.37

mg/l

0.42

374

2879

Cystic fibrosis, other manifestations/unspecified

9.09

7.36

5.8

7.2

1.64

1.18

mg/l

—

Benign neoplasm: Tongue

216

2.39

7.34

3.1

2.9

1.33

1.63

mg/l

1.77

197

Moderate visual impairment, binocular

222

2.36

7.34

4.6

4.5

1.91

1.71

mg/l

0.79

195

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

111

637

1.77

7.32

3.6

2.9

1.53

1.40

mg/l

0.84

103

596

Dermatitis due to substances taken internally

479

1.89

7.28

5.6

5.9

1.56

1.46

mg/l

0.55

445

Alzheimer disease, including avohilmo

194

2096

0.66

7.25

2.3

2.5

1.79

1.89

mg/l

0.84

155

1826

malignant neoplasm of female genital organs

171

1099

1.57

7.24

4.1

2.8

1.42

1.59

mg/l

2.18

159

988

Lower back pain or/and sciatica

1505

8992

1.16

7.17

3.0

3.3

1.55

1.51

mg/l

1.01

1358

8308

Orchitis and epididymitis

147

915

1.63

7.17

4.2

4.0

1.60

1.55

mg/l

0.28

132

842

Other strabismus

339

2483

1.37

7.14

8.6

6.8

1.36

1.33

mg/l

0.41

313

2347

Vitamin B12 deficiency anaemia

133

809

1.66

7.08

2.7

1.78

1.66

mg/l

0.85

121

714

Diseases of external ear

477

3686

1.30

7.06

6.3

4.6

1.62

1.50

mg/l

2.21

429

3394

Post-traumatic stress disorder

109

630

1.75

7.02

6.1

4.3

1.27

1.23

mg/l

0.27

104

601

Recurring oral aphthae, including avohilmo

196

1310

1.51

6.98

13.5

4.9

1.31

1.43

mg/l

2.21

186

1212

Reactive arthropathies

128

775

1.67

6.97

3.4

3.8

1.57

1.40

mg/l

1.34

117

720

Other and unspecified vascular occlusions

120

715

1.70

6.94

4.5

2.5

2.05

1.69

mg/l

3.60

109

626

Benign neoplasm of eye and adnexa

136

839

1.64

6.89

3.7

3.3

1.55

1.57

mg/l

0.10

122

762

Follow-up examination after treatment for conditions other than malignant neoplasms

599

3104

1.27

6.89

3.7

2.7

1.47

1.48

mg/l

0.14

565

2847

Campylobacter enteritis

216

2.33

6.89

5.2

4.1

1.67

1.47

mg/l

0.81

196

Alzheimer’s disease, wide definition

111

1549

0.59

6.88

2.2

2.4

1.68

1.90

mg/l

1.79

1343

Other sleep disorders

162

1043

1.57

6.86

3.4

3.8

1.59

1.48

mg/l

0.75

152

963

Benign neoplasm of middle ear and respiratory system

101

576

1.78

6.84

2.8

2.9

1.46

1.58

mg/l

0.87

520

Childhood asthma (age<16), excluding more controls

197

1042

1.51

6.81

8.0

5.1

1.19

1.12

mg/l

0.89

191

1001

Fracture of shoulder and upper arm

508

3974

1.29

6.81

5.0

4.5

1.62

1.51

mg/l

1.81

469

3642

Malignant neoplasm of eye, brain and central nervous system, excluding all cancers (controls excluding all cancers)

100

571

1.78

6.76

12.0

4.3

1.38

1.48

mg/l

0.61

519

Open wound of forearm

136

844

1.63

6.74

4.9

3.7

1.64

1.46

mg/l

1.66

124

776

Other eating disorders

434

1.90

6.74

7.7

7.9

1.15

1.17

mg/l

0.08

411

Benign neoplasm: Parotid gland

550

1.79

6.71

3.4

2.6

1.55

1.56

mg/l

0.03

494

Mental retardation, excluding more controls

536

1.81

6.70

12.3

12.8

1.11

1.18

mg/l

0.62

522

Intracranial injury

826

6604

1.21

6.63

4.3

4.5

1.60

1.49

mg/l

2.97

747

6101

Poisoning by medicine

304

2223

1.38

6.61

3.3

3.9

1.44

1.38

mg/l

0.79

282

2089

Atopic dermatitis, strict definition with reimbursement

453

3406

1.30

6.53

6.7

6.2

1.34

1.28

mg/l

1.04

435

3227

Idiopathic pulmonary fibrosis

570

1.76

6.52

2.6

2.7

1.82

1.79

mg/l

0.12

502

Familial hypercholesterolemia

186

1248

1.50

6.50

3.3

1.82

1.60

mg/l

2.73

165

1114

Other dorsopathies, not elsewhere classified

1603

7354

1.15

6.48

3.3

3.7

1.50

1.48

mg/l

0.55

1470

6814

Other localized connective tissue disorders

130

2.70

6.48

4.8

3.2

2.09

1.53

mg/l

1.64

119

Fissure and fistula of anal and rectal regions

328

2436

1.36

6.46

3.4

3.1

1.52

1.49

mg/l

0.25

292

2234

Other abnormal uterine and vaginal bleeding

269

1369

1.41

6.45

2.7

3.0

1.56

1.51

mg/l

0.57

243

1246

Other disorders of conjunctiva

187

1260

1.50

6.43

4.1

3.5

1.74

1.62

mg/l

0.97

172

1146

Malignant neoplasm of respiratory system and intrathoracic organs

263

1733

1.41

6.43

3.4

2.8

1.39

1.79

mg/l

14.63

248

1538

Irritable bowel syndrome

343

2566

1.35

6.43

2.7

3.3

1.40

1.43

mg/l

0.39

313

2364

Other follicular disorders

104

610

1.73

6.43

5.2

3.3

1.83

1.42

mg/l

3.33

572

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

229

1606

1.44

6.39

3.0

3.8

1.44

1.37

mg/l

0.77

213

1514

Olecranon bursitis

100

582

1.75

6.38

3.2

2.8

1.82

1.58

mg/l

2.29

529

Congenital malformations of great veins

3.47

6.36

15.7

24.0

1.15

1.06

mg/l

0.54

Primary open-angle glaucoma, strict

306

2250

1.37

6.35

2.9

2.6

1.77

1.76

mg/l

0.08

277

1987

Ulcerative rectosigmoiditis

121

741

1.66

6.35

3.1

1.34

1.47

mg/l

1.10

108

693

Abscess of anal and rectal regions

128

795

1.63

6.35

4.2

4.5

1.68

1.43

mg/l

1.98

120

739

Congenital malformations and deformations of the musculoskeletal system

181

1211

1.51

6.35

11.0

11.8

1.19

1.20

mg/l

0.16

172

1162

Non-allergic asthma (mode), excluding more controls

233

1624

1.43

6.34

6.1

4.1

1.45

1.33

mg/l

1.42

221

1490

Myalgia

296

2171

1.37

6.33

3.0

3.4

1.37

1.44

mg/l

0.76

267

2004

Malignant neoplasm of other and unspecified major salivary glands, excluding all cancers (controls excluding all cancers)

3.71

6.29

2.1

2.5

1.10

1.60

mg/l

3.42

Other and unspecified follicular disorders

339

1.99

6.29

4.6

2.9

1.81

1.48

mg/l

1.44

314

L04AC Interleukin inhibitors

445

1.86

6.29

2.7

3.7

1.43

1.39

mg/l

0.15

423

Early onset COPD

310

2295

1.36

6.27

2.9

3.1

1.81

1.60

mg/l

2.84

275

2093

Childhood asthma (age<16)

197

1062

1.48

6.27

8.0

5.1

1.19

1.14

mg/l

0.62

191

1021

Benign neoplasm of other and unspecified endocrine glands

171

1138

1.52

6.26

3.1

3.4

1.56

1.53

mg/l

0.20

158

1051

Primary open-angle glaucoma

368

2720

1.33

6.26

2.8

2.7

1.82

1.75

mg/l

0.69

331

2416

Benign neoplasm: Skin of eyelid, including canthus

164

1081

1.53

6.26

3.0

2.7

1.57

1.64

mg/l

0.53

154

969

Benign neoplasm: Pituitary gland, craniopharyngeal duct

367

1.94

6.25

3.1

3.6

1.44

1.48

mg/l

0.23

332

Abdominal aortic aneurysm (AAA)

124

760

1.64

6.25

3.4

2.5

2.25

1.82

mg/l

4.85

110

646

Disorders of continuity of bone

130

814

1.62

6.24

4.1

3.9

1.74

1.43

mg/l

2.42

117

764

Presence of other devices

233

1645

1.42

6.22

3.7

2.3

1.75

1.60

mg/l

2.13

218

1457

Mental and behavioural disorders due to alcohol, excluding acute intoxication

657

5354

1.23

6.17

3.5

3.1

1.61

1.55

mg/l

0.98

602

4942

Injuries to the shoulder and upper arm

1223

8823

1.17

6.15

4.0

3.8

1.55

1.51

mg/l

0.66

1121

8126

Pyogenic arthritis

528

1.77

6.15

5.0

3.3

2.12

1.48

mg/l

4.70

486

Other disorders of eyelid

539

4157

1.26

6.14

3.1

3.0

1.64

1.67

mg/l

0.34

486

3743

Corns and callosities

551

1.75

6.13

4.8

3.3

2.07

1.50

mg/l

5.45

500

Other disorders of nervous system

552

1.75

6.10

4.0

3.1

1.72

1.59

mg/l

0.60

505

Muscular dystrophy

101

2.97

6.09

3.9

11.7

1.20

1.33

mg/l

0.49

Symptoms and signs involving speech and voice

410

3171

1.30

6.09

3.4

1.49

1.55

mg/l

0.88

367

2897

Exposure to other specified factors

1097

8796

1.17

6.08

3.9

4.4

1.50

1.46

mg/l

0.94

1005

8170

Disorders of optic nerve and visual pathways

137

875

1.59

6.07

5.8

5.5

1.55

1.43

mg/l

0.75

123

820

Injuries to the elbow and forearm

988

7568

1.18

6.07

5.1

4.3

1.53

1.46

mg/l

1.92

903

6996

Cholecystitis

169

1129

1.51

6.07

3.8

2.7

1.70

1.63

mg/l

0.55

158

1003

Leisure time condition

245

1758

1.41

6.04

6.7

4.6

1.58

1.45

mg/l

1.53

215

1630

Other perinatal digestive system disorders

10.50

6.02

16.4

23.4

1.23

1.07

mg/l

0.46

Benign neoplasm: Ascending colon

161

1068

1.52

6.01

4.0

2.8

1.87

1.69

mg/l

1.62

153

960

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

118

729

1.64

6.00

6.4

4.1

1.65

1.44

mg/l

1.29

106

669

Disorders of conjunctiva

1196

8624

1.17

5.97

5.0

4.5

1.43

1.44

mg/l

0.20

1111

7989

Injuries to unspecified part of trunk, limb or body region

143

927

1.56

5.95

4.3

5.6

1.93

1.45

mg/l

4.06

129

856

COPD, hospital admissions 3, with asthma pneumonia sepsis

332

2123

1.34

5.94

2.6

2.9

2.14

1.76

mg/l

7.20

283

1895

Dental caries 3, only avohilmo

1381

6118

1.16

5.92

3.7

4.8

1.55

1.49

mg/l

1.72

1282

5651

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

384

2956

1.31

5.92

3.0

3.6

1.45

1.38

mg/l

1.00

356

2781

Single spontaneous delivery

301

2154

0.74

5.90

2.6

3.4

1.39

1.52

mg/l

2.31

283

1967

Biological medication for rheuma

223

1582

1.42

5.89

3.2

5.0

1.30

1.37

mg/l

0.85

211

1501

Embedded and impacted teeth

368

2392

1.32

5.85

6.9

5.4

1.37

1.25

mg/l

2.66

349

2270

Unspecified misadventure during surgical and medical care

441

1.82

5.85

3.9

3.4

1.87

1.59

mg/l

1.35

402

Urticaria

413

3219

1.29

5.81

7.6

5.5

1.40

1.38

mg/l

0.31

387

3012

Benign neoplasm of major salivary glands

115

712

1.63

5.81

3.4

2.7

1.56

1.60

mg/l

0.21

102

640

Injuries to the hip and thigh

612

4564

1.23

5.77

3.9

3.7

1.71

1.60

mg/l

2.29

553

4140

All dysplastic lesions of the cervix uteri, vagina or vulva

301

2232

1.35

5.77

3.7

2.9

1.42

1.32

mg/l

1.30

284

2081

Migraine

638

4436

1.23

5.77

4.7

1.28

1.35

mg/l

2.08

604

4148

Fracture of femur

313

2143

1.34

5.76

3.8

3.5

1.91

1.70

mg/l

2.73

272

1910

Bitten or struck by other mammals

152

1006

1.53

5.75

3.6

5.0

1.37

mg/l

0.01

137

947

Menorrhagia

412

1757

1.30

5.74

3.8

3.2

1.45

mg/l

0.03

385

1613

Other abnormal findings in urine

127

2.62

5.73

6.4

4.5

1.75

1.65

mg/l

0.31

112

Temporomandibular joint disorders

198

1383

1.44

5.68

3.0

3.3

1.31

1.40

mg/l

1.02

184

1278

Restrictive cardiomyopathy

4.37

5.63

22.8

6.4

2.09

1.60

mg/l

0.68

Ingrowing nail

521

1.74

5.62

5.9

4.9

1.65

1.39

mg/l

1.56

487

Complications of other internal prosthetic devices, implants and grafts

290

2.01

5.61

6.8

4.0

2.00

1.55

mg/l

1.51

261

Coeliac disease

180

1240

1.47

5.61

4.7

6.4

1.62

1.38

mg/l

3.10

167

1156

Suicide or other Intentional self-harm

332

2529

1.32

5.57

3.1

3.6

1.49

1.40

mg/l

1.25

312

2369

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

110

682

1.64

5.57

3.4

3.6

1.42

1.32

mg/l

0.68

103

644

Myositis

217

2.18

5.56

4.3

3.5

1.70

1.56

mg/l

0.36

200

Visual field defects

114

713

1.62

5.56

5.6

3.7

1.67

1.59

mg/l

0.49

106

641

Benign neoplasm: Caecum

130

839

1.57

5.55

2.9

2.8

1.92

1.67

mg/l

1.97

116

751

Macular pucker

177

1218

1.47

5.55

3.3

2.8

1.85

1.69

mg/l

1.39

153

1083

Early syphilis

112

2.70

5.51

1.8

2.9

1.16

1.37

mg/l

1.55

105

Delivery

309

2165

0.75

5.49

2.8

3.5

1.41

1.52

mg/l

1.81

289

1977

Psoriatic and enteropathic arthropathies

155

1041

1.50

5.49

2.8

2.9

1.47

1.38

mg/l

0.75

136

975

Other/unspecified dorsalgia

507

4061

1.25

5.44

3.8

3.4

1.57

1.52

mg/l

0.78

457

3733

Melanoma in situ

266

2.03

5.43

5.1

2.5

1.90

1.65

mg/l

0.94

235

Paraplegia, diplegia of upper limbs

174

2.30

5.41

4.2

3.7

1.64

1.55

mg/l

0.21

159

Degenerative diseases of the nervous system

207

2174

0.71

5.40

2.5

1.77

1.85

mg/l

0.61

168

1906

Oxicams

243

1887

0.73

5.39

2.1

3.9

1.47

1.77

mg/l

6.50

220

1738

Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)

228

1370

1.40

5.38

3.1

2.7

1.51

1.81

mg/l

6.34

214

1196

Varicose veins

780

4942

1.20

5.37

2.8

2.7

1.69

1.58

mg/l

2.69

696

4479

Unspecified chronic bronchitis

274

2.01

5.36

4.3

3.8

1.75

1.71

mg/l

0.12

250

Ulcerative proctitis

528

1.71

5.35

2.7

3.8

1.30

1.45

mg/l

1.58

494

Other diseases of upper respiratory tract

1789

8284

1.13

5.35

4.0

4.5

1.46

1.51

mg/l

1.83

1650

7658

Leiomyoma of uterus

482

2157

1.26

5.35

3.0

2.8

1.48

1.45

mg/l

0.36

438

1991

Sulfasalazine

352

2720

1.30

5.33

2.5

2.8

1.48

1.45

mg/l

0.33

315

2500

Adenocarcinomas of cervix

4.31

5.30

4.6

1.9

1.06

1.29

mg/l

0.99

Chronic laryngitis and laryngotracheitis

179

1246

1.45

5.29

2.7

2.9

1.46

1.57

mg/l

0.94

161

1149

Pneumonia derived septicemia

318

1.93

5.29

9.7

7.7

1.60

1.53

mg/l

0.21

295

Alcohol use disorder, ICD-based

600

4938

1.22

5.26

3.5

3.1

1.60

1.54

mg/l

1.07

551

4552

Alzheimer disease

166

1803

0.69

5.24

2.4

1.81

1.90

mg/l

0.57

129

1563

Embedded teeth, including avohilmo

132

868

1.54

5.20

5.9

5.8

1.47

1.24

mg/l

2.97

127

820

Chronic rhinitis, nasopharyngitis and pharyngitis

437

3483

1.26

5.17

3.5

4.5

1.44

1.46

mg/l

0.24

397

3244

Other/unspecified crystal arthropathies

3.49

5.16

3.9

2.2

1.56

1.70

mg/l

0.33

Colonic or urogenital fistula

357

2778

1.29

5.15

3.7

3.1

1.56

1.54

mg/l

0.19

320

2553

Psoriasis vulgaris

250

1854

1.36

5.10

3.8

3.5

1.59

1.53

mg/l

0.47

230

1718

Alzheimer’s disease (Late onset)

104

1398

0.63

5.09

2.1

2.4

1.70

1.92

mg/l

1.72

1206

Congenital absence, atresia and stenosis of small intestine

5.76

5.09

17.2

16.7

1.03

1.09

mg/l

0.18

Subjective visual disturbances

300

2286

1.32

5.08

2.7

3.8

1.55

1.51

mg/l

0.37

282

2104

Dental pulpitis 4, only avohilmo

1750

8132

1.13

5.07

3.1

4.3

1.54

1.47

mg/l

2.70

1606

7526

Other benign neoplasms of connective and other soft tissue

112

714

1.58

5.06

2.2

3.4

1.56

1.52

mg/l

0.21

101

649

Other ill-defined and unspecified causes of mortality

454

1.74

5.05

3.0

2.9

2.06

1.80

mg/l

1.25

399

Melanoma of uvea

3.16

5.03

2.6

2.3

1.81

1.53

mg/l

0.57

Other specified/unspecified bacterial intestinal infections

553

1.67

5.03

5.2

4.2

1.85

1.53

mg/l

1.83

505

Haemangioma and lymphangioma, any site

110

700

1.59

5.02

5.9

4.7

1.44

mg/l

0.02

104

642

Paracetamol of NSAID medication

366

1425

1.30

5.00

6.2

7.6

1.42

1.39

mg/l

0.26

342

1352

Ulcer of oesophagus

577

1.65

4.99

3.0

2.8

1.98

1.67

mg/l

1.65

520

Dorsopathies

1664

7543

1.13

4.98

3.6

4.1

1.47

mg/l

0.03

1524

7001

Disorders of adult personality and behaviour

374

2942

1.28

4.96

2.9

3.4

1.42

1.37

mg/l

0.46

342

2778

Use of donepezil

1413

0.62

4.94

2.1

2.4

1.65

1.88

mg/l

1.75

1216

Hyperplasia of prostate

545

2531

1.23

4.94

3.0

1.73

1.65

mg/l

1.00

486

2322

Generalized skin eruption due to drugs and medicaments

340

1.86

4.93

6.1

5.9

1.49

mg/l

0.01

315

Inflammatory diseases of the central nervous system

117

759

1.56

4.93

5.8

4.3

1.61

1.47

mg/l

0.94

110

707

Other and unspecified drugs and medicaments

108

689

1.59

4.90

6.8

4.0

1.70

1.51

mg/l

0.98

638

Otitis externa

294

2247

1.32

4.89

7.9

4.8

1.61

1.45

mg/l

2.52

273

2098

Cerebral aneurysm, nonruptured

111

713

1.58

4.89

3.9

3.1

1.51

1.53

mg/l

0.08

101

646

Leukaemia of unspecified cell type

3.20

4.88

33.1

5.8

1.18

1.53

mg/l

1.48

Emphysema

558

1.65

4.86

2.2

3.2

1.94

1.70

mg/l

1.65

493

Phobic anxiety disorders

181

1284

1.42

4.85

8.3

4.9

1.30

1.23

mg/l

0.68

175

1220

Speech disturbances, not elsewhere classified

110

707

1.57

4.84

3.1

3.2

1.61

mg/l

0.01

632

Abnormal findings in secretions and smears from cervix uteri vagina vulva

515

3298

1.23

4.83

3.6

2.9

1.41

1.38

mg/l

0.28

489

3057

Complications of internal orthopaedic prosthetic devices, implants and grafts

257

1932

1.34

4.81

3.9

2.8

1.90

1.62

mg/l

4.15

233

1720

Haemangioma, any site

102

645

1.60

4.81

5.7

4.7

1.44

1.45

mg/l

0.07

591

Other and unspecified psoriasis

568

1.64

4.80

3.9

3.5

1.66

1.55

mg/l

0.60

522

Emergency coronary revascularization (for ACS)

717

4334

1.19

4.80

3.6

2.9

2.06

1.68

mg/l

20.06

650

3897

Bulimia nervosa (incl. atypical)

210

2.08

4.76

3.1

3.7

1.24

1.27

mg/l

0.09

195

malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)

396

1910

1.27

4.75

3.0

2.8

1.73

1.76

mg/l

0.24

356

1701

Urethral stricture

478

1.70

4.74

4.8

3.0

1.95

1.64

mg/l

1.89

421

Bullous disorders

471

1.70

4.72

4.6

3.6

1.89

1.62

mg/l

1.70

429

Fracture of skull and facial bones

294

2260

1.31

4.71

4.4

4.0

1.47

mg/l

0.02

271

2095

Scleritis and episcleritis

479

1.69

4.70

3.1

3.3

1.51

1.46

mg/l

0.26

444

Other melanin hyperpigmentation

146

2.32

4.70

3.8

3.0

1.78

1.71

mg/l

0.15

132

Spondylopathies (FG)

175

1245

1.42

4.64

2.8

3.0

1.46

1.36

mg/l

0.95

162

1169

Benign neoplasm: Descending colon

535

1.65

4.63

4.1

2.8

1.78

1.67

mg/l

0.54

484

Pain and other conditions associated with female genital organs and menstrual cycle

215

1516

1.37

4.63

5.0

3.6

1.27

1.34

mg/l

0.74

202

1415

Disorders of tyrosine metabolism

9.13

4.62

7.3

9.2

1.46

1.44

mg/l

—

Other and unspecified injuries of lower leg

103

660

1.58

4.61

3.7

5.4

1.49

1.39

mg/l

0.54

619

Other shoulder lesions

126

844

1.51

4.60

3.2

1.56

1.42

mg/l

0.89

120

778

Malignant neoplasm of endocrine gland

590

1.61

4.60

7.3

4.4

1.55

1.49

mg/l

0.24

548

Maternal care for other conditions predominantly related to pregnancy

214

1555

1.37

4.58

3.4

3.0

1.34

1.26

mg/l

0.90

200

1465

Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)

152

1057

1.45

4.57

3.8

2.6

1.68

1.69

mg/l

0.04

142

936

Allergic asthma (mode), excluding more controls

282

2123

1.31

4.56

3.6

3.7

1.27

1.24

mg/l

0.28

264

1982

Benign neoplasm: Adrenal gland

506

1.66

4.56

2.7

2.8

1.58

mg/l

0.00

458

Single delivery by forceps and vacuum extractor

876

0.63

4.55

1.8

3.7

1.11

1.35

mg/l

3.34

823

Atopic dermatitis, strict definition

439

3489

1.24

4.51

6.9

7.0

1.31

1.26

mg/l

0.82

422

3317

Impacted teeth

252

1774

1.33

4.51

7.5

5.7

1.32

1.22

mg/l

1.51

238

1689

Internal derangement of knee

506

4154

1.22

4.49

2.8

3.1

1.54

1.45

mg/l

1.38

456

3833

Use of other anti-dementia drugs

131

1659

0.68

4.49

2.1

2.4

1.63

1.92

mg/l

4.69

1434

Use of memantine

131

1659

0.68

4.49

2.1

2.4

1.63

1.92

mg/l

4.69

1434

Cardiac murmurs and other cardiac sounds

151

1042

1.45

4.48

11.4

9.9

1.37

1.25

mg/l

1.41

143

989

Retinal breaks without detachment

187

1355

1.39

4.48

3.8

2.8

1.59

1.54

mg/l

0.40

170

1249

Asthma and allergy, excluding more controls

162

1131

1.42

4.45

4.4

4.5

1.23

1.17

mg/l

0.66

153

1072

Emotionally unstable personality disorder

151

1055

1.44

4.45

2.7

3.5

1.32

1.30

mg/l

0.15

141

1006

Superficial injury of thorax

193

1408

1.38

4.44

3.8

3.7

1.71

1.51

mg/l

1.83

176

1305

Other specified and unspecified personality disorders

123

827

1.50

4.43

3.2

1.49

1.39

mg/l

0.69

117

784

Pain associated with micturition

140

966

1.46

4.42

4.8

4.9

1.50

1.47

mg/l

0.20

133

893

Impacted cerumen

134

918

1.48

4.41

5.8

5.7

1.69

1.51

mg/l

1.18

116

838

Non-allergic asthma (mode)

233

1734

1.34

4.40

6.1

4.0

1.45

1.40

mg/l

0.45

221

1585

Benign neoplasm of bone and articular cartilage

620

1.58

4.40

4.3

3.6

1.39

1.45

mg/l

0.40

575

Bronchiectasis

101

653

1.57

4.37

5.2

3.8

1.66

1.65

mg/l

0.04

592

Iron deficiency

151

2.24

4.36

4.1

8.7

1.25

1.22

mg/l

0.10

136

Human immunodeficiency virus [HIV] disease resulting in malignant neoplasms

13.61

4.34

2.6

1.9

1.32

1.57

mg/l

—

Drug-induced hypopituitarism

10.02

4.33

14.3

14.5

1.49

1.60

mg/l

—

Arthrosis

1013

4845

1.15

4.29

2.8

1.60

1.46

mg/l

5.10

922

4468

Soft tissue disorders related to use, overuse and pressure

337

2671

1.27

4.28

3.1

2.9

1.62

1.52

mg/l

1.46

306

2438

Persistent mood disorders

235

1777

1.33

4.27

3.6

3.0

1.53

1.45

mg/l

0.77

212

1638

Marginal zone B-cell lymphoma, excluding all cancers (controls excluding all cancers)

2.57

4.27

3.4

2.3

1.74

1.67

mg/l

0.18

Acute generalized exanthematous pustulosis

394

1.73

4.26

5.9

5.5

1.49

mg/l

0.01

365

Hyperprolactinaemia

248

1.93

4.24

2.9

3.3

1.62

1.31

mg/l

1.29

231

Otitis externa, unspecified

148

1041

1.44

4.24

9.5

5.4

1.70

1.41

mg/l

3.16

139

981

Other and unspecified mononeuropathies, also in other diseases

242

1.94

4.21

4.0

2.8

1.93

1.62

mg/l

1.20

219

Other inflammation of eyelid

163

1168

1.41

4.20

5.3

4.2

1.49

1.50

mg/l

0.03

153

1071

Other symptoms and signs involving the nervous and musculoskeletal systems

556

4651

1.20

4.20

5.1

4.4

1.50

1.49

mg/l

0.13

518

4286

Injuries to the wrist and hand

1460

9462

1.12

4.19

3.6

4.2

1.44

1.49

mg/l

1.77

1350

8759

Adhesive capsulitis of shoulder

212

1586

1.35

4.17

3.4

2.8

1.68

1.54

mg/l

1.37

192

1446

Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)

158

1061

1.41

4.16

2.9

2.7

1.43

1.81

mg/l

8.66

149

923

Amblyopia ex anopsia

537

1.61

4.14

15.7

12.2

1.38

1.24

mg/l

1.02

507

Diaphragmatic hernia

431

3524

1.23

4.14

3.4

2.8

1.65

1.62

mg/l

0.35

395

3183

Benign neoplasm: Skin of other and unspecified parts of face

112

750

1.51

4.13

4.8

2.8

1.76

1.64

mg/l

0.70

662

Normotensive glaucoma

608

1.56

4.09

2.9

2.7

1.74

1.73

mg/l

0.06

542

Complications following infusion, transfusion and therapeutic injection

117

2.38

4.08

8.9

3.9

1.62

1.46

mg/l

0.36

107

Rheumatoid arthritis, including avohilmo

453

3731

1.22

4.05

2.9

1.65

1.58

mg/l

0.92

399

3397

Endometriosis of pelvic peritoneum

171

1226

1.38

4.04

2.2

3.1

1.23

1.40

mg/l

3.03

158

1144

Cystic fibrosis with pulmonary manifestations

8.49

4.04

6.1

7.0

1.68

1.17

mg/l

—

Use of rivastigmine

991

0.59

4.04

1.8

2.4

1.72

1.87

mg/l

0.68

846

113

735

1.53

4.04

23.3

19.1

1.13

1.03

mg/l

1.76

113

723

Poor fetal growth

124

853

1.46

4.00

3.6

3.0

1.37

1.25

mg/l

1.05

117

805

Tonsillectomy and adenotomy

861

5202

1.16

4.00

6.3

5.4

1.22

1.32

mg/l

4.08

814

4930

Pneumococcal septicemia

305

1.81

3.99

8.4

8.1

1.50

mg/l

0.01

284

Nummular dermatitis

108

725

1.51

3.97

3.8

3.6

1.62

1.53

mg/l

0.44

100

659

Anogenital herpesviral [herpes simplex] infection

463

1.64

3.97

3.8

2.9

1.42

1.33

mg/l

0.45

437

Personality disorders

343

2751

1.25

3.96

3.1

3.2

1.44

1.38

mg/l

0.67

315

2599

Benign neoplasm: Rectum, anus and anal canal

235

1799

1.32

3.96

2.9

2.8

1.71

1.65

mg/l

0.39

219

1630

Benign neoplasm of middle ear and respiratory system

101

670

1.52

3.93

2.8

3.4

1.46

1.60

mg/l

1.03

611

Conjunctivitis

1044

8020

1.14

3.93

5.2

4.6

1.39

1.42

mg/l

0.73

973

7450

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

422

2248

1.23

3.93

2.5

2.8

1.38

1.49

mg/l

2.40

378

2048

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

422

2248

1.23

3.93

2.5

2.8

1.38

1.49

mg/l

2.40

378

2048

Melanoma in situ

299

1.80

3.92

5.1

2.8

1.90

1.77

mg/l

0.40

269

Paralytic ileus

277

1.83

3.92

3.6

3.5

1.78

1.72

mg/l

0.19

247

HSIL lesion of the cervix uteri, vagina or vulva

197

1473

1.34

3.90

3.5

2.9

1.42

1.32

mg/l

1.02

189

1385

Benign neoplasm: Small intestine

263

1.85

3.90

4.1

2.9

1.73

1.62

mg/l

0.37

236

Malignant neoplasm of lip, excluding all cancers (controls excluding all cancers)

3.05

3.89

3.8

2.1

1.77

1.83

mg/l

0.10

Malignant melanoma

168

1228

1.38

3.88

3.8

2.9

1.74

1.65

mg/l

0.57

159

1115

Dental pulpitis 1, only avohilmo

1732

8180

1.11

3.87

3.0

4.2

1.54

1.47

mg/l

2.48

1587

7575

Benign neoplasm: Sigmoid colon

214

1624

1.33

3.85

3.4

2.7

1.78

1.66

mg/l

1.02

201

1470

Transport accidents

631

4764

1.18

3.85

4.0

3.9

1.45

1.44

mg/l

0.17

580

4434

Right bundle-branch block

214

1.94

3.85

3.3

3.6

1.70

1.51

mg/l

0.70

198

Other peripheral vascular diseases

609

1.54

3.85

2.9

3.2

1.53

1.49

mg/l

0.21

552

Other/unspecified rheumatoid arthritis

141

1002

1.42

3.85

3.6

3.0

1.77

1.61

mg/l

1.09

127

899

Panic disorder

177

1307

1.36

3.82

3.7

1.35

1.31

mg/l

0.36

167

1241

Reactive arthropathies, FINNGEN

594

1.55

3.82

3.4

4.1

1.50

1.38

mg/l

0.94

553

Other disorders of pigmentation

331

1.75

3.82

4.3

5.0

1.85

1.48

mg/l

1.78

302

Other noninflammatory disorders of vagina

570

1.56

3.82

3.2

3.1

1.57

1.42

mg/l

0.86

529

Anorexia (incl.atypical)

523

1.58

3.81

5.2

5.0

1.35

1.31

mg/l

0.18

488

Benign leiomyoma with endometriosis

143

1020

1.41

3.81

3.1

2.7

1.63

1.59

mg/l

0.22

129

920

Follow-up examination after treatment for malignant neoplasms

121

838

1.46

3.80

3.2

2.6

1.73

1.71

mg/l

0.12

110

743

Hypertrophy of tongue papillae

2.52

3.78

3.0

2.9

1.84

1.51

mg/l

0.54

Diabetes mellitus in pregnancy

331

1713

1.26

3.77

3.5

3.1

1.40

1.23

mg/l

4.44

313

1621

Unspecified event, undetermined intent

238

1.89

3.76

3.4

5.7

1.65

1.41

mg/l

0.93

225

Other keratitis

141

1008

1.41

3.74

4.0

3.4

1.67

1.45

mg/l

1.83

133

934

Injury of unspecified body region

103

695

1.50

3.72

4.8

5.8

1.92

1.48

mg/l

2.70

640

Other disorders of cornea

118

818

1.46

3.71

3.7

3.3

1.55

1.53

mg/l

0.11

106

751

Paget disease

3.44

3.71

2.4

2.1

1.84

1.68

mg/l

0.28

Deforming dorsopathies

368

2999

1.23

3.70

3.6

4.1

1.44

1.46

mg/l

0.23

341

2775

Other disorders of eye and adnexa

178

1324

1.36

3.70

7.2

5.3

1.52

1.41

mg/l

0.98

168

1236

Adalimumab

124

869

1.44

3.69

3.3

5.1

1.29

1.35

mg/l

0.53

118

827

Somatoform disorder

193

1453

1.34

3.69

3.0

3.2

1.38

1.43

mg/l

0.41

172

1354

Superficial injury of abdomen, lower back and pelvis

191

1437

1.34

3.67

4.5

4.9

1.52

1.44

mg/l

0.68

180

1334

Benign neoplasm: Stomach

114

787

1.46

3.67

4.5

2.9

1.86

1.62

mg/l

2.03

106

711

Arthropathy in hypersensitivity reactions classified elsewhere

7.13

3.67

13.9

6.6

0.97

1.13

mg/l

—

Other and unspecified effects of external causes

368

3003

1.23

3.67

5.0

5.3

1.48

1.38

mg/l

1.61

337

2822

Other and unspecified urticaria

256

2005

1.28

3.66

6.9

5.9

1.40

1.38

mg/l

0.16

239

1876

Adverse effects, not elsewhere classified

251

1961

1.29

3.66

5.7

5.8

1.49

1.38

mg/l

1.33

232

1831

Pediculosis, acariasis and other infestations

569

1.55

3.66

6.8

4.5

1.67

1.43

mg/l

1.23

534

Benign neoplasm: salivary glands, exclude unknown (D119)

106

723

1.48

3.64

3.3

2.9

1.55

1.58

mg/l

0.18

659

Erectile dysfunction

108

740

1.48

3.63

6.1

3.9

1.78

1.75

mg/l

0.13

664

Ill-defined and unknown causes of mortality

530

1.56

3.63

3.6

3.0

2.02

1.76

mg/l

1.29

465

Speech therapy

334

2702

1.24

3.62

4.4

3.7

1.57

1.55

mg/l

0.14

289

2479

Specific personality disorders

292

2327

1.26

3.61

3.0

3.3

1.41

1.38

mg/l

0.27

272

2198

Benign neoplasm: Rectum

207

1580

1.32

3.61

2.9

2.8

1.64

1.66

mg/l

0.11

192

1434

Posteruptive colour changes of dental hard tissues

9.88

3.60

37.4

9.6

1.17

1.08

mg/l

—

Respiratory conditions due to other external agents

137

2.17

3.60

2.9

1.64

1.72

mg/l

0.21

123

Asthma and allergy

161

1170

1.37

3.58

3.9

4.5

1.22

1.20

mg/l

0.21

152

1105

Myocardial infarction, with ST-elevation

213

1634

1.31

3.58

3.3

2.6

2.12

1.74

mg/l

5.42

188

1454

Transient ischemic attack

617

4374

1.17

3.58

2.9

2.8

1.75

1.66

mg/l

1.55

548

3943

Benign neoplasm: Parotid gland

653

1.50

3.56

3.4

2.9

1.55

1.60

mg/l

0.20

595

Nutritional and metabolic disorders in diseases classified elsewhere

10.37

3.54

41.1

23.5

1.43

0.90

mg/l

—

Dental caries 3 and operation codes, only avohilmo

458

2757

0.83

3.53

5.1

7.4

1.38

1.43

mg/l

0.80

431

2618

Gonarthrosis [arthrosis of knee](FG)

991

5148

1.14

3.52

2.6

2.7

1.66

1.48

mg/l

8.06

894

4721

Other disorders of penis

156

1149

1.37

3.50

6.0

6.6

1.57

1.44

mg/l

1.00

140

1074

Eustachian salpingitis and obstruction

110

763

1.46

3.48

5.5

3.7

1.42

1.28

mg/l

1.19

105

724

Benign neoplasm: Pituitary gland, craniopharyngeal duct

441

1.61

3.48

3.1

3.7

1.44

1.50

mg/l

0.34

406

Acute nasopharyngitis (common cold)

181

1356

1.34

3.47

4.6

3.8

1.50

1.37

mg/l

1.28

171

1274

Sequelae of cerebrovascular disease

402

2919

1.21

3.45

3.4

2.8

1.93

1.70

mg/l

4.46

354

2598

Anisometropia and aniseikonia

312

1.73

3.44

15.9

7.4

1.36

1.39

mg/l

0.17

289

Congenital malformations of genital organs

143

1035

1.39

3.44

8.8

9.9

1.23

1.22

mg/l

0.05

137

997

Hypothyroidism due to medicaments and other exogenous substances

2.52

3.44

6.8

4.0

1.67

1.58

mg/l

0.19

Dysplasia of cervi uteri

244

1475

1.28

3.44

3.8

3.0

1.36

1.40

mg/l

0.30

230

1378

Melanocytic naevi of upper limb, including shoulder

167

2.02

3.43

8.7

4.2

1.77

1.47

mg/l

1.03

149

Paralytic strabismus

594

1.52

3.43

4.4

3.9

1.62

1.60

mg/l

0.05

535

Other disorders of bone

246

1936

1.28

3.41

6.1

3.9

1.34

1.40

mg/l

0.82

228

1802

Monoarthritis, not elsewhere classified

336

1.69

3.37

3.8

3.2

1.63

1.42

mg/l

0.75

310

Melanoma of uvea

2.50

3.37

2.6

2.5

1.81

1.61

mg/l

0.38

Allergic asthma (mode)

282

2218

1.25

3.34

3.6

3.7

1.27

1.29

mg/l

0.22

264

2067

Injury of eye and orbit

197

1512

1.31

3.34

5.0

4.2

1.39

1.44

mg/l

0.40

184

1412

Mental and behavioural disorders due to sedatives or hypnotics

622

1.50

3.34

3.0

3.3

1.52

1.41

mg/l

0.62

582

Parkinson's disease, strict definition

1149

0.66

3.33

2.2

2.7

1.62

1.75

mg/l

0.91

1012

Ascorbic acid deficiency

5.71

3.33

31.1

12.9

1.00

1.14

mg/l

—

Polymyalgia rheumatica

139

1013

1.38

3.33

2.4

2.6

1.91

1.74

mg/l

1.26

115

891

665

0.55

3.32

2.5

2.9

2.06

1.71

mg/l

0.82

594

Tumor necrosis factor alpha inhibitors

185

1409

1.32

3.32

3.2

5.1

1.31

1.35

mg/l

0.33

175

1335

Viral agents as the cause of diseases classified to other chapters

220

1.86

3.29

14.8

8.1

1.54

1.39

mg/l

0.44

206

Coronary angioplasty

461

2977

1.19

3.28

3.7

2.8

1.99

1.60

mg/l

14.74

416

2679

Disturbances of skin sensation

321

2617

1.23

3.27

3.0

3.1

1.40

1.44

mg/l

0.41

297

2425

Parkinson's disease

1263

0.68

3.27

2.4

2.7

1.66

1.75

mg/l

0.56

1114

Diplopia

156

1162

1.35

3.26

3.7

3.6

1.53

1.54

mg/l

0.06

140

1060

Atrophic disorders of skin

154

1145

1.35

3.25

5.5

3.4

1.46

1.44

mg/l

0.11

138

1052

Dementia

314

2660

0.81

3.24

2.2

2.7

1.77

1.82

mg/l

0.45

259

2345

Redundant prepuce, phimosis and paraphimosis

316

2565

1.23

3.24

4.5

4.2

1.65

1.43

mg/l

4.02

288

2400

Leukaemia of unspecified cell type

2.50

3.20

33.1

5.0

1.18

1.57

mg/l

1.87

Tobacco use

427

1.59

3.20

3.0

3.1

1.67

1.52

mg/l

0.72

392

Benign neoplasm of meninges

644

1.47

3.19

2.7

2.9

1.56

1.62

mg/l

0.26

571

Seronegative rheumatoid arthritis

127

919

1.39

3.19

2.7

1.62

1.46

mg/l

1.05

107

836

Benign neoplasm: Choroid

388

1.62

3.19

3.0

1.67

1.58

mg/l

0.35

345

Anaemia due to enzyme disorders

6.90

3.18

9.4

9.2

1.02

1.44

mg/l

—

Benign neoplasm: Other parts of oropharynx

2.71

3.18

2.9

2.2

1.19

1.52

mg/l

1.50

LSIL lesion of the cervix uteri, vagina or vulva

138

1013

1.37

3.17

3.8

2.8

1.39

1.34

mg/l

0.41

128

954

Colorectal cancer, excluding all cancers (controls excluding all cancers)

272

2114

1.25

3.16

3.1

2.6

1.81

1.74

mg/l

0.56

245

1871

Benign neoplasm of major salivary glands

115

820

1.41

3.16

3.4

2.9

1.56

1.59

mg/l

0.17

102

747

Fall on same level involving ice and snow

731

6409

1.14

3.15

4.0

3.5

1.58

1.51

mg/l

1.62

672

5873

Wet age-related macular degeneration

166

1232

1.33

3.14

3.2

2.4

1.91

1.84

mg/l

0.48

142

1059

Asthma, hospital admissions , main diagnosis only

1169

9432

1.11

3.13

4.4

1.47

mg/l

0.03

1086

8728

Other condition

180

1379

1.31

3.12

6.9

4.1

1.56

1.44

mg/l

0.87

167

1287

Trigger finger

172

1309

1.32

3.12

4.6

3.0

1.83

1.49

mg/l

4.66

162

1203

Listeriosis

3.41

3.12

3.8

2.0

2.10

1.84

mg/l

0.31

Valgus deformity, not elsewhere classified

2.60

3.10

21.6

5.3

1.32

1.38

mg/l

0.12

Parkinson's disease, including avohilmo

1320

0.69

3.10

2.3

2.7

1.63

1.74

mg/l

0.78

1169

Use of levodopa decarboxylase inhibitor

1070

0.66

3.10

2.9

2.6

1.69

1.77

mg/l

0.42

942

Faecal incontinence

632

1.47

3.09

2.6

1.56

1.61

mg/l

0.22

573

Non-selective monoamine reuptake inhibitors

467

3846

1.18

3.09

2.6

2.9

1.55

1.59

mg/l

0.38

408

3499

Other (seronegative) rheumatoid arthritis, wide

214

1679

1.28

3.09

3.0

2.9

1.68

1.58

mg/l

0.76

187

1533

Mixed and other personality disorders

104

732

1.43

3.09

3.0

3.2

1.53

1.37

mg/l

0.83

695

670

1.47

3.05

23.4

19.9

1.13

1.03

mg/l

1.70

659

Chronic sinusitis

552

4754

1.16

3.05

3.4

3.3

1.46

1.51

mg/l

0.80

505

4373

Sudden idiopathic hearing loss

118

851

1.40

3.05

3.5

3.0

1.71

1.58

mg/l

0.67

106

778

Asthma mixed form (mode), excluding more controls

377

1.61

3.04

5.3

4.3

1.49

1.29

mg/l

1.28

347

Seropositive rheumatoid arthritis, wide

304

2488

1.23

3.02

2.7

2.8

1.69

1.60

mg/l

0.96

273

2267

Follicular cysts of skin and subcutaneous tissue

221

1748

1.27

3.00

4.0

3.3

1.61

1.51

mg/l

0.88

214

1613

Voice disturbances

301

2466

1.23

2.97

3.5

3.4

1.45

1.54

mg/l

1.18

272

2265

Propionic acid derivatives

440

2615

0.84

2.97

4.3

6.4

1.40

1.59

mg/l

4.70

402

2444

Heterophoria

108

772

1.41

2.96

9.1

8.2

1.44

1.33

mg/l

0.63

100

727

Ethmoidectomy

160

1218

1.32

2.93

2.9

3.3

1.34

1.48

mg/l

1.62

141

1137

Left bundle-branch block

469

1.53

2.91

2.5

2.7

1.82

1.47

mg/l

2.88

426

Superficial injury of head

292

2391

1.23

2.90

4.2

5.2

1.53

1.46

mg/l

0.76

259

2217

FESS (DNB20)

154

1168

1.33

2.90

3.0

3.3

1.33

1.48

mg/l

1.71

135

1091

Endometriosis of ovary

173

1330

1.30

2.88

2.8

3.0

1.33

1.44

mg/l

1.33

162

1230

Pleural plaque

110

793

1.40

2.87

2.5

2.6

1.83

1.81

mg/l

0.10

680

Persons encountering health services in circumstances related to reproduction

896

5416

1.12

2.85

6.3

5.4

1.25

1.37

mg/l

6.28

846

5114

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

2.72

2.83

9.6

2.2

2.07

1.63

mg/l

0.51

Migraine without aura

238

1913

1.25

2.83

6.1

5.9

1.22

1.27

mg/l

0.71

226

1810

Artificial joint operation, meniscal resection

1245

7520

1.10

2.82

2.6

3.1

1.60

1.57

mg/l

0.43

1119

6900

Multiple delivery

769

0.62

2.82

2.8

3.6

1.37

1.47

mg/l

0.33

715

Congenital malformations of eye, ear, face and neck

108

781

1.40

2.80

9.6

10.6

1.39

1.27

mg/l

0.86

101

747

Other and unspecified visual disturbances

108

781

1.39

2.78

2.5

4.1

1.50

1.52

mg/l

0.08

103

717

Benign neoplasm: Cerebral meninges

565

1.46

2.76

2.9

1.63

1.59

mg/l

0.17

503

Migraine with aura

274

2243

1.23

2.75

4.5

4.4

1.28

1.33

mg/l

0.70

257

2104

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

164

1265

1.30

2.74

3.5

3.6

1.30

1.34

mg/l

0.29

154

1179

Other headache syndromes

499

4308

1.16

2.74

3.3

3.5

1.35

1.45

mg/l

2.41

459

3984

Schizophrenia

130

1724

0.75

2.73

2.7

3.1

1.58

1.43

mg/l

1.26

120

1620

Epilepsy

431

3674

1.17

2.70

5.5

5.7

1.52

1.44

mg/l

1.18

394

3411

Pneumonia due to Streptococcus pneumoniae

319

1.62

2.68

7.1

4.4

1.57

1.49

mg/l

0.30

289

Any dementia

278

2380

0.82

2.68

2.2

2.6

1.81

1.83

mg/l

0.12

227

2089

Lyme disease

196

2462

0.79

2.68

2.6

3.6

1.29

1.55

mg/l

7.26

179

2263

Obstructed labour due to malposition and malpresentation of fetus

143

1761

0.76

2.68

2.7

3.2

1.33

1.31

mg/l

0.11

136

1657

Alcohol induced polyneuropathy

2.32

2.65

3.5

2.5

1.74

1.62

mg/l

0.19

COPD, hospital admissions 1, only main diagnosis

406

2942

1.18

2.65

2.5

3.0

1.96

1.73

mg/l

3.76

347

2642

Oesophageal obstruction

259

1.68

2.63

3.5

2.7

1.71

1.77

mg/l

0.15

232

Status post-ami

469

0.57

2.63

3.5

2.4

2.13

1.87

mg/l

0.80

402

Dental caries 1 and operation codes, only avohilmo

401

2372

0.85

2.63

4.8

7.6

1.40

1.45

mg/l

0.69

378

2246

Melanocytic naevi of upper limb, including shoulder

185

1.82

2.60

8.7

4.5

1.77

1.47

mg/l

1.03

167

Benign neoplasm: Other parts of oropharynx

2.42

2.60

2.9

2.5

1.19

1.53

mg/l

1.60

Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)

548

1.45

2.59

1.7

2.5

1.46

1.72

mg/l

2.51

478

Scoliosis

111

818

1.37

2.58

5.1

6.3

1.27

1.39

mg/l

1.08

102

765

Benign neoplasm: Appendix

2.48

2.57

4.4

2.3

1.61

1.60

mg/l

0.02

Short Achilles tendon (acquired)

210

0.38

2.56

2.0

2.7

1.36

1.46

mg/l

—

196

Unspecified/other endometriosis

624

1.42

2.56

2.6

3.0

1.30

1.31

mg/l

0.03

586

Injury of muscle and tendon at lower leg level

194

1546

1.26

2.54

3.3

3.1

1.54

1.52

mg/l

0.10

181

1428

Family history of malignant neoplasm

692

1.40

2.54

3.1

2.2

1.31

1.28

mg/l

0.18

646

Unspecified urinary incontinence

668

1.40

2.53

4.2

4.5

1.66

1.52

mg/l

0.80

609

Factitial dermatitis

2.93

2.52

3.4

4.1

1.90

1.37

mg/l

0.89

Ectropion of eyelid

270

1.65

2.52

3.1

2.8

1.78

1.87

mg/l

0.27

231

Shigellosis

4.01

2.51

2.1

2.5

1.55

1.54

mg/l

—

Deep endometriosis

669

1.40

2.50

1.9

2.9

1.23

1.46

mg/l

3.36

616

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

290

2414

1.21

2.50

2.8

1.70

1.59

mg/l

1.23

260

2201

Ptosis of eyelid

123

926

1.34

2.50

3.3

3.5

1.53

1.63

mg/l

0.76

114

837

Abnormal findings in nipple discharge synovial fluid wound secretions

123

1.99

2.49

5.2

3.8

1.59

1.49

mg/l

0.21

111

Abnormal pulmonary venous return

2.76

2.49

14.1

19.1

1.10

1.06

mg/l

0.17

Other spirochaetal diseases

202

2504

0.80

2.49

2.8

3.7

1.29

1.54

mg/l

7.46

185

2304

Haemorrhoids and perianal venous thrombosis

323

2715

1.19

2.48

2.6

2.8

1.67

1.61

mg/l

0.54

289

2436

Unstable angina pectoris

455

3257

1.16

2.48

3.0

2.7

1.94

1.66

mg/l

7.11

395

2920

Leiomyosarcoma, excluding all cancers (controls excluding all cancers)

2.62

2.47

1.7

2.1

1.71

1.57

mg/l

0.29

211

1.74

2.47

12.6

9.7

1.14

1.06

mg/l

0.45

202

All dysplastic lesions of the cervix uteri

241

1969

1.23

2.46

3.9

2.9

1.38

1.31

mg/l

0.64

229

1846

Correction of physiology of bite - demanding therapy visit

546

1.44

2.46

3.1

3.5

1.21

1.40

mg/l

1.93

514

Sequelae of other external causes

432

1.50

2.44

4.2

3.7

1.71

1.52

mg/l

0.97

399

Other/unspecified seropositive rheumatoid arthritis

294

2458

1.20

2.43

2.8

1.70

1.59

mg/l

1.14

263

2238

Maternal care related to the fetus and amniotic cavity and possible delivery problems

357

2476

0.85

2.43

2.8

3.4

1.24

1.36

mg/l

2.88

336

2314

Interstitial emphysema and related conditions originating in the perinatal period

2.78

2.43

34.9

15.1

1.38

1.01

mg/l

1.55

Long labour

156

1736

0.78

2.42

2.4

3.2

1.36

1.31

mg/l

0.31

147

1634

Other infective otitis externa

515

1.45

2.42

5.2

4.0

1.58

1.52

mg/l

0.24

475

Malignant neoplasm of renal pelvis

2.86

2.42

2.3

1.82

mg/l

0.00

Aneurysms, operations, SAH

183

1459

1.26

2.40

3.8

2.9

1.63

1.58

mg/l

0.32

167

1317

Nosocomial condition (hospital)

2.71

2.40

5.5

2.1

1.74

1.59

mg/l

0.21

Fall on and from stairs and steps

297

2489

1.20

2.40

4.3

4.0

1.57

1.52

mg/l

0.46

276

2288

Intermittent heterotropia

103

761

1.37

2.40

14.7

11.8

1.25

1.22

mg/l

0.17

728

Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)

280

1889

1.21

2.39

2.7

2.8

1.39

1.53

mg/l

2.26

248

1710

Memory loss

737

0.65

2.38

2.7

1.36

1.71

mg/l

3.30

651

Varicose veins of other sites

617

1.41

2.38

3.8

3.5

1.37

1.45

mg/l

0.45

566

Thyrotoxicosis, other and/or unspecified

210

1702

1.24

2.38

2.9

3.3

1.62

1.46

mg/l

1.94

193

1572

Localized scleroderma [morphea]

2.18

2.37

2.9

2.3

1.51

1.55

mg/l

0.06

False labour

210

1627

0.81

2.37

2.4

3.4

1.12

1.30

mg/l

4.97

200

1529

Malignant neoplasm of bladder

542

1.43

2.37

2.9

2.7

2.05

1.83

mg/l

0.97

465

Asthma mixed form (mode)

402

1.50

2.37

5.3

4.2

1.49

1.35

mg/l

0.79

363

Striking against or struck by other objects

467

4064

1.15

2.35

4.4

5.4

1.47

1.40

mg/l

1.21

430

3807

Other sexually transmitted chlamydial diseases

526

1.44

2.35

3.3

1.24

1.21

mg/l

0.19

496

Other secondary gonarthrosis

444

1.48

2.35

3.4

2.9

1.63

1.58

mg/l

0.18

408

Benign lipomatous neoplasm

297

2494

1.20

2.35

3.0

2.8

1.55

1.60

mg/l

0.36

277

2244

Carcinoma in situ of prostate

2.79

2.32

1.3

2.5

1.46

1.67

mg/l

0.65

Unspecified parasitic disease

2.29

2.32

4.5

2.8

1.71

1.51

mg/l

0.36

Other maternal disorders predominantly related to pregnancy

591

3276

1.14

2.32

3.2

3.1

1.44

1.37

mg/l

1.37

553

3048

Later onset COPD

297

1957

1.20

2.31

2.2

2.6

2.10

1.85

mg/l

3.64

252

1718

Fracture of neck

487

1.45

2.31

3.9

3.1

1.65

1.63

mg/l

0.04

437

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

482

4206

1.15

2.30

4.6

4.7

1.37

1.33

mg/l

0.58

451

3963

Perforation of tympanic membrane

119

904

1.33

2.30

5.9

4.6

1.47

1.45

mg/l

0.13

113

832

Family history of other conditions

2.06

2.29

6.0

7.2

1.41

1.16

mg/l

0.80

Sexual dysfunction

120

1.96

2.29

3.0

3.1

1.39

1.45

mg/l

0.16

112

Atopic dermatitis

741

5671

1.12

2.27

5.0

4.9

1.35

mg/l

0.07

700

5313

Benign neoplasm of brain and other parts of central nervous system

489

1.44

2.26

4.8

3.8

1.41

1.47

mg/l

0.23

449

Dementia, including avohilmo

355

2861

0.85

2.26

2.2

2.7

1.77

1.82

mg/l

0.48

293

2534

Gonarthrosis

847

4381

1.11

2.24

2.7

2.8

1.65

1.48

mg/l

6.10

767

4022

Ovarian dysfunction, other/unspecified

2.87

2.23

4.3

4.1

0.93

1.18

mg/l

—

Postmenopausal atrophic vaginitis

260

1297

1.21

2.23

2.8

3.0

1.47

1.53

mg/l

0.61

232

1180

Other and unspecified abdominal hernia

328

1.54

2.21

6.9

3.6

1.79

1.64

mg/l

0.51

297

Psoriatic arthropathies

118

901

1.32

2.21

2.7

2.8

1.50

1.40

mg/l

0.62

100

843

Sequelae of infectious and parasitic diseases

643

1.38

2.21

4.1

2.9

1.72

1.52

mg/l

1.16

595

Female infertility, cervigal, vaginal, other or unspecified origin

273

1526

1.20

2.20

2.7

3.1

1.27

1.39

mg/l

2.10

253

1423

Other and unspecified mood [affective] disorders

610

1.39

2.19

3.8

4.1

1.50

1.29

mg/l

1.05

577

Benign neoplasm: Small intestine

313

1.55

2.19

4.1

3.3

1.73

1.68

mg/l

0.14

283

Arthropathic psoriasis

134

1043

1.29

2.18

3.2

1.54

1.50

mg/l

0.23

115

975

Endometriosis ASRM stages 1,2

174

1397

1.25

2.18

2.3

2.9

1.22

1.37

mg/l

2.48

161

1306

Superficial injury of ankle and foot

159

1265

1.26

2.17

5.5

6.0

1.51

1.30

mg/l

1.67

147

1200

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

620

1.38

2.17

4.2

5.4

1.37

1.40

mg/l

0.12

579

Disorders of synovium and tendon

675

5445

1.12

2.16

4.4

3.2

1.60

1.48

mg/l

3.26

625

5020

Mental retardation

716

1.36

2.16

12.3

15.4

1.11

1.19

mg/l

0.76

694

Sequelae of other and unspecified infectious and parasitic diseases

494

1.43

2.16

4.4

3.0

1.60

1.41

mg/l

1.02

468

Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)

118

904

1.31

2.16

2.5

2.6

1.77

1.73

mg/l

0.21

108

793

Adenomyosis (Endometriosis of uterus)

134

1045

1.29

2.15

2.4

2.9

1.46

1.50

mg/l

0.20

122

961

Dislocation, sprain and strain of joints and ligaments of knee

804

6759

1.11

2.13

2.9

3.5

1.36

1.44

mg/l

2.36

749

6286

Benign neoplasm: Adrenal gland

606

1.38

2.11

2.7

3.0

1.58

1.60

mg/l

0.08

552

Fracture of forearm

684

5753

1.12

2.11

4.8

4.1

1.55

1.46

mg/l

1.73

625

5307

Intracerebral haemorrhage

130

1013

1.29

2.10

6.3

2.9

1.75

1.71

mg/l

0.18

120

891

Somnolence, stupor and coma

357

1.50

2.09

4.7

4.4

1.75

1.61

mg/l

0.53

327

Female infertility

301

1574

1.18

2.07

2.9

3.0

1.29

1.39

mg/l

1.79

281

1467

Benign neoplasm: Skin of eyelid, including canthus

164

1318

1.25

2.07

3.0

2.9

1.57

1.61

mg/l

0.26

154

1189

Status epilepticus

326

1.52

2.06

6.5

1.72

1.48

mg/l

0.73

300

Other trisomies and partial trisomies of the autosomes, not elsewhere classified

3.39

2.05

11.8

19.4

1.42

1.16

mg/l

—

Disorders of vestibular function (Vertigo)

525

4623

1.13

2.05

2.9

3.0

1.57

1.60

mg/l

0.35

477

4183

Premature rupture of membranes

137

1275

0.79

2.05

2.6

3.2

1.15

1.31

mg/l

3.23

130

1200

Benign neoplasm: Floor of mouth

2.94

2.04

4.0

2.3

1.38

1.63

mg/l

—

Monoamine oxidase A inhibitors

136

1071

1.28

2.04

3.1

2.9

1.48

1.55

mg/l

0.50

120

985

Superficial injury of wrist and hand

253

2128

1.19

2.03

4.7

5.5

1.41

1.36

mg/l

0.53

237

1998

Haemangioma and lymphangioma, any site

110

844

1.31

2.03

5.9

5.5

1.44

1.46

mg/l

0.10

104

785

Haemangioma, any site

102

775

1.33

2.02

5.7

5.5

1.44

1.47

mg/l

0.14

718

HSIL lesion of the cervix uteri

165

1331

1.24

2.01

3.6

3.0

1.36

1.31

mg/l

0.37

158

1255

Alzheimer’s disease, wide definition, excluding more controls

100

894

0.76

2.01

2.1

2.5

1.70

1.76

mg/l

0.28

779

Childhood allergy (age < 16)

242

1669

1.20

2.00

9.9

11.2

1.14

1.12

mg/l

0.17

233

1612

Pustulosis palmaris et plantaris

328

1.51

2.00

3.1

3.3

1.60

1.52

mg/l

0.24

308

Car occupant injured in other and unspecified transport accidents

222

1848

1.21

2.00

4.1

3.5

1.55

1.42

mg/l

1.33

207

1723

Other female pelvic inflammatory diseases

156

1252

1.25

2.00

2.9

2.8

1.50

1.45

mg/l

0.35

142

1152

Arthropathy in Crohn disease

2.13

1.99

3.6

2.9

1.37

1.49

mg/l

0.28

Assault

172

1397

1.24

1.99

4.3

3.8

1.50

1.36

mg/l

1.42

162

1326

Other inherited muscular atrophy

4.02

1.98

11.8

8.6

0.83

1.08

mg/l

—

Other benign neoplasms of connective and other soft tissue

112

865

1.30

1.97

2.2

3.6

1.56

1.52

mg/l

0.18

101

796

Viral haemorrhagic fevers, not elsewhere classified/unspecified

700

1.34

1.97

3.0

3.1

1.52

1.54

mg/l

0.08

647

Other and unspecified injuries of ankle and foot

412

1.45

1.96

6.5

6.6

1.58

1.30

mg/l

1.26

388

Benign neoplasm: Female genital organ, unspecified

3.90

1.96

3.5

2.2

1.11

1.34

mg/l

—

Severe visual impairment, monocular

2.17

1.95

2.9

3.5

1.70

1.51

mg/l

0.34

Supervision of normal pregnancy

156

1109

0.80

1.95

2.2

3.5

1.10

1.31

mg/l

5.21

146

1047

Malignant neoplasm of breast, ER-negative, excluding all cancers (controls excluding all cancers)

188

1483

1.22

1.94

2.1

2.7

1.44

1.57

mg/l

1.62

166

1326

Alcohol abuse, main dg, excluding more controls

182

1493

1.22

1.92

4.4

3.4

1.50

1.45

mg/l

0.40

168

1396

Fibroblastic disorders

277

2361

1.18

1.92

3.4

2.8

1.66

1.61

mg/l

0.47

253

2136

Conditions involving the integument and temperature regulation of fetus and newborn

3.15

1.90

15.0

19.4

1.10

1.14

mg/l

—

Adult-onset Still disease

3.28

1.90

3.3

3.2

1.26

1.22

mg/l

—

Disorders of muscles

120

941

1.28

1.89

4.1

3.4

1.61

1.47

mg/l

0.89

109

868

Parkinson's disease, strict definition, excluding more controls

1003

0.74

1.88

2.2

2.6

1.62

1.69

mg/l

0.37

889

Open wound of wrist and hand

596

5304

1.12

1.88

3.3

3.8

1.39

1.47

mg/l

2.04

541

4927

Delivery, wide proxy

283

1764

0.85

1.87

2.7

3.4

1.41

1.52

mg/l

1.73

259

1597

Thyrotoxicosis

264

2247

1.18

1.87

2.9

3.2

1.64

1.49

mg/l

1.96

239

2068

Viral meningitis

309

1.50

1.87

3.4

3.0

1.28

1.36

mg/l

0.45

287

Disorder of bilirubin metabolism, other/unspecified

4.50

1.87

10.0

18.9

1.34

1.07

mg/l

—

Benign neoplasm: Anus and anal canal

159

1.72

1.87

3.6

2.5

2.21

1.68

mg/l

1.13

144

Colon adenocarcinoma, excluding all cancers (controls excluding all cancers)

104

802

1.30

1.86

2.7

2.5

1.93

1.77

mg/l

0.86

696

Benign neoplasm: Connective and other soft tissue of trunk, unspecified

2.57

1.86

1.5

2.1

1.44

1.53

mg/l

—

Other noninflammatory disorders of uterus, except cervix

221

1259

1.20

1.86

3.2

3.0

1.69

1.55

mg/l

1.76

207

1144

Superficial injury of hip and thigh

153

1237

1.24

1.85

3.1

3.7

1.64

1.57

mg/l

0.48

137

1106

Use of galantamine

467

0.62

1.85

2.3

2.6

1.57

1.88

mg/l

1.71

393

Other bursitis of elbow

2.18

1.85

4.1

2.8

1.57

1.61

mg/l

0.10

Benign paroxysmal vertigo

309

2666

1.16

1.85

3.1

3.0

1.64

1.60

mg/l

0.31

282

2423

Barrett oesophagus

384

1.45

1.85

2.7

3.2

1.80

1.60

mg/l

0.86

347

Need for immunization against other single infectious diseases

3.87

1.85

23.0

18.9

1.40

1.00

mg/l

—

Bus occupant injured in other and unspecified transport accidents

2.33

1.84

2.8

2.3

1.62

1.40

mg/l

0.51

Mental retardation, wide definition

737

1.32

1.82

12.3

15.1

1.11

1.21

mg/l

1.03

714

TMD related operations

186

1539

1.21

1.82

4.4

3.5

1.29

1.42

mg/l

1.93

172

1438

Endometriosis ASRM stages 3,4

220

1849

1.19

1.81

2.6

2.8

1.31

1.44

mg/l

2.16

205

1711

Unspecified protein-energy malnutrition

2.43

1.81

9.8

6.1

1.55

1.52

mg/l

0.05

Family history of certain disabilities and chronic diseases leading to disablement

311

1.49

1.81

3.0

3.4

1.12

1.21

mg/l

0.64

287

Impingement syndrome of shoulder

217

2575

0.84

1.81

2.9

1.55

1.53

mg/l

0.10

197

2367

Uterine polyps

749

0.70

1.79

2.9

3.0

1.56

1.45

mg/l

0.36

698

Acute alcohol intoxication, ICD10

251

2138

1.18

1.79

4.0

3.7

1.51

1.48

mg/l

0.28

232

1993

Benign neoplasm of bone and articular cartilage

747

1.31

1.78

4.3

3.9

1.39

1.46

mg/l

0.43

700

Abnormal findings in cerebrospinal fluid

3.47

1.77

4.2

2.2

2.16

1.45

mg/l

—

2.59

1.77

4.4

2.1

1.83

1.73

mg/l

—

Other conditions of integument specific to fetus and newborn

3.29

1.77

8.4

21.0

1.05

1.18

mg/l

—

Other endophthalmitis

2.58

1.76

5.4

3.3

1.73

1.61

mg/l

—

Other/unspecified reactive arthropathies

592

1.34

1.76

3.7

4.3

1.50

1.47

mg/l

0.10

551

Malignant neoplasm of penis, excluding all cancers (controls excluding all cancers)

2.56

1.76

3.3

2.6

2.06

1.84

mg/l

—

Oral leukoplakia

132

1.77

1.76

2.3

2.5

1.63

1.64

mg/l

0.01

122

Parkinson's disease, excluding more controls

1096

0.76

1.76

2.4

2.7

1.66

1.68

mg/l

0.12

974

Traumatic subdural haemorrhage

136

1075

1.25

1.76

4.5

2.7

2.10

1.68

mg/l

4.09

116

969

Mouth breathing

576

5187

1.11

1.76

5.7

5.2

1.48

1.47

mg/l

0.14

536

4838

Generalized anxiety disorder

163

1339

1.22

1.73

3.5

3.8

1.25

1.30

mg/l

0.38

150

1265

Smoking dependency

725

1.31

1.72

3.3

3.0

1.71

1.50

mg/l

1.48

677

Bell's palsy

136

1098

1.25

1.71

4.9

3.5

1.57

1.49

mg/l

0.45

119

1014

Postpartum haemorrhage

173

1815

0.83

1.71

2.8

3.3

1.18

1.32

mg/l

2.66

165

1710

Purulent endophthalmitis

2.45

1.70

3.0

2.2

1.62

1.70

mg/l

—

Mental and behavioural disorders due to tobacco

726

1.30

1.70

3.3

3.0

1.71

1.50

mg/l

1.46

679

Calculus of lower urinary tract

450

1.39

1.70

2.7

2.9

1.55

1.72

mg/l

0.99

397

Event of undetermined intent

596

1.34

1.70

3.1

5.0

1.54

1.38

mg/l

0.92

558

Burkitt lymphoma

4.12

1.69

34.4

10.7

0.99

1.30

mg/l

—

Burkitt lymphoma, helper endpoint

4.12

1.69

34.4

10.7

0.99

1.30

mg/l

—

Pilonidal cyst

110

868

1.27

1.69

3.1

3.6

1.52

1.34

mg/l

1.17

817

Pustular psoriasis

375

1.43

1.68

3.1

3.7

1.57

1.53

mg/l

0.09

354

Benign neoplasm: Skin of other and unspecified parts of face

112

886

1.27

1.68

4.8

3.1

1.76

1.60

mg/l

1.05

798

Preterm labour and delivery

253

2169

1.17

1.67

3.4

3.1

1.44

1.40

mg/l

0.39

237

2022

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

2.08

1.67

9.6

2.9

2.07

1.60

mg/l

0.56

Allergic contact dermatitis

144

1173

1.23

1.67

2.7

3.6

1.30

1.40

mg/l

1.02

129

1092

Other osteochondropathies

676

1.31

1.67

7.2

3.5

1.35

1.47

mg/l

1.01

632

Pulmonary eosinophilia, not elsewhere classified

1.96

1.66

2.6

2.3

1.67

1.62

mg/l

0.09

Examination and encounter for administrative purposes

334

1.45

1.66

5.1

2.8

1.87

1.64

mg/l

0.61

303

Salpingitis and oophoritis

175

1455

1.21

1.66

3.7

2.8

1.53

1.45

mg/l

0.64

165

1337

Entropion and trichiasis of eyelid

642

1.32

1.65

3.2

2.9

1.92

1.78

mg/l

0.82

559

Migraine without aura and triptan purchases

171

1420

1.21

1.64

5.2

4.5

1.19

1.29

mg/l

1.59

159

1352

Sleep terrors [night terrors]

3.73

1.64

13.8

19.4

1.35

1.10

mg/l

—

Heartburn

107

845

1.27

1.64

3.7

3.1

1.68

1.45

mg/l

1.81

101

778

Benign neoplasm of ovary

142

1158

1.23

1.63

2.9

1.47

1.57

mg/l

0.91

131

1039

Superficial injury of forearm

117

935

1.26

1.63

3.6

6.1

1.44

1.38

mg/l

0.36

105

873

Familial hypercholesterolemia, with ischemic heart disease

758

1.29

1.62

3.6

2.5

1.89

1.67

mg/l

1.80

668

Scabies

429

1.39

1.62

7.8

4.8

1.71

1.39

mg/l

1.15

400

Other and unspecified disorders of vitreous body

432

3833

1.12

1.61

3.0

2.9

1.58

1.62

mg/l

0.58

391

3467

Spontaneous rupture of synovium and tendon

698

1.30

1.60

3.5

2.8

1.76

1.56

mg/l

1.08

633

Early lumbar disc prolapse operation

1073

0.77

1.59

3.1

1.33

1.32

mg/l

0.03

1027

Inguinal or femoral hernia, bilateral

136

1109

1.23

1.59

5.0

3.5

1.71

1.69

mg/l

0.07

130

1012

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

125

1010

1.24

1.58

2.8

1.51

1.55

mg/l

0.18

114

917

Complications of labour and delivery

541

3342

0.90

1.57

2.8

3.2

1.33

1.42

mg/l

2.06

497

3103

Medical treatment for female infertility

184

1542

1.19

1.57

2.3

3.0

1.11

1.28

mg/l

5.96

172

1460

Acute gastritis

613

1.31

1.56

3.1

1.78

1.57

mg/l

1.18

553

Diseases of inner ear

624

5567

1.10

1.56

2.9

3.0

1.57

1.60

mg/l

0.41

567

5052

Inguinal hernia

873

5434

1.09

1.55

4.7

3.8

1.59

1.52

mg/l

1.50

802

5011

Any dementia, excluding more controls

274

2189

0.87

1.55

2.2

2.6

1.81

1.82

mg/l

0.05

226

1922

Early lumbar disc prolapse, operated

1034

0.77

1.54

3.2

3.1

1.34

1.30

mg/l

0.18

988

Myocardial infarction, unclassifiable

235

1799

1.17

1.54

3.1

2.7

2.09

1.80

mg/l

4.07

218

1586

Thyrotoxicosis with toxic multinodular goitre

433

1.37

1.54

2.4

3.1

1.81

1.60

mg/l

0.96

398

Convergent concomitant strabismus

615

1.31

1.54

8.7

7.9

1.30

1.28

mg/l

0.12

586

Other conditions originating in the perinatal period

2.67

1.53

36.8

25.8

2.19

1.16

mg/l

—

Oral lichen ruber planus wide, hypothyreosis or thyroxin

391

1.39

1.53

2.6

3.1

1.49

1.59

mg/l

0.25

361

Malignant neoplasm of prostate

413

2921

0.89

1.52

2.7

2.9

1.92

1.76

mg/l

2.70

365

2625

Atypical virus infections of central nervous system

1.94

1.52

2.0

2.6

1.18

1.47

mg/l

1.17

TMD related pain

242

1.50

1.51

2.4

3.7

1.05

1.35

mg/l

4.64

223

Endometriosis of rectovaginal septum and vagina

564

1.32

1.50

1.8

2.9

1.25

1.48

mg/l

2.74

522

Spirochaetal infections, other/unspecified

705

1.28

1.50

2.9

3.9

1.28

1.55

mg/l

3.00

652

Carcinoma in situ of cervix uteri, endocervix

2.03

1.50

3.5

2.2

1.45

1.34

mg/l

0.15

Obstructed labour due to maternal pelvic abnormality

102

1275

0.80

1.50

2.7

3.0

1.44

mg/l

0.01

1191

Palatinal maxillary operation

132

1.71

1.50

19.3

14.7

1.18

1.06

mg/l

0.42

127

Lateral epicondylitis

103

1284

0.80

1.48

2.8

1.38

1.44

mg/l

0.40

1192

Prepatellar bursitis

445

1.36

1.48

3.8

3.1

1.67

1.50

mg/l

0.78

411

ILD and respiratory illness in diseases classified elsewhere

2.44

1.48

4.4

2.1

1.83

1.70

mg/l

—

Colorectal adenocarcinoma, excluding all cancers (controls excluding all cancers)

173

1455

1.19

1.48

2.7

1.88

1.79

mg/l

0.66

155

1272

Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)

168

1410

1.20

1.47

3.4

2.6

1.83

1.77

mg/l

0.27

150

1229

Benign neoplasm: Appendix

1.91

1.47

4.4

2.7

1.61

1.70

mg/l

0.22

Contact with machinery

1148

0.79

1.46

2.5

3.1

1.52

1.56

mg/l

0.17

1059

Disorders of breast

393

4073

0.89

1.46

3.2

3.0

1.46

1.45

mg/l

0.10

367

3734

Benign neoplasm: Parathyroid gland

1.95

1.46

3.6

2.4

2.12

1.63

mg/l

1.15

Benign neoplasm: Ill-defined sites within the digestive system

2.37

1.45

2.1

2.3

1.30

1.63

mg/l

—

HSIL lesion of the vagina

1.82

1.45

3.1

2.3

2.01

1.43

mg/l

1.06

Anti-inflammatory and antirheumatic products, non-steroids

469

2618

0.90

1.44

4.5

6.4

1.46

1.59

mg/l

2.57

436

2447

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

360

3205

1.13

1.43

3.3

3.4

1.46

1.49

mg/l

0.26

333

2946

Malignant neoplasm of other and ill-defined sites, excluding all cancers (controls excluding all cancers)

1.84

1.42

3.8

4.1

1.43

1.55

mg/l

0.18

Other and unspecified nonscarring hair loss

2.30

1.41

5.3

2.6

1.29

1.32

mg/l

—

Inguinal hernia, bilateral

132

1089

1.22

1.41

4.9

3.5

1.69

mg/l

0.01

126

994

Appendicitis, broad definition

989

8435

1.07

1.41

3.5

3.3

1.52

1.49

mg/l

0.46

916

7801

Rheumatism, unspecified

138

1143

1.21

1.41

2.6

2.9

1.52

1.49

mg/l

0.18

121

1047

Epidermolysis bullosa

2.81

1.41

4.5

22.4

0.99

1.35

mg/l

—

Diseases of appendix

997

8478

1.07

1.41

3.5

3.3

1.52

1.49

mg/l

0.38

924

7840

Hemiplegia

449

1.35

1.41

9.5

4.0

1.61

1.58

mg/l

0.08

417

Other enthesopathy of foot (+metatarsalgia)

106

855

1.25

1.40

3.3

3.4

1.57

1.47

mg/l

0.57

788

Dental caries 2, only avohilmo

1035

7626

1.07

1.40

4.3

4.5

1.36

1.42

mg/l

2.04

967

7121

Injuries to the neck

263

2300

1.15

1.39

2.9

3.9

1.45

1.43

mg/l

0.12

245

2145

Other degenerative diseases of the basal ganglia

120

0.41

1.39

1.6

2.9

1.43

1.76

mg/l

—

109

Postinfectious hypothyroidism

2.25

1.39

2.4

2.0

1.78

1.37

mg/l

—

Acute alcohol intoxication

321

2846

1.13

1.38

3.9

3.4

1.60

1.54

mg/l

0.56

299

2620

Focal epilepsy, strict definition

249

2171

1.15

1.38

5.9

6.2

1.47

1.45

mg/l

0.14

227

2019

Metatarsalgia

794

1.25

1.38

3.1

3.4

1.56

1.47

mg/l

0.46

732

Tick-borne viral encephalitis

0.00

1.37

0.0

4.2

—

1.51

—

Use of riluzole

0.00

1.36

0.0

2.1

—

1.45

—

Non-small cell lung cancer

158

1331

1.19

1.36

2.9

2.7

1.43

1.77

mg/l

7.21

149

1187

Other and unspecified trigeminal disorders

120

1.69

1.36

1.8

3.1

1.35

1.45

mg/l

0.18

111

Benign neoplasm: Connective and other soft tissue of trunk, unspecified

2.18

1.36

1.5

2.9

1.44

1.58

mg/l

—

Focal epilepsy

269

2361

1.14

1.35

5.8

6.2

1.47

1.44

mg/l

0.28

244

2191

Asthma, including avohilmo

1740

9594

1.05

1.35

3.8

4.4

1.50

1.48

mg/l

0.48

1607

8874

Giant cell arteritis

282

1.43

1.35

2.3

2.8

1.82

1.74

mg/l

0.20

254

Benign mammary dysplasia

1102

0.80

1.35

3.2

2.8

1.58

1.51

mg/l

0.37

1004

Other otitis externa (chronic)

540

1.30

1.34

7.1

4.2

1.58

1.52

mg/l

0.27

499

Pain in thoracic spine

169

1435

1.18

1.33

3.4

1.48

1.47

mg/l

0.07

154

1333

Benign neoplasm of breast

762

1.25

1.33

3.0

2.9

1.42

1.52

mg/l

0.64

694

Medical abortion

665

3321

1.09

1.33

2.8

3.1

1.41

1.44

mg/l

0.40

619

3048

Other mental disorders due to brain damage and dysfunction and to physical disease

113

925

1.23

1.32

3.2

2.7

1.66

1.68

mg/l

0.09

103

821

Placenta praevia

332

0.63

1.32

1.4

3.0

1.12

1.28

mg/l

0.62

314

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

368

0.65

1.32

1.3

3.4

1.38

1.51

mg/l

0.39

347

Benign neoplasm: Choroid

472

1.32

1.31

3.0

2.9

1.67

1.61

mg/l

0.23

433

Dermatographic urticaria

533

1.30

1.31

7.9

3.8

1.43

1.40

mg/l

0.11

502

Cervicobrachial syndrome

191

2218

0.86

1.31

2.7

3.0

1.44

1.48

mg/l

0.32

176

2054

Congenital malformations of nose

2.94

1.31

6.0

23.6

1.11

1.12

mg/l

—

Sequelae of injuries, of poisoning and of other consequences of external causes

278

2453

1.14

1.31

2.9

3.3

1.49

mg/l

0.03

253

2280

Hypertrophy of breast

113

1373

0.82

1.31

2.5

3.1

1.37

1.39

mg/l

0.09

105

1286

Bronchitis, not specified as acute or chronic

800

1.24

1.31

3.6

3.4

1.59

1.52

mg/l

0.38

736

Other parasitologically confirmed or unspecified malaria

2.88

1.30

4.2

2.2

1.61

1.79

mg/l

—

Other/unspecified synovitis and tenosynovitis

128

1063

1.21

1.30

4.0

3.1

1.70

1.48

mg/l

1.87

119

976

Perioral dermatitis

161

1.57

1.30

15.6

4.1

1.62

1.31

mg/l

0.95

145

Benign neoplasm: Brain, supratentorial

114

1.69

1.29

6.2

4.4

1.21

1.40

mg/l

1.04

104

Neurofibromatosis, type 1

2.05

1.29

6.7

5.8

1.18

1.33

mg/l

0.61

Dissection of cerebral arteries, nonruptured

2.04

1.29

2.1

2.4

1.52

1.44

mg/l

0.09

Birth injury to scalp

3.09

1.29

39.2

23.3

1.02

1.05

mg/l

—

Infarction of spleen

2.10

1.28

2.8

2.4

1.46

1.81

mg/l

—

Unspecified visual impairment (binocular)

162

1.57

1.28

4.4

8.4

1.58

1.40

mg/l

0.52

150

Other symptoms and signs involving cognitive functions and awareness

502

4296

1.10

1.28

3.1

1.67

1.64

mg/l

0.34

457

3879

Alzheimer’s disease (Late onset), excluding more controls

798

0.81

1.27

2.1

2.4

1.70

1.80

mg/l

0.47

690

Other benign neoplasms of uterus

311

1.39

1.26

2.0

2.4

1.71

1.68

mg/l

0.08

272

Contact with sharp object, undetermined intent

216

0.55

1.26

2.8

3.8

1.23

1.38

mg/l

0.45

199

Blepharochalasis

293

2602

1.13

1.26

2.9

2.8

1.58

1.67

mg/l

1.01

259

2347

Left hemicolectomy

195

1.50

1.26

2.8

3.3

1.67

1.76

mg/l

0.22

178

Otalgia

778

1.24

1.25

6.7

9.1

1.38

1.35

mg/l

0.10

736

Carbimazole or st.post thyroidectomy, condition for graves disease

209

1816

1.15

1.25

2.8

3.2

1.54

1.45

mg/l

0.79

198

1682

Hereditary corneal dystrophies

245

1.44

1.24

3.9

3.1

1.44

1.64

mg/l

0.59

222

Ulcer of vagina/vulva

163

1.55

1.24

2.6

4.2

1.50

1.39

mg/l

0.21

146

Other bursopathies

144

1217

1.19

1.23

3.3

2.9

1.69

1.55

mg/l

1.12

125

1109

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

116

1.65

1.22

2.2

3.2

0.91

1.29

mg/l

4.18

108

Pregnancy, childbirth and the puerperium

258

1533

0.88

1.22

2.8

3.6

1.45

1.52

mg/l

0.68

234

1378

Benign leiomyoma with endometriosis

143

1209

1.19

1.21

3.1

2.8

1.63

1.53

mg/l

0.71

129

1109

Other puerperal infections

496

1.30

1.21

2.6

2.8

1.19

1.24

mg/l

0.28

469

Postmenopausal bleeding

267

1294

1.14

1.19

2.7

2.9

1.63

1.56

mg/l

0.81

248

1176

Triptan medication for migraine, min. 3 purchases

639

4663

1.08

1.19

2.8

3.7

1.19

1.38

mg/l

14.43

590

4379

Appendectomy

829

7462

1.07

1.19

3.5

3.3

1.48

1.46

mg/l

0.23

778

6903

Other disorders of the genitourinary system

118

984

1.20

1.18

3.3

3.0

1.71

1.61

mg/l

0.57

108

894

Marginal zone B-cell lymphoma

1.84

1.17

3.3

2.3

1.61

1.57

mg/l

0.07

Cachexia

2.10

1.17

3.8

2.7

2.06

1.82

mg/l

—

Lesion of ulnar nerve

158

1353

1.17

3.1

3.0

1.73

1.50

mg/l

1.88

145

1255

Infective bursitis

258

1.41

1.15

4.1

2.8

1.70

1.59

mg/l

0.36

238

Other nonscarring hair loss

1.93

1.13

4.6

2.4

1.64

1.47

mg/l

0.25

Benign neoplasm of meninges

771

1.22

1.12

2.7

3.0

1.56

1.61

mg/l

0.20

707

Chronic respiratory disease originating in the perinatal period

1.84

1.12

12.3

22.0

1.09

1.02

mg/l

0.38

Malignant neoplasm of eye and adnexa

1.77

1.11

11.5

4.5

1.03

1.57

mg/l

4.70

Burn and corrosion confined to eye and adnexa

207

0.57

1.11

4.0

3.1

1.16

1.41

mg/l

1.07

192

Alcohol dependence

336

3035

1.11

3.6

3.0

1.62

1.57

mg/l

0.53

309

2796

Benign neoplasm: Other/unspecified site

104

1.65

1.10

2.1

2.8

1.67

1.52

mg/l

0.26

Psoriatic arthropathies, ICD10

114

955

1.20

1.10

2.8

3.1

1.49

mg/l

0.03

892

Cluster headache, wide,, including avohilmo

442

1.30

1.10

2.5

3.2

1.26

1.41

mg/l

0.77

412

Open wound of thorax

144

1.55

1.10

4.4

2.7

1.89

1.44

mg/l

1.02

134

Torsion of ovary, ovarian pedicle and fallopian tube

138

0.50

1.10

1.3

3.0

1.31

1.27

mg/l

—

130

Maternal care for known or suspected disproportion

316

0.66

1.09

3.6

3.0

1.50

1.31

mg/l

0.34

305

Other and specified injuries of hip and thigh

169

1.49

1.08

3.9

3.3

1.60

1.57

mg/l

0.07

151

Cluster headache, wide

330

1.34

1.08

2.5

3.2

1.27

1.39

mg/l

0.42

306

LSIL lesion of the cervix uteri

784

1.22

1.07

4.0

2.9

1.36

1.30

mg/l

0.40

740

Benign neoplasm: Parathyroid gland

1.74

1.06

3.6

2.3

2.12

1.58

mg/l

1.33

Arthropod-borne viral fevers and viral haemorrhagic fevers

107

895

1.20

1.06

3.4

3.1

1.52

1.55

mg/l

0.12

828

Other specified/unspecified nutritional deficiencies

1.83

1.06

4.5

2.4

1.80

1.43

mg/l

0.61

Pigmented purpuric dermatosis

1.82

1.06

4.0

2.4

1.77

1.46

mg/l

0.56

Crushing injury of wrist and hand

148

0.53

1.05

7.9

3.9

1.69

1.53

mg/l

—

134

Congenital malformations of the nervous system

315

1.35

1.05

12.5

13.2

1.13

mg/l

0.01

301

Primary coxarthrosis, bilateral

298

2685

1.11

1.05

2.9

2.7

1.80

1.71

mg/l

0.92

263

2389

Injury of cranial nerves

1.88

1.04

2.3

2.9

1.21

1.34

mg/l

0.28

Acute and transient psychotic disorders

132

1127

1.18

1.04

3.5

3.2

1.71

1.44

mg/l

2.73

120

1063

Other psoriatic arthropathies

111

934

1.19

1.04

2.7

3.0

1.49

mg/l

0.01

873

Glaucoma-related operations

411

1.30

1.04

2.6

2.9

1.66

1.71

mg/l

0.13

369

Amoebiasis

1.96

1.03

4.2

9.6

1.77

1.40

mg/l

—

Scissor bite

527

1.26

1.02

17.2

15.1

1.16

1.08

mg/l

0.59

515

Injury of muscle and tendon at shoulder and upper arm level

359

3935

0.91

1.01

2.7

3.0

1.57

1.60

mg/l

0.34

326

3599

Sciatica+with lumbago

615

5439

1.07

1.01

2.8

3.0

1.55

1.52

mg/l

0.35

556

5017

Use of levodopa decarbox-comt-inhibitor

238

0.63

1.01

2.2

3.0

1.48

1.84

mg/l

1.09

210

Varus deformity, not elsewhere classified

1.64

1.01

2.9

6.2

1.45

1.54

mg/l

0.13

Other and unspecified nonorganic psychotic disorders

234

2086

1.12

1.00

3.4

1.42

1.36

mg/l

0.56

216

1967

Schizophrenia or delusion, excluding more controls

356

3220

1.10

1.00

3.2

2.9

1.51

1.40

mg/l

1.70

327

2988

Abnormal serum enzyme levels

363

3270

1.10

1.00

3.8

3.4

1.57

1.67

mg/l

1.44

342

2962

Café au lait spots

0.00

0.99

0.0

21.7

—

1.01

—

L02BB Anti-androgens

762

0.80

0.99

2.5

2.6

2.02

1.89

mg/l

0.45

664

Carcinoma in situ of endometrium

0.00

0.98

0.0

1.6

—

1.25

—

Hallux rigidus

1177

0.84

0.98

2.6

2.8

1.51

1.52

mg/l

0.03

1075

Labour and delivery complicated by umbilical cord complications

366

0.71

0.98

2.0

3.3

1.18

1.37

mg/l

1.28

342

Disorders of pituitary gland, other and/or unspecified

1.83

0.98

12.8

2.2

1.47

1.48

mg/l

—

Shoulder lesions

1020

5911

1.06

0.98

3.0

1.57

1.53

mg/l

0.73

930

5437

Overexertion and strenuous or repetitive movements

112

950

1.18

0.97

3.3

1.42

1.45

mg/l

0.14

107

888

Malignant neoplasm of lip

1.88

0.97

2.3

2.4

1.97

1.94

mg/l

—

Palmar fascial fibromatosis [Dupuytren]

172

1508

1.14

0.97

3.3

2.8

1.70

1.69

mg/l

0.06

157

1346

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

319

1.32

0.96

2.0

2.9

1.43

1.46

mg/l

0.08

294

Pedal cyclist injured in noncollision transport accidents

1131

0.84

0.96

5.3

5.2

1.38

1.42

mg/l

0.26

1065

Other peripheral vertigo

731

1.21

0.96

2.6

3.0

1.59

1.61

mg/l

0.10

660

Cluster headache, strict

302

1.33

0.96

2.7

3.1

1.28

1.36

mg/l

0.22

280

Torsion of testis

242

1.38

0.96

8.7

8.8

1.27

1.23

mg/l

0.13

232

Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)

595

1.23

0.96

2.6

2.7

1.64

1.66

mg/l

0.10

526

Excessive vomiting in pregnancy

559

1.24

0.96

3.6

2.9

1.45

1.28

mg/l

1.05

526

Complications predominantly related to the puerperium

236

2112

1.12

0.96

3.0

2.9

1.39

1.35

mg/l

0.34

219

1979

Lichen planus

125

1072

1.17

0.95

2.5

3.0

1.66

1.59

mg/l

0.37

111

973

Alzheimer’s disease (Atypical or mixed), excluding more controls

467

1.25

0.95

2.9

2.4

2.05

1.87

mg/l

0.79

402

Liveborn infants according to place of birth

209

1.41

0.95

13.2

19.2

0.98

mg/l

0.03

203

Fracture at wrist and hand level

440

4059

1.09

0.95

3.4

4.1

1.50

1.44

mg/l

0.84

421

3775

Other appendicitis

788

1.20

0.94

4.4

3.2

1.45

1.50

mg/l

0.29

738

Malignant melanoma of skin

109

926

1.18

0.94

3.6

2.8

1.65

1.66

mg/l

0.03

103

838

Acute myeloid leukaemia, excluding all cancers (controls excluding all cancers)

1.74

0.93

8.4

5.8

1.23

1.55

mg/l

1.53

Acute myeloid leukaemia, helper endpoint

1.74

0.93

8.4

5.8

1.23

1.55

mg/l

1.53

Degenerative macular diseases, drug-induced

2.20

0.93

2.8

2.6

1.95

1.74

mg/l

—

Mixed disorders of conduct and emotions, excluding more controls

218

1.39

0.92

12.9

11.8

1.47

1.08

mg/l

1.86

208

Haemorrhage in early pregnancy

254

2233

1.11

0.92

2.6

2.9

1.41

1.34

mg/l

0.69

241

2080

Stenosis and insufficiency of lacrimal passages

781

1.20

0.92

3.6

4.2

1.48

1.55

mg/l

0.36

713

Abnormal involuntary movements

143

1244

1.15

0.92

3.7

4.4

1.50

mg/l

0.05

128

1152

Vestibular neuronitis

763

1.20

0.92

3.0

3.1

1.51

1.57

mg/l

0.29

699

Additional codes for the location of defect, injury or illness

500

1.25

0.91

5.1

4.3

1.63

1.49

mg/l

0.59

465

Cluster headache, strict, including avohilmo

420

1.27

0.91

2.6

3.2

1.26

1.38

mg/l

0.50

393

Nontoxic multinodular goitre

182

1611

1.13

0.90

3.1

2.9

1.70

1.58

mg/l

0.85

161

1452

Cholesteatoma of middle ear

451

0.75

0.90

5.0

3.4

1.85

1.62

mg/l

0.57

408

Transient global amnesia

730

0.80

0.90

2.3

2.9

1.48

1.66

mg/l

1.33

650

Spondylopathies in diseases classified elsewhere

1.63

0.88

7.4

3.0

1.58

1.71

mg/l

0.26

Acute appendicitis, with complications

224

2011

1.12

0.88

3.4

3.0

1.75

1.53

mg/l

3.18

208

1855

Idiopathic peripheral autonomic neuropathy

2.05

0.88

1.7

2.9

0.95

1.78

mg/l

—

Benign neoplasm of brain and other parts of central nervous system

575

1.22

0.88

4.8

4.5

1.41

1.51

mg/l

0.50

533

Dislocation, sprain and strain of joints and ligaments of elbow

657

1.21

0.88

9.6

7.6

1.22

1.31

mg/l

0.77

621

Benign neoplasm: Spinal meninges

1.74

0.87

1.4

2.4

1.12

1.50

mg/l

1.83

Nontraumatic intracranial haemmorrhage

200

1786

1.12

0.87

5.3

2.9

1.76

1.68

mg/l

0.59

185

1590

Adenocarcinoma and papillary adenocarcinoma of stomach

204

0.63

0.86

3.2

2.9

2.12

1.81

mg/l

0.31

182

Glaucoma, exfoliation

805

1.18

0.86

2.2

2.4

1.95

1.80

mg/l

0.72

696

Oter anti-inflammatory and antirheumatic agents, non-steroids

275

1681

0.91

0.86

2.7

3.9

1.63

1.81

mg/l

2.83

247

1541

Mental disorders, not otherwise specified

723

1.19

0.86

3.4

3.6

1.49

1.37

mg/l

0.70

686

Carcinoma in situ of cervix uteri, endocervix

1.64

0.85

3.5

2.5

1.45

1.38

mg/l

0.08

Neuroendocrine tumor and carcinoma of pancreas, excluding all cancers (controls excluding all cancers)

1.81

0.85

1.4

2.7

1.56

1.46

mg/l

—

Multifocal fibrosclerosis

1.81

0.85

4.3

2.3

2.22

1.62

mg/l

—

Dacryoadenitis

1.78

0.84

21.2

3.5

1.66

1.48

mg/l

—

Labour and delivery complicated by fetal stress [distress]

174

1309

0.89

0.84

2.5

3.1

1.16

1.25

mg/l

1.11

162

1232

Other arthrosis

619

4157

1.07

0.84

3.1

2.8

1.61

1.49

mg/l

2.80

560

3815

Other disorders of binocular vision

114

0.52

0.83

10.5

4.5

1.15

1.31

mg/l

—

104

Trigeminal neuralgia

443

1.25

0.83

2.4

3.0

1.53

1.55

mg/l

0.07

407

Temporal arteritis

257

1.33

0.83

2.4

2.8

1.88

1.72

mg/l

0.39

230

Precocious central puberty

1.64

0.83

29.7

12.4

1.16

1.05

mg/l

0.39

Benign neoplasm: Cerebral meninges

689

1.19

0.83

2.9

3.1

1.63

1.61

mg/l

0.07

632

Pedal cyclist injured in transport accident

213

2364

0.90

0.82

4.5

4.7

1.35

1.43

mg/l

1.10

194

2200

Transitory disorders of carbohydrate metabolism specific to fetus and newborn

492

1.24

0.82

17.6

21.6

1.04

1.05

mg/l

0.17

487

Giant cell arteritis with polymyalgia rheumatica

258

1.33

0.82

2.4

2.8

1.88

1.71

mg/l

0.42

229

Hyperkinetic disorders (excl. ADHD)

344

1.28

0.82

10.2

14.5

1.20

1.10

mg/l

0.71

335

Postpartum hemorraghe, all women as controls

173

1933

0.89

0.82

2.8

3.1

1.18

1.30

mg/l

2.01

165

1831

Laparoscopic right hemicolectomy

400

1.26

0.81

2.8

2.9

1.91

1.75

mg/l

0.52

357

Palatinal maxillary canine

106

1.54

0.81

24.2

15.9

1.30

1.08

mg/l

0.66

101

Chronic suppurative otitis media

664

1.20

0.80

7.7

6.0

1.50

1.42

mg/l

0.34

612

Schizoid personality disorder

147

0.61

0.80

2.7

2.9

1.74

1.42

mg/l

—

137

Congenital malformations of breast

1.54

0.79

5.1

3.0

1.42

1.25

mg/l

0.24

Psychotic depression

492

1.22

0.79

4.4

3.8

1.63

1.48

mg/l

0.61

461

Transitory endocrine and metabolic disorders specific to fetus and newborn

503

1.23

0.78

17.3

21.3

1.04

1.05

mg/l

0.10

498

Certolizumab pegol

123

0.56

0.78

2.0

3.4

1.45

1.27

mg/l

—

111

Other cestode infections

0.00

0.78

0.0

2.7

—

1.55

—

Antenatal screening

182

1147

0.89

0.78

2.5

3.6

1.18

1.31

mg/l

2.19

171

1083

Maternal care for known or suspected abnormality of pelvic organs

229

1429

1.11

0.78

2.9

3.2

1.30

1.32

mg/l

0.21

220

1339

Spinal stenosis

588

4334

1.06

0.78

2.7

2.9

1.74

1.65

mg/l

1.74

525

3937

Other benign neoplasms of uterus

340

1.27

0.77

2.0

2.5

1.71

1.65

mg/l

0.19

301

Spermatocele

723

1.18

0.77

2.8

3.0

1.88

1.65

mg/l

1.14

660

Liposarcoma

1.72

0.76

3.0

2.5

1.82

1.67

mg/l

—

Exposure to other and unspecified man-made environmental factors

124

1.47

0.76

5.3

3.1

1.27

1.36

mg/l

0.36

114

Nail dystrophy

1.69

0.75

3.2

3.0

1.75

1.49

mg/l

—

Temporomandibular joint disorders, including avohilmo

447

4171

1.07

0.75

2.9

3.7

1.27

1.39

mg/l

3.17

407

3901

Maternal care for other known or suspected fetal problems

217

1258

1.11

0.75

2.8

3.3

1.23

1.28

mg/l

0.56

204

1181

Unspecified dementia

712

0.83

0.75

2.8

2.5

2.11

1.91

mg/l

1.17

615

Unspecified renal colic

1.66

0.74

7.0

4.0

1.55

1.59

mg/l

—

Malignant neoplasm of heart, mediastinum and pleura, excluding all cancers (controls excluding all cancers)

108

1.49

0.74

9.5

2.7

1.07

1.66

mg/l

3.62

Other specified/unspecified inflammatory spondylopathies

415

1.23

0.73

2.5

3.1

1.51

1.40

mg/l

0.38

390

Benign neoplasm of soft tissue of retroperitoneum and peritoneum

1.83

0.73

1.6

2.3

1.49

1.48

mg/l

—

Neonatal aspiration syndromes

2.03

0.73

19.4

27.6

0.93

1.02

mg/l

—

Other and unspecified injuries of thorax

142

1.42

0.73

4.1

2.8

1.34

1.44

mg/l

0.32

130

Other congenital malformations of female genitalia

1.64

0.72

2.8

6.1

1.64

1.17

mg/l

0.98

Personal history of allergy to drugs, medicaments and biological substances

1.60

0.72

4.3

4.1

1.52

1.30

mg/l

0.54

Lichen ruber planus, wide definition including periferal and oral lichen planus

207

1878

1.10

0.72

2.2

2.9

1.48

1.58

mg/l

0.93

187

1720

Unspecified abortion

344

1.26

0.72

3.7

3.2

1.56

1.39

mg/l

0.65

331

Other acantholytic disorders

1.98

0.72

10.2

2.8

2.50

1.85

mg/l

—

Acute appendicitis

906

8164

1.05

0.71

3.5

3.3

1.52

1.49

mg/l

0.61

838

7550

Mandibular retrognathia

774

1.16

0.70

15.1

9.5

1.17

1.24

mg/l

0.74

744

Dental caries 2 and operation codes, only avohilmo

947

6146

0.95

0.70

4.4

5.2

1.37

1.48

mg/l

4.29

884

5740

severe traumatic brain injury, does not include concussion

230

2100

1.10

0.70

4.1

3.0

1.85

1.65

mg/l

2.18

204

1893

Alcohol abuse, main dg

182

1643

1.11

0.70

4.4

3.9

1.50

1.47

mg/l

0.24

168

1531

Outcome of delivery

154

850

1.12

0.70

2.6

3.1

1.15

1.29

mg/l

3.01

144

798

Foreign body in alimentary tract

555

1.20

0.70

3.8

6.2

1.39

1.48

mg/l

0.35

511

Assault by sharp object

152

1.39

0.70

7.0

3.3

2.05

1.37

mg/l

1.77

142

Other specified disorders of external ear

310

1.27

0.70

3.4

3.0

1.74

1.64

mg/l

0.21

282

Chronic suppurative otitis media, including avohilmo

852

1.15

0.69

7.5

7.8

1.48

1.41

mg/l

0.40

794

Glucosamine medication

473

4016

0.94

0.69

2.6

2.8

1.71

1.69

mg/l

0.17

422

3581

Other and unspecified hydrocephalus

161

1.38

0.69

12.4

5.8

1.92

1.46

mg/l

1.13

147

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

575

1.19

0.68

3.0

2.8

1.50

1.52

mg/l

0.09

527

Ankylosing spondylitis, ICD10

854

1.15

0.67

2.6

3.3

1.44

1.47

mg/l

0.18

791

Enthesopathies of lower limb, excluding foot

251

2307

1.09

0.67

3.5

3.3

1.42

1.48

mg/l

0.52

230

2133

Coxibs

383

2186

0.93

0.67

2.2

4.1

1.41

1.70

mg/l

9.66

343

2022

Burns and corrosions confined to eye and internal organs

249

0.72

0.67

4.3

3.5

1.18

1.44

mg/l

1.87

232

conjunctival degenerations and deposits

162

1.37

0.67

2.9

2.8

1.50

1.58

mg/l

0.15

144

Ankylosing spondylitis

102

893

1.15

0.66

2.6

3.2

1.45

1.48

mg/l

0.17

833

Acute poliomyelitis

112

1.44

0.64

2.1

2.4

1.16

1.51

mg/l

1.98

103

Benign neoplasm: Orbit, unspecified

1.66

0.63

2.4

2.7

1.44

1.63

mg/l

—

Deep bite that required surgery

103

0.58

0.62

3.8

3.3

1.08

1.37

mg/l

—

1.65

0.62

4.1

5.5

2.09

1.75

mg/l

—

Osteochondrodysplasia with defects of growth of tubular bones and spine

1.72

0.62

1.8

17.3

0.85

1.14

mg/l

—

Meralgia paraesthetica

262

1.27

0.61

2.5

3.2

1.51

1.56

mg/l

0.12

241

Asthma/COPD (KELA code 203)

1334

9086

1.04

0.61

3.8

4.4

1.51

1.46

mg/l

1.45

1226

8424

Benign neoplasm: Anus and anal canal

209

1.30

0.60

3.6

3.0

2.21

1.72

mg/l

1.01

189

Other extrapyramidal and movement disorders in other diseases

227

2091

1.09

0.60

3.7

3.3

1.58

mg/l

0.03

209

1907

Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)

319

1782

1.08

0.60

2.9

2.8

1.87

1.79

mg/l

0.74

282

1580

Neuroendocrine tumor and carcinoma of pancreas

1.56

0.60

1.4

2.5

1.56

mg/l

—

Tic disorders

201

1.31

0.60

8.4

13.8

1.10

1.06

mg/l

0.17

193

Leiomyoma of uterus

616

3330

1.05

0.60

2.9

2.8

1.51

1.46

mg/l

0.76

558

3064

Divergent concomitant strabismus

733

1.15

0.59

5.9

5.3

1.45

1.41

mg/l

0.15

692

Poisoning by medicine, drug-induced

113

0.61

0.58

1.9

3.0

1.39

1.33

mg/l

—

104

Contraceptive management

464

3449

0.94

0.58

3.7

3.3

1.27

1.39

mg/l

3.88

440

3250

Helminthiases

158

1.34

0.58

5.4

7.0

1.26

1.42

mg/l

0.58

146

Hereditary ataxia

115

1.41

0.57

4.4

7.3

1.59

1.49

mg/l

0.12

104

Focal epilepsy, mode (most common among epilepsy diagnosis)

219

2022

1.09

0.56

4.8

6.1

1.50

1.46

mg/l

0.29

199

1880

Monocytic leukaemia

1.66

0.56

6.3

3.9

1.39

1.59

mg/l

—

Other abnormal auditory perceptions

0.56

6.4

5.3

1.00

1.29

mg/l

—

Rheumatic fever with heart involvement

1.64

0.56

4.0

2.6

1.91

1.60

mg/l

—

Other contact dermatitis

690

1.15

0.56

5.9

3.0

1.50

1.47

mg/l

0.11

638

Endometriosis diagnosis and infertility diagnosis occurring together

765

1.14

0.56

2.1

2.9

1.11

1.32

mg/l

3.56

722

therapeutic use

221

1.27

0.56

7.1

2.9

2.07

1.59

mg/l

1.85

200

Acute myeloid leukaemia

1.48

0.55

8.4

5.5

1.23

1.57

mg/l

1.60

Unequal limb length (acquired)

1.48

0.55

11.0

7.3

1.10

1.14

mg/l

0.12

Undefined dementia

711

0.86

0.55

2.8

2.5

2.13

1.90

mg/l

1.48

602

Motor neuron disease (with DMD)

142

1.35

0.55

4.3

4.8

1.09

1.55

mg/l

2.13

131

Malignant neoplasm of gallbladder, excluding all cancers (controls excluding all cancers)

1.59

0.54

3.0

2.0

1.33

1.58

mg/l

—

Use of interferon beta-1a

182

0.71

0.54

1.8

2.8

1.19

1.33

mg/l

0.46

171

Benign lipomatous neoplasm of other sites/unspecified

617

1.15

0.54

2.8

2.7

1.62

1.60

mg/l

0.05

551

Demyelinating diseases of the central nervous system

729

0.86

0.54

1.9

3.3

1.31

1.39

mg/l

0.29

687

Gestational diabetes (for exclusion)

319

2115

1.07

0.54

2.9

3.1

1.30

1.27

mg/l

0.37

299

2007

Benign neoplasm: Spinal meninges

1.50

0.54

1.4

2.4

1.12

1.58

mg/l

2.43

Single delivery by caesarean section

166

1051

0.91

0.54

3.1

3.7

1.22

1.38

mg/l

3.36

159

988

Down's syndrome

1.46

0.53

3.7

18.1

1.06

1.08

mg/l

—

Other congenital malformations of tongue, mouth and pharynx

285

1.24

0.53

17.5

17.7

1.19

1.09

mg/l

0.52

277

Malignant neoplasm of colon

134

1214

1.11

0.53

3.2

2.7

1.88

1.72

mg/l

0.98

118

1082

Benign neoplasm: Cranial nerves

187

1.29

0.53

5.5

3.2

1.58

1.55

mg/l

0.08

167

Postprocedural musculoskeletal disorders, not elsewhere classified

563

1.16

0.53

4.0

3.2

1.69

1.63

mg/l

0.20

513

Coxarthrosis, primary

651

5410

1.05

0.52

2.9

2.8

1.76

1.67

mg/l

1.79

581

4879

Benign neoplasm: Other/unspecified site

126

1.36

0.52

2.1

2.9

1.67

1.62

mg/l

0.08

114

Unspecified mental disorder

487

4633

1.05

0.52

3.1

1.51

1.44

mg/l

1.06

442

4310

Toxic effect of alcohol

179

1.29

0.51

7.0

3.3

1.92

1.48

mg/l

1.23

165

Other and unspecified nerve root and plexus disorders, also in other diseases

197

1822

1.08

0.51

2.6

3.0

1.56

1.49

mg/l

0.46

177

1688

Congenital malformations of oesophagus

1.52

0.51

3.7

15.1

0.94

1.22

mg/l

—

Radiculopathy

169

1554

1.09

0.50

2.9

2.8

1.67

1.61

mg/l

0.33

151

1403

Guillain-Barre syndrome

127

1.35

0.50

4.5

3.6

1.57

1.52

mg/l

0.10

117

Contact with heat and hot substances

585

1.15

0.50

3.9

7.4

1.60

1.37

mg/l

1.46

552

Adenocarcinoma and papilloma adenocarcinoma of rectum, excluding all cancers (controls excluding all cancers)

688

1.14

0.50

2.5

2.7

1.86

1.72

mg/l

0.67

605

Artrosis, including avohilmo

1129

6396

0.97

0.49

2.8

3.1

1.55

1.53

mg/l

0.41

1030

5926

Impaction of intestines

1.57

0.49

3.0

2.3

1.42

1.71

mg/l

—

Noise effects on inner ear

388

0.82

0.48

2.9

3.0

1.64

1.57

mg/l

0.18

351

Inflammatory disease of uterus

117

1060

1.11

0.48

2.7

2.9

1.38

1.37

mg/l

0.05

110

989

Persistent delusional disorders

667

0.87

0.48

3.7

2.9

1.67

1.50

mg/l

0.63

618

Impacted maxillary canine

155

1.31

0.48

18.8

16.3

1.29

1.13

mg/l

0.40

150

Migraine with aura and triptan purchases

146

1338

1.09

0.48

3.1

4.6

1.17

1.33

mg/l

4.20

134

1263

Acetic acid derivatives and related substances

390

2144

0.95

0.47

2.7

4.1

1.59

1.71

mg/l

1.69

356

1983

Disorders of brain, other and unspecified

1.43

0.47

14.2

3.3

1.38

1.60

mg/l

0.43

Ulcer of oesophagus, drug-induced

1.48

0.47

2.9

2.6

1.94

1.80

mg/l

—

Spontaneous abortion

391

2803

0.95

0.47

3.0

1.40

mg/l

0.01

357

2605

Melanoma in situ of upper limb, including shoulder

1.47

0.47

10.1

2.3

2.41

1.62

mg/l

—

Dental pulpitis 3, only avohilmo

152

1208

0.92

0.47

5.6

11.6

1.23

1.09

mg/l

1.61

142

1167

Gonarthrosis,primary

1051

6821

0.97

0.47

2.6

3.0

1.68

1.60

mg/l

2.34

949

6223

Pedestrian injured in collision with pedal cycle

273

1.21

0.46

2.6

3.1

1.34

1.51

mg/l

0.99

252

Reduction defects of upper limb

1.43

0.46

2.7

16.4

1.05

1.06

mg/l

—

Vascular dementia (multiple infarctions)

0.61

0.46

4.2

2.1

1.87

2.19

mg/l

—

Other deformities of toe(s)

254

0.78

0.46

1.9

2.7

1.94

1.54

mg/l

1.13

238

Somnolence

121

1.33

0.44

5.9

6.9

1.44

1.40

mg/l

0.05

110

Universal erythroderma, KELA reimbursement

121

1.33

0.44

3.4

3.2

1.79

1.54

mg/l

0.47

111

Foreign body on external eye

154

1667

0.92

0.44

3.8

3.6

1.51

1.48

mg/l

0.16

144

1561

Other disorders of the musculoskeletal system and connective tissue

142

1306

1.09

0.44

3.2

3.1

1.57

1.56

mg/l

0.05

126

1195

Other fall from one level to another

285

2688

1.06

0.44

6.2

6.3

1.39

1.40

mg/l

0.08

264

2517

Triptan medication for migraine, single purchase ok

939

6562

0.97

0.44

3.3

3.8

1.30

1.42

mg/l

6.55

879

6127

Migraine, single triptan purchase ok & required. ICD-code if available is included

939

6562

0.97

0.44

3.3

3.8

1.30

1.42

mg/l

6.55

879

6127

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum, excluding all cancers (controls excluding all cancers)

714

1.12

0.44

2.4

2.7

1.88

1.72

mg/l

0.80

627

Polyp of the female genital tract

295

1618

1.06

0.44

3.0

1.58

1.48

mg/l

1.17

274

1483

Other disturbances of cerebral status of newborn

1.43

0.44

21.6

24.2

1.20

1.06

mg/l

—

Lichen sclerosus et atrophicus

743

1.12

0.44

2.5

2.9

1.53

1.47

mg/l

0.26

668

Respiratory tuberculosis, bacteriologically and histologically confirmed

157

1.28

0.43

2.8

2.7

1.59

1.75

mg/l

0.27

143

Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)

386

1.17

0.43

6.0

3.0

1.55

1.57

mg/l

0.06

346

Chalazion

117

1068

1.10

0.43

3.7

4.0

1.44

1.49

mg/l

0.39

109

991

Extrapyramidal and movement disorders

353

3714

0.95

0.43

3.3

3.2

1.59

1.64

mg/l

0.46

322

3360

Inflammatory diseases of prostate (prostatitis)

142

1308

1.09

0.43

3.1

2.9

1.69

1.61

mg/l

0.46

125

1191

Neuralgia and neuritis, unspecified

405

1.16

0.43

2.0

2.9

1.58

1.49

mg/l

0.22

372

Nasal polyp

185

1985

0.93

0.43

2.8

3.0

1.54

1.59

mg/l

0.32

169

1819

Fibrosarcoma, excluding all cancers (controls excluding all cancers)

1.44

0.43

7.3

4.3

1.22

1.64

mg/l

—

Inflammatory disorders of male genital organs, not elsewhere classified

122

1.32

0.43

6.4

3.0

1.85

1.57

mg/l

0.70

112

Unspecified organic or symptomatic mental disorder

1.58

0.42

1.4

2.3

2.02

1.61

mg/l

—

Conductive hearing loss, unspecified

764

1.12

0.42

8.5

5.4

1.54

1.47

mg/l

0.29

707

Other adrenocortical overactivity

1.38

0.42

13.1

13.3

1.17

1.05

mg/l

0.39

Colon adenocarcinoma

104

945

1.10

0.42

2.7

1.93

1.72

mg/l

1.26

834

Paranoid personality disorder

139

0.72

0.42

8.2

2.9

1.76

1.48

mg/l

—

127

Atopic conjunctivitis

425

1.16

0.42

7.9

7.2

1.40

1.34

mg/l

0.22

399

L02BX Other hormone antagonists and related agents

456

0.85

0.42

3.0

2.8

1.91

1.84

mg/l

0.17

400

Assault by drugs, medicaments and biological substances

0.00

0.42

0.0

3.2

—

1.50

—

Other or unspecified paralytic strabismus

1.37

0.41

2.8

2.6

1.56

1.41

mg/l

—

Medicines for HER+ breast cancer

315

2912

1.05

0.41

2.6

2.8

1.37

1.55

mg/l

3.69

280

2646

Macular hole

398

1.16

0.41

3.3

2.8

1.87

1.68

mg/l

0.40

365

Other congenital malformations of ear

138

0.72

0.41

5.4

14.9

1.10

mg/l

—

132

Other specified/unspecified diseases of inner ear

1.48

0.40

2.0

2.6

1.44

1.80

mg/l

—

Benign neoplasm: Brain, supratentorial

150

1.28

0.40

6.2

5.2

1.21

1.43

mg/l

1.32

138

Respiratory tuberculosis, confirmed

150

1.27

0.40

2.9

2.7

1.58

1.76

mg/l

0.27

136

Vascular dementia (subcortical)

177

1.25

0.40

1.3

2.2

1.64

1.97

mg/l

0.87

151

Coxarthrosis, primary, with hip surgery

481

4374

1.04

0.40

2.8

2.7

1.78

1.70

mg/l

1.23

426

3917

Cramp and spasm

427

1.15

0.40

3.6

4.5

1.44

1.49

mg/l

0.19

401

D07AA Corticosteroids, weak (group I)

189

1766

1.07

0.40

6.4

8.2

1.47

1.31

mg/l

1.82

182

1676

Pregnancy with abortive outcome

667

3364

1.04

0.39

2.9

3.1

1.43

1.44

mg/l

0.18

621

3088

Other congenital malformations of nervous system

106

1.33

0.39

14.9

11.2

1.16

1.14

mg/l

0.08

101

Postpartum hemorraghe, parous women as controls

173

1623

0.93

0.39

2.8

3.0

1.18

1.28

mg/l

1.52

165

1546

Biological medicines for asthma

115

1.31

0.39

1.2

2.9

1.08

1.37

mg/l

2.04

106

Alopecia areata

233

1.21

0.39

6.3

7.7

1.20

1.32

mg/l

0.61

219

Drug-induced headache, not elsewhere classified

1.40

0.38

3.2

3.0

1.01

1.53

mg/l

—

Restless leg syndrome

112

1029

1.09

0.38

3.7

3.2

1.57

1.52

mg/l

0.24

100

944

Other neurotic disorders

401

1.15

0.38

2.6

3.0

1.68

1.54

mg/l

0.50

370

Xanthelasma of eyelid

1.33

0.38

3.1

2.8

1.92

1.51

mg/l

—

Other vitreous opacities

308

1.17

0.37

2.8

3.1

1.84

1.62

mg/l

0.37

281

Oral lichen ruber planus, including avohilmo

458

1.14

0.37

2.2

3.2

1.23

1.56

mg/l

3.19

429

Other drug-induced secondary parkinsonism

1.40

0.37

1.5

2.3

1.63

1.57

mg/l

—

L02BG Aromatase inhibitors

246

2329

1.06

0.37

2.4

2.9

1.43

1.57

mg/l

1.90

220

2116

Alzheimer’s disease (Atypical or mixed)

599

1.12

0.37

2.9

2.4

2.05

1.95

mg/l

0.35

508

Other noninflammatory disorders of cervix uteri

365

1.15

0.36

2.0

2.9

1.59

1.50

mg/l

0.29

334

Thiamine deficiency

1.48

0.36

3.5

2.7

1.47

1.45

mg/l

—

Drug-induced gout

1.45

0.36

8.0

2.5

2.93

1.77

mg/l

—

Cleft lip and cleft lip and palate

0.63

0.36

15.8

11.1

1.34

1.21

mg/l

—

Multiple gestation

713

0.90

0.36

3.3

3.2

1.35

1.33

mg/l

0.09

675

Galactorrhea

0.62

0.35

6.0

2.7

1.39

1.41

mg/l

—

Abscess of external ear

108

1.30

0.35

6.9

4.1

1.58

1.38

mg/l

0.47

Superficial injury of shoulder and upper arm

113

1043

1.09

0.35

3.2

4.1

1.50

1.47

mg/l

0.12

100

961

Acute otitis externa, noninfective

126

1.28

0.35

8.0

2.9

1.62

1.47

mg/l

0.36

114

Dental pulpitis 3

190

1286

1.07

0.35

8.1

11.5

1.22

1.10

mg/l

1.86

178

1244

Fibromyalgia

660

1.11

0.35

3.1

2.8

1.30

1.36

mg/l

0.43

613

Gastrointestinal stromal tumor and sarcoma, excluding all cancers (controls excluding all cancers)

1.38

0.35

2.4

2.2

1.34

1.56

mg/l

—

Ankyloglossia

348

1.16

0.34

16.7

18.1

1.12

1.09

mg/l

0.13

338

Osteitis due to dental implant

1.34

0.34

6.7

2.4

1.70

1.67

mg/l

—

Serous carcinoma of ovary

232

0.82

0.34

5.3

3.1

1.37

1.53

mg/l

0.71

212

Achilles tendinitis

111

1027

1.08

0.34

2.7

3.0

1.45

1.51

mg/l

0.29

952

Spondylolisthesis/Spondylolysis

189

1783

1.06

0.33

2.6

3.2

1.52

mg/l

0.02

176

1637

Communicating hydrocephalus

177

0.79

0.33

5.0

6.2

1.59

1.48

mg/l

0.13

160

Inhalation and ingestion of food causing obstruction of respiratory tract

0.68

0.33

8.0

9.5

1.23

1.42

mg/l

—

Thyroiditis

568

1.11

0.33

2.2

3.7

1.36

1.48

mg/l

0.86

532

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

812

0.91

0.32

2.5

2.8

1.87

1.69

mg/l

0.84

726

Benign neoplasm: Brain, unspecified

1.28

0.32

7.5

3.5

1.30

1.57

mg/l

—

Other benign neoplasm of uterus: Corpus uteri

1.28

0.32

1.8

2.6

1.73

1.54

mg/l

—

Toxic effect of carbon monoxide

132

0.75

0.32

3.9

2.7

1.55

1.54

mg/l

—

120

Burns and corrosions of external body surface, specified by site

128

1194

1.07

0.32

4.3

6.3

1.50

1.40

mg/l

0.74

120

1123

Plantar fascial fibromatosis

829

1.09

0.31

3.2

2.8

1.50

1.46

mg/l

0.23

766

Contact with venomous snakes and lizards

0.72

0.31

2.7

5.2

1.01

1.40

mg/l

—

Sequelae of injuries of lower limb

858

1.09

0.31

3.4

3.1

1.54

1.47

mg/l

0.40

800

Intussusception

156

1.22

0.31

6.3

5.9

1.28

1.49

mg/l

1.00

148

Lichen planus, including avohilmo

170

1604

1.06

0.31

2.3

3.0

1.54

1.58

mg/l

0.24

154

1470

Degeneration of nervous system due to alcohol

193

1.20

0.31

2.8

3.1

1.62

1.71

mg/l

0.20

175

Degeneration of the brain due to alcohol

193

1.20

0.31

2.8

3.1

1.62

1.72

mg/l

0.22

177

Postpartum haemorrhage due to anatomy

653

0.90

0.31

2.1

2.9

1.15

1.20

mg/l

0.25

629

Chronic diseases of tonsils and adenoids

1127

6977

1.02

0.30

5.0

4.8

1.33

1.44

mg/l

5.84

1050

6524

Transient synovitis

1.32

0.30

36.4

8.3

1.24

1.17

mg/l

0.10

Gonarthrosis, primary, with knee surgery

612

4853

1.03

0.30

2.5

2.8

1.72

1.66

mg/l

0.89

537

4376

Nontoxic single thyroid nodule

553

1.11

0.30

3.3

3.2

1.60

1.50

mg/l

0.37

515

Melanoma in situ of upper limb, including shoulder

1.26

0.29

10.1

2.1

2.41

1.66

mg/l

—

Adenocarcinoma and papillary adenocarcinoma of stomach, excluding all cancers (controls excluding all cancers)

163

0.80

0.29

3.2

2.4

2.12

1.70

mg/l

0.45

141

Benign neoplasm: Bronchus and lung

107

0.74

0.29

1.5

2.9

1.43

1.60

mg/l

—

Other abortion

1.23

0.29

3.7

2.3

2.14

1.34

mg/l

—

Convergence insufficiency and excess

110

0.72

0.29

2.5

4.2

1.08

1.26

mg/l

—

102

Artificial joint re-operation

535

1.11

0.29

2.6

2.8

1.64

1.69

mg/l

0.21

482

Supervision of high-risk pregnancy

187

1071

1.06

0.29

3.0

3.5

1.21

1.31

mg/l

2.00

177

1009

Exposure to other and unspecified inanimate mechanical forces

708

1.09

0.29

6.9

6.1

1.61

1.38

mg/l

1.12

662

Brachial plexus disorders

785

1.08

0.28

2.6

3.2

1.34

1.37

mg/l

0.12

737

Lumbar disc prolapse

758

6176

0.97

0.28

2.8

3.0

1.53

1.52

mg/l

0.06

692

5697

Open wound of neck

1.33

0.28

2.8

3.5

1.58

1.40

mg/l

—

Causalgia

129

0.77

0.28

3.6

2.9

1.68

1.45

mg/l

—

117

Twin gestation

690

0.91

0.28

3.3

3.2

1.35

1.33

mg/l

0.11

653

Acute myringitis

1.26

0.27

10.4

8.1

1.38

1.25

mg/l

—

Sixth [abducent] nerve palsy

280

1.15

0.27

6.3

4.5

1.70

1.62

mg/l

0.24

255

Chondropathies

165

1564

1.06

0.27

6.3

4.0

1.31

1.43

mg/l

1.62

149

1463

Recurrent dislocation and subluxation of joint

614

1.09

0.27

3.0

3.4

1.33

1.30

mg/l

0.14

578

Retained placenta and membranes, without haemorrhage

968

0.93

0.27

2.7

2.9

1.35

1.42

mg/l

0.37

908

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

113

1.25

0.27

3.4

5.6

1.63

1.33

mg/l

0.62

107

Adenocarcinoma and papilloma adenocarcinoma of rectum

780

0.92

0.26

2.6

2.9

1.84

1.69

mg/l

0.66

696

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

303

3145

0.96

0.26

3.4

4.3

1.35

1.39

mg/l

0.44

274

2942

Other and unspecified injuries of abdomen, lower back and pelvis

132

1.22

0.26

3.3

2.9

1.81

1.43

mg/l

1.19

119

Burns and corrosions

160

1521

1.05

0.25

4.2

6.0

1.47

1.40

mg/l

0.63

150

1428

Kela-code for severe mental illness

428

4153

1.03

0.25

3.0

3.1

1.51

1.45

mg/l

0.84

386

3854

Dislocation, sprain and strain of joints and ligaments of head

397

1.11

0.25

10.6

9.0

1.45

1.30

mg/l

0.47

374

Chondrocostal junction syndrome [Tietze]

283

1.13

0.24

3.3

1.33

1.50

mg/l

0.75

261

Thyrotoxicosis with diffuse goitre

120

1132

1.06

0.24

2.5

3.3

1.56

1.45

mg/l

0.71

113

1055

Phlebitis and thrombophlebitis of lower extremities, unspecified, drug-induced

1.29

0.24

5.1

2.3

2.19

1.55

mg/l

—

Benign neoplasm: Short bones of lower limb

0.71

0.24

6.2

3.2

2.24

1.49

mg/l

—

Nontoxic diffuse goitre

227

1.15

0.24

2.3

2.7

1.82

1.51

mg/l

0.58

206

Contact with nonpowered hand tool

427

1.10

0.24

3.4

3.2

1.47

1.50

mg/l

0.15

396

Assault by bodily force

745

1.08

0.24

3.5

3.8

1.46

1.32

mg/l

0.86

706

Typhoid and paratyphoid fevers

1.36

0.24

1.4

2.6

1.43

1.46

mg/l

—

Hypersensitivity pneumonitis due to organic dust

134

1.20

0.23

9.1

3.0

1.74

1.64

mg/l

0.13

123

Ménière disease

786

1.07

0.22

2.3

2.9

1.40

1.61

mg/l

2.32

709

Exophthalmic conditions

1.27

0.22

3.2

2.4

1.61

1.51

mg/l

—

Lumbosacral root disorders, not elsewhere classified

0.73

0.22

3.4

2.9

1.67

1.56

mg/l

—

Rotator cuff syndrome

709

5379

0.98

0.22

2.8

2.9

1.58

1.55

mg/l

0.34

645

4930

Miliaria rubra

0.00

0.22

0.0

9.3

—

1.71

—

Sequelae of injuries of upper limb

923

1.06

0.22

2.3

3.5

1.54

1.47

mg/l

0.35

865

Other sex chromosome abnormalities, female phenotype, not elsewhere classified

0.00

0.22

0.0

14.9

—

1.43

—

Hereditary angioödema type 1

0.00

0.22

0.0

2.3

—

1.45

—

Explosion and rupture of other specified pressurized devices

0.00

0.21

0.0

1.7

—

1.16

—

Traumatic subcutaneous emphysema

0.00

0.21

0.0

3.2

—

2.17

—

Other intervertebral disc disorders

1048

6526

0.98

0.21

2.8

3.0

1.56

1.52

mg/l

0.69

950

6014

Exposure to electric transmission lines

0.00

0.21

0.0

2.7

—

1.41

—

Pedal cyclist injured in other and unspecified transport accidents

114

1080

1.06

0.21

4.0

4.4

1.32

1.46

mg/l

1.33

102

1005

Other birth injuries

0.00

0.21

0.0

16.1

—

1.17

—

Benign neoplasm of ovary

142

1354

1.05

0.21

2.9

1.47

1.52

mg/l

0.34

131

1240

Other and unspecified hypertrophic disorders of skin

1.17

0.21

9.4

2.2

1.65

1.43

mg/l

—

Malignant neoplasm of heart, mediastinum and pleura

1.24

0.21

13.3

3.7

1.07

1.78

mg/l

2.77

Maze procedure for atrial fibrillation

1.26

0.20

1.7

2.2

2.13

1.60

mg/l

—

Optic neuritis

316

1.11

0.20

2.8

3.2

1.61

1.38

mg/l

0.76

294

Dementia in Alzheimer disease

124

1114

0.95

0.20

2.4

1.84

1.91

mg/l

0.37

959

Exposure to other and unspecified animate mechanical forces

278

1.12

0.20

3.0

7.9

1.63

1.34

mg/l

1.01

262

Unspecified lump in breast

128

1219

1.05

0.20

2.7

2.8

1.44

1.46

mg/l

0.16

119

1119

Premature separation of placenta [abruptio placentae]

155

0.84

0.20

2.8

3.2

1.17

1.31

mg/l

0.67

149

Colorectal cancer

218

2104

1.04

0.19

3.0

2.7

1.84

1.70

mg/l

1.29

196

1878

Benign neoplasm of breast

899

1.06

0.19

3.0

1.42

1.48

mg/l

0.38

827

Chronic conjunctivitis

308

1.11

0.19

7.3

7.4

1.53

1.36

mg/l

0.49

288

Pollen allergy

241

2307

1.03

0.19

4.2

8.7

1.19

1.23

mg/l

0.43

228

2220

Fetus and newborn affected by complications of placenta, cord and membranes

1.26

0.19

9.7

22.3

1.00

1.13

mg/l

—

Pemphigus

1.16

0.19

11.0

2.2

2.40

1.46

mg/l

—

Fetus and newborn affected by noxious influences transmitted via placenta or breast milk

1.19

0.19

31.9

30.1

1.16

1.01

mg/l

—

Habitual aborter

118

1.19

0.19

3.6

2.6

1.33

1.19

mg/l

0.40

113

Other congenital malformations of upper alimentary tract

1.24

0.19

36.2

9.2

1.35

1.40

mg/l

—

Female genital prolapse

269

1504

1.03

0.19

2.8

2.9

1.43

1.50

mg/l

0.93

233

1379

Tinnitus

234

2264

1.03

0.19

3.6

3.0

1.40

1.54

mg/l

2.41

214

2085

L02BA Anti-estrogens

122

1278

0.95

0.19

3.2

2.8

1.24

1.50

mg/l

5.49

110

1177

Dissocial personality disorder

156

1.16

0.18

2.7

3.2

1.80

1.36

mg/l

0.78

149

Contusion of ankle

386

1.09

0.18

5.6

5.5

1.83

1.33

mg/l

1.06

361

Unspecified threat to breathing

100

1.21

0.18

4.0

8.3

1.29

1.23

mg/l

0.15

Ectopic pregnancy

134

1399

0.96

0.18

2.8

2.9

1.49

1.39

mg/l

0.59

126

1304

Other hammer toe(s) (acquired)

144

1295

1.04

0.18

2.9

2.6

1.65

1.54

mg/l

0.97

132

1164

Preparation and fitting of bite rail to mouth

131

1255

1.04

0.17

4.8

3.6

1.28

1.43

mg/l

1.75

121

1181

Other abnormal products of conception

284

1838

1.03

0.17

2.7

3.1

1.22

1.30

mg/l

1.23

266

1737

Drug-induced tremor

1.13

0.17

2.1

4.2

1.34

1.51

mg/l

—

Trichomoniasis

1.13

0.17

5.1

2.9

2.08

1.48

mg/l

—

Fatigue fracture of vertebra

0.76

0.17

2.8

11.6

1.31

1.37

mg/l

—

Congenital malformations of eyelid, lacrimal apparatus and orbit

167

1.15

0.17

13.3

17.8

1.08

1.14

mg/l

0.40

162

Cervical disc disorders

413

4038

1.02

0.17

2.5

3.0

1.51

1.57

mg/l

0.78

368

3710

Fetus and newborn affected by maternal factors and by complications of pregnancy, labour and delivery

528

1.07

0.17

18.6

22.1

1.07

1.05

mg/l

0.16

522

0.73

0.17

3.2

2.7

1.85

1.44

mg/l

—

Algoneurodystrophy

253

1.11

0.17

2.8

3.3

1.21

1.42

mg/l

1.51

234

Acute alcohol intoxication ICD-9

288

0.90

0.16

3.8

3.0

1.63

mg/l

0.01

263

Seropositive rheumatoid arthritis, strict definition

126

1311

0.96

0.15

2.4

2.9

1.64

1.55

mg/l

0.62

112

1200

Other demyelinating diseases of the central nervous system

297

0.91

0.15

1.9

3.4

1.26

1.38

mg/l

0.46

277

Mesothelioma, excluding all cancers (controls excluding all cancers)

1.21

0.15

12.3

3.2

1.74

1.73

mg/l

—

Malignant neoplasm of breast

447

3160

1.02

0.15

2.5

2.9

1.41

1.53

mg/l

2.72

394

2891

Organic, including symptomatic, mental disorders

502

3555

1.02

0.15

2.7

2.8

1.80

1.73

mg/l

0.85

436

3181

Prolapse and hernia of ovary and fallopian tube

232

0.89

0.15

2.6

2.4

1.61

1.77

mg/l

0.33

203

Exclusion endpoint for supernumerary teeth

188

1.12

0.15

10.7

14.7

1.17

1.16

mg/l

0.03

182

Contracture of joint

0.78

0.14

2.3

2.5

1.17

1.44

mg/l

—

Effects of foreign body entering through natural orifice

299

2921

1.02

0.14

5.1

4.9

1.45

mg/l

0.05

280

2716

Hypertrophy of breast in women and men

163

1683

0.97

0.14

3.4

3.2

1.46

1.42

mg/l

0.27

155

1573

Alzheimer disease, excluding more controls

142

982

0.96

0.14

2.4

2.6

1.75

mg/l

0.01

110

861

Dislocation, sprain and strain of joints and ligaments at neck level

147

1421

1.04

0.14

2.6

3.9

1.37

mg/l

0.01

140

1339

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

392

1.07

0.14

2.0

3.1

1.43

1.52

mg/l

0.35

365

Malignant neoplasm of breast, HER-positive

273

2756

0.98

0.14

2.5

2.8

1.38

1.55

mg/l

3.67

242

2504

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

724

1.05

0.14

3.1

3.4

1.33

1.31

mg/l

0.08

681

Vascular dementia (mixed)

0.83

0.14

1.6

2.2

2.28

2.13

mg/l

—

Secondary malignant neoplasm of other and unspecified sites

100

0.80

0.13

1.4

2.8

1.42

1.71

mg/l

—

Peritonsillar abscess

222

2277

0.97

0.13

3.0

3.5

1.35

1.44

mg/l

0.92

210

2137

Acute appendicitis, no complications

682

6708

1.01

0.13

3.5

3.3

1.45

mg/l

0.08

630

6227

Suggestive for eosinophilic asthma

805

1.04

0.12

3.1

1.52

1.57

mg/l

0.27

740

Other disorders of patella

163

1676

0.97

0.12

2.9

2.8

1.38

1.35

mg/l

0.18

152

1561

Sequelae of tuberculosis

116

0.86

0.12

2.5

2.2

2.13

2.01

mg/l

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

125

1211

1.03

0.11

2.8

3.0

1.51

1.52

mg/l

0.03

114

1120

Viral conjunctivitis

183

1.10

0.10

7.8

4.2

1.77

1.33

mg/l

0.62

169

Flat foot [pes planus] (acquired)

771

1.04

0.10

3.5

3.9

1.63

1.43

mg/l

1.10

713

Other specified and unspecified disorders of eyelid

106

1.14

0.10

3.6

2.5

1.41

1.62

mg/l

0.47

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

606

5889

1.01

0.09

3.1

4.1

1.35

1.42

mg/l

1.42

554

5470

Cleft lip, lip and palate or palate

176

0.91

0.09

10.2

10.4

1.44

1.24

mg/l

0.46

167

Malignant neoplasm of bronchus and lung

161

1471

1.02

0.09

2.8

2.7

1.48

1.81

mg/l

5.69

150

1303

Schizophrenia, schizotypal and delusional disorders

361

3557

1.02

0.09

3.2

3.1

1.52

1.43

mg/l

1.28

332

3315

Benign neoplasm: Retina

1.04

0.09

5.8

2.4

1.42

1.60

mg/l

—

Trochanteric bursitis

112

1089

1.03

0.09

2.8

1.51

mg/l

0.01

992

Cutis laxa senilis

1.09

0.09

2.5

2.6

1.15

1.45

mg/l

—

Patellar tendinitis

165

1.09

0.09

7.8

4.1

1.27

1.36

mg/l

0.29

154

Other disorders of peripheral nervous system

1.07

0.08

1.5

2.3

1.80

1.56

mg/l

—

Endometroid carcinoma of ovary, excluding all cancers (controls excluding all cancers)

1.05

0.08

1.2

2.9

1.33

1.69

mg/l

—

Contact with lifting and transmission devices, not elsewhere classified

175

0.91

0.08

2.9

3.4

1.38

1.49

mg/l

0.21

163

Neuroendocrine tumor and carcinoma of lung

1.04

0.08

3.8

2.4

1.41

1.55

mg/l

—

Injury of nerves at ankle and foot level

0.83

0.08

4.4

2.5

1.30

1.38

mg/l

—

TMD muscular pain linked with fibromyalgia

0.83

0.08

2.0

2.6

1.03

1.37

mg/l

—

Vascular dementia

558

1.04

0.08

1.7

2.5

1.98

1.93

mg/l

0.17

476

Melanocytic naevi of eyelid, including canthus

1.10

0.08

3.3

2.0

1.47

1.55

mg/l

—

Follicular adenocarcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)

1.10

0.08

2.9

3.9

1.68

1.52

mg/l

—

Benign neoplasm: Brain, infratentorial

1.08

0.08

8.3

9.5

1.11

1.39

mg/l

—

Fall on and from ladder

734

0.97

0.08

2.9

3.4

1.43

1.64

mg/l

1.65

667

Narcolepsy and cataplexy

1.08

0.08

4.6

3.3

1.48

1.34

mg/l

—

Thyroiditis, unspecified

123

0.89

0.08

2.5

3.5

1.35

1.46

mg/l

0.36

113

Subarachnoid haemorrhage

865

0.97

0.08

3.7

3.0

1.77

1.60

mg/l

0.91

773

Idiopathic urticaria

166

1.09

0.08

6.0

4.0

1.25

1.37

mg/l

0.55

154

Foreign body in genitourinary tract

0.83

0.07

1.5

3.6

1.10

1.47

mg/l

—

Calcific tendinitis

0.82

0.07

3.0

2.6

1.28

1.53

mg/l

—

Maternal care for known or suspected malpresentation of fetus

150

1095

1.02

0.07

2.9

3.2

1.17

1.29

mg/l

1.50

143

1025

Hereditary motor and sensory neuropathy

0.81

0.07

4.8

4.6

1.37

1.54

mg/l

—

Osteomalacia

1.08

0.07

2.8

2.5

1.74

1.44

mg/l

—

Pregnancy examination and test

133

812

1.02

0.07

2.5

3.5

1.18

1.27

mg/l

1.16

127

759

Schizoaffective disorder

698

1.03

0.07

2.6

3.1

1.51

1.38

mg/l

0.68

657

Other diseases caused by chlamydiae

1.04

0.07

8.9

3.1

1.89

1.38

mg/l

—

Evidence of alcohol involvement determined by level of intoxication

0.87

0.07

2.6

3.5

1.25

1.35

mg/l

—

Benign lipomatous neoplasm of other sites/unspecified

732

0.97

0.07

2.8

2.9

1.62

mg/l

0.01

660

Panniculitis, unspecified

1.07

0.07

8.1

3.0

2.06

1.50

mg/l

—

Malignant neoplasm of breast, HER2-negative

431

3134

1.01

0.07

2.4

2.9

1.41

1.53

mg/l

2.89

380

2867

Burns and corrosions of multiple body regions

0.87

0.07

2.0

5.0

1.65

1.43

mg/l

—

Fasciculation

0.88

0.07

3.6

3.2

1.48

1.44

mg/l

—

Malignant neoplasm of other and ill-defined digestive organs, excluding all cancers (controls excluding all cancers)

0.87

0.07

4.8

2.4

1.97

1.68

mg/l

—

Malignant neoplasm of breast, HER-negative

158

1606

0.98

0.06

2.2

2.8

1.47

1.59

mg/l

1.25

138

1458

Dystonia

463

1.04

0.06

2.8

4.2

1.46

1.47

mg/l

0.02

436

Cervicalgia

205

2022

1.01

0.06

2.5

3.1

1.62

1.52

mg/l

0.78

184

1858

Injury of muscle and tendon at forearm level

172

0.93

0.06

4.3

4.0

1.83

1.44

mg/l

0.90

160

Polypectomy (DHB20)

638

0.97

0.06

3.0

2.9

1.55

1.56

mg/l

0.03

589

Cervicocranial syndrome

100

979

1.02

0.06

2.7

3.2

1.60

1.53

mg/l

0.39

902

Congenital musculoskeletal deformities of head, face, spine and chest

178

1.07

0.05

12.8

13.6

1.44

1.16

mg/l

0.73

170

Crushed, pushed or stepped on by crowd or human stampede

799

0.98

0.05

3.2

7.1

1.25

1.28

mg/l

0.12

753

Allergic rhinitis

378

3777

0.99

0.05

4.3

6.5

1.26

1.29

mg/l

0.38

356

3579

Primary gonarthrosis, bilateral

526

4635

0.99

0.05

2.5

2.8

1.78

1.65

mg/l

2.33

466

4193

Allergic conjunctivitis

643

6287

1.01

0.05

3.5

4.2

1.35

1.42

mg/l

1.30

587

5852

Mixed disorders of conduct and emotions

287

1.05

0.05

12.9

13.6

1.47

1.11

mg/l

1.68

275

Shoulder region

110

1.09

0.05

4.4

4.1

2.03

1.52

mg/l

0.79

Mixed conductive and sensorineural hearing loss

103

1049

0.98

0.05

4.9

3.4

1.58

1.62

mg/l

0.21

958

Ankylosing spondylitis, strict definition

416

1.03

0.05

2.8

2.9

1.27

1.37

mg/l

0.67

390

Systemic atrophies primarily affecting the central nervous system

357

1.04

0.04

6.9

5.4

1.57

1.64

mg/l

0.17

326

Ganglion

203

2053

0.99

0.04

3.6

3.1

1.39

1.43

mg/l

0.31

189

1895

Motorcycle rider injured in other and unspecified transport accidents

625

1.02

0.04

3.1

4.3

1.32

1.35

mg/l

0.12

591

Malignant neoplasm of rectum

784

1.02

0.04

2.4

2.9

1.81

1.69

mg/l

0.58

698

Vasomotor and allergic rhinitis

468

4581

1.01

0.04

4.1

5.5

1.32

1.38

mg/l

1.01

440

4305

Dependent personality disorder

170

1.06

0.04

2.6

3.2

1.85

1.56

mg/l

0.46

160

Benign neoplasm: Cranial nerves

230

1.04

0.03

5.5

3.6

1.58

1.61

mg/l

0.06

208

Gastrointestinal stromal tumor and sarcoma

1.09

0.03

2.4

1.34

1.65

mg/l

—

Carpal tunnel syndrome

672

6043

1.00

0.02

2.9

1.68

1.52

mg/l

5.03

614

5541

Deviated nasal septum

398

3958

1.00

0.02

2.8

3.2

1.49

1.56

mg/l

1.03

366

3655

Schizophrenia or delusion

356

3542

1.01

0.02

3.2

3.1

1.51

1.43

mg/l

1.10

327

3302

Epiphora

168

0.95

0.02

1.9

3.6

1.23

1.67

mg/l

2.12

150

Hallux valgus (acquired)

318

2289

1.01

0.02

2.8

2.7

1.52

1.47

mg/l

0.44

288

2091

Burn and corrosion of head and neck

208

0.96

0.02

3.7

4.4

1.26

1.38

mg/l

0.68

193

Use of disulfiram, acamprosate or naltrexone

920

1.01

0.02

3.0

3.1

1.41

1.47

mg/l

0.31

863

Other menopausal disorders

239

1385

0.99

0.02

2.2

3.0

1.27

1.48

mg/l

5.10

226

1278

Nonspecific lymphadenitis

512

1.02

0.01

8.4

3.8

1.40

1.37

mg/l

0.12

476

Serous carcinoma of ovary, excluding all cancers (controls excluding all cancers)

197

0.96

0.01

5.3

3.3

1.37

1.55

mg/l

0.82

182

Benign lipomatous neoplasm

297

2959

1.00

0.01

3.0

1.55

1.56

mg/l

0.03

277

2713

Other degenerative diseases of the nervous system

251

1911

1.00

0.01

2.4

2.7

1.64

1.57

mg/l

0.52

209

1730

Other enthesopathies

312

3109

1.00

0.01

2.8

3.1

1.49

1.47

mg/l

0.16

283

2853

Muscle strain

277

0.97

0.01

6.9

3.9

1.51

1.43

mg/l

0.20

260

Fenamates

196

1328

1.00

0.01

2.4

4.1

1.37

1.72

mg/l

9.45

179

1226

Family history of other specific disorders

1.07

0.01

8.1

4.1

1.27

1.30

mg/l

—

Cleft palate

114

1.05

0.00

7.2

10.2

1.18

1.23

mg/l

0.13

108

Asymmetry of jaw

136

0.95

0.00

5.2

5.5

1.21

1.34

mg/l

0.35

125

malignant neoplasm of male genital organs

480

3042

1.00

0.00

2.7

2.9

1.81

1.74

mg/l

0.93

431

2739

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

686

0.99

0.00

3.0

3.2

1.50

1.55

mg/l

0.24

637

Postpartum care and examination

113

717

1.01

0.00

3.6

3.3

1.28

1.27

mg/l

0.03

108

668

Nontoxic goitre/thyroid nodule

262

2616

1.00

0.00

3.0

2.9

1.68

1.58

mg/l

0.97

232

2365

Radial styloid tenosynovitis [de Quervain]

415

1.01

0.00

2.9

1.56

1.38

mg/l

0.68

391

Puerperal sepsis

100

1002

1.00

0.00

3.2

3.0

1.47

1.44

mg/l

0.17

938

Sequelae of injuries of head

515

1.01

0.00

2.4

3.2

1.31

1.50

mg/l

1.62

483

Malignant neoplasm of corpus uteri

549

1.00

0.00

2.6

1.69

1.64

mg/l

0.15

494

Synovial cyst of popliteal space [Baker]

599

1.00

0.00

2.4

3.2

1.70

1.59

mg/l

0.39

544

Assault by blunt object

136

1.03

0.00

3.4

3.7

1.55

1.33

mg/l

0.61

127

Chronic crepitant synovitis/bursitis of hand and wrist/periarthritis of wrist

113

0.97

0.00

2.7

2.8

1.77

1.56

mg/l

0.29

102

Mesothelioma

1.02

0.00

12.3

3.7

1.74

1.79

mg/l

—

Injury of muscle and tendon at wrist and hand level

141

1406

1.00

0.00

3.2

3.4

1.38

1.50

mg/l

1.57

133

1316

Colorectal adenocarcinoma

173

1733

1.00

0.00

2.7

1.88

1.72

mg/l

1.38

155

1545

Mesial bite

117

1.03

0.00

9.8

11.5

1.08

1.20

mg/l

0.56

109

Motorcycle rider injured in noncollision transport accidents

305

0.98

0.00

3.1

4.5

1.55

1.35

mg/l

0.56

286

Malignant neoplasm of ovary

315

0.98

0.00

4.8

3.1

1.51

1.53

mg/l

0.05

291

Carcinoma in situ, other and unspecified urinary organs

0.00

0.0

2.4

—

2.11

—

Melanoma in situ of eyelid, including canthus

0.00

0.0

6.4

—

2.52

—

Other protozoal diseases, not elsewhere classified/unspecified

0.00

0.0

2.6

—

1.31

—

Accident to watercraft causing other injury

0.00

0.0

4.6

—

1.22

—

Drug-induced tics and other tics of organic origin

0.00

0.0

12.5

—

1.27

—

Previous suicide attempt

0.90

0.00

1.3

5.9

1.56

1.28

mg/l

—

Sequelae of other accidents

110

1.00

0.00

1.6

3.0

1.13

1.51

mg/l

2.58

Endometroid carcinoma of ovary

1.00

0.00

1.2

2.8

1.33

1.68

mg/l

—

Anaphylactic shock due to adverse effect of correct drug or medication properly administered

0.99

0.00

8.6

2.1

1.70

1.36

mg/l

—

Other congenital malformations of integument

0.00

0.0

26.3

—

0.96

—

Lymphocyte function antigen-1 [LFA-1] defect

0.00

0.0

3.1

—

2.44

—

Other acute disseminated demyelination

0.99

0.00

4.7

3.3

1.26

1.38

mg/l

—

Carcinoma in situ of breast, lobular

1.00

0.00

4.2

2.5

1.91

1.48

mg/l

—

Androgen resistance syndrome

0.00

0.0

12.8

—

0.90

—

Congenital and developmental myasthenia

0.00

0.0

18.2

—

1.35

—

Melanocytic naevi of eyelid, including canthus

0.93

0.00

3.3

2.1

1.47

1.54

mg/l

—

Operations for atrial fibrillation

130

1.00

0.00

2.6

3.0

2.12

1.69

mg/l

0.64

117

Lesion of femoral nerve

0.89

0.00

1.4

2.6

1.00

1.55

mg/l

—

Benign neoplasm: Short bones of lower limb

0.92

0.00

6.2

3.3

2.24

1.45

mg/l

—

Osteolysis

0.00

0.0

1.6

—

1.36

—

Benign neoplasm: Bronchus and lung

0.92

0.00

1.5

2.3

1.43

1.61

mg/l

—

Drowning and submersion, undetermined intent

0.00

0.0

1.6

—

1.02

—

Carcinoma in situ of other/unspecified digestive organs

0.00

0.0

2.6

—

2.01

—

Obstetric and gynaecological devices associated with adverse incidents

0.00

0.0

1.6

—

1.03

—

Total (external) ophthalmoplegia

0.00

0.0

2.0

—

1.64

—

Carcinoma in situ of lip, excluding all cancers

0.00

0.0

2.6

—

2.12

—

Multiple superficial injuries of ankle and foot

0.00

0.0

2.9

—

0.95

—

Flexion deformity

0.00

0.0

3.3

—

1.39

—

Retained (old) foreign body following penetrating wound of orbit

0.00

0.0

2.0

—

1.49

—

Other and unspecified disorders of refraction

0.00

0.0

3.0

—

2.20

—

Pedal cyclist injured in collision with pedestrian or animal

0.97

0.00

4.3

2.8

1.34

1.39

mg/l

—

Caries in Clefts patients

0.96

0.00

14.8

9.6

1.39

1.16

mg/l

—

Migraine without aura, drug-induced

1.00

0.00

4.0

2.4

1.47

1.40

mg/l

—

Benign neoplasm: Urethra

0.00

0.0

1.2

—

1.24

—

Migraine with aura, drug-induced

0.98

0.00

7.4

2.4

1.65

1.46

mg/l

—

Alcoholic myopathy

0.00

0.0

2.6

—

1.32

—

Exposure to other and unspecified forces of nature

0.91

0.00

5.0

5.3

2.04

1.49

mg/l

—

Other intestinal obstruction of newborn

0.00

0.0

43.1

—

1.07

—

Pedestrian injured in collision with railway train or railway vehicle

0.00

0.0

2.8

—

1.02

—

Defects in glycoprotein degradation

0.00

0.0

10.0

—

0.95

—

Accident to powered aircraft causing injury to occupant

0.00

0.0

3.0

—

2.04

—

Transitory neonatal disorders of calcium and magnesium metabolism

0.00

0.0

38.2

—

0.87

—

Unspecified drowning and submersion

0.00

0.0

3.4

—

2.06

—

Other specified and unspecified disorders of conjunctiva

0.97

0.00

9.4

3.4

1.99

1.44

mg/l

—

Malignant neoplasm of placenta, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.4

—

1.32

—

Infantile papular acrodermatitis [Gianotti-Crosti]

0.00

0.0

6.4

—

1.05

—

Carcinoma in situ, other/unspecified

0.00

0.0

1.4

—

1.53

—

Handgun discharge

0.00

-0.00

0.0

2.3

—

1.39

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Cystatin C [Mass/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS